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ABSTRACT 
 
The anterior cruciate ligament (ACL) is one of the most frequently injured ligaments 
of the knee. It provides joint stability by constraining anterior tibial translations or 
internal rotations. This ligament suffers from one of the highest injury rates and, due 
to the fact that it has very poor healing properties, in many cases requires surgery to 
be reconstructed. Nowadays the “gold standard” for surgical intervention is to 
reconstruct the ACL from autografts, but this procedure generates problems such as 
muscle weakness related to the donor site, or graft site morbidity, therefore other 
grafts solutions should be investigated. The aim of this thesis was to design, 
manufacture and test tissue engineered prototypes that could be used for surgical 
reconstruction of the ACL with comparable mechanical behaviour and nano and 
micro morphology to the native ACL. The in vivo mechanical behaviour of the ACL 
was investigated during a range of daily activities to understand its failure 
mechanisms and obtain the mechanical specifications to design and assess the new 
ACL prototypes. Currently, solely mechanical properties such as Young’s modulus 
or ultimate tensile strength are used to determine the suitability of an ACL implant, 
however, the work for this thesis has shown that other aspects including dynamic 
loading and shear loading are crucial for accurately replicating the in vivo 
mechanical behaviour of the ACL. Electrospinning was shown to offer great 
potential for manufacturing ACL implants with scaffolds of fibre diameter and 
orientation mimicking the collagen fibres in the extracellular matrix (ECM) of the 
native ACL. These biomimetic scaffolds can promote cell growth and would enhance 
mechanical properties. The suitability of two different polymers (a natural polymer: 
gelatin and a synthetic polymer: polyvinyl alcohol, PVA) were tested as potential 
ACL scaffolds: morphologically, topographically, mechanically and chemically 
through degradation assays. The optimisation of solution and process parameters was 
essential with the aim of creating scaffolds with mechanical properties and 
morphologies comparable to the native ACL, all crucial aspects that were missing 
from the current literature in this field. To date most of the experiments with 
electrospinning were manufactured 2D scaffolds, which does not represent the real 
three dimensional structure of the ACL. Only four researchers have worked on 
creating 3D structures from 2D electrospun scaffolds. However, none of them 
managed to produce morphology nor mechanical behaviour mimicking the natural 
ACL. Moreover, no comparison of 2D and multiple different 3D structures was 
performed before the work in this thesis. This PhD establishes the fundamentals for 
designing and manufacturing biomimetic ACL prototypes, which could be used as a 
baseline for cell testing, animal models and at the final stage clinical trials.  
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1. Introduction 
 
The anterior cruciate ligament (ACL) has the highest injury rates [1] in 
comparison to the rest of the knee ligaments, offering 49% of these injuries [2]. 
Ligament injuries are among the most common health problem affecting in the 
majority of the cases both recreational and professional athletes [2]. However, 
victims of accidents such as motor vehicle accidents may also injure their ACL [2]. It 
is estimated that athletes are 7 times more likely to sustain ACL injuries in 
competition than in practice [3], and 78% of the ACL ruptures occur during non-
contact mechanisms such as landing, jumping, side and crossover cutting or pivoting 
[3], [4]. Athletic ACL injuries are increasing in both adult and youth athletes [5]–[7]. 
Among those of high school-aged, 60% of high school sport-related surgeries are 
associated with knee injuries and 50% of these knee injuries are related to ACL 
ruptures [3]. High rates of knee injuries are reported in female athletes [3], [8]–[16], 
being between 4 to 6 times more likely to sustain ACL injuries than male athletes 
[4], [17]; this fact is attributed to anatomical, environmental, hormonal, 
neuromuscular and biomechanical differences between gender [3], [8], [9], [12], 
[18]. 
 
 According to a study performed in 100 United States high schools which 
reported ACL injuries during 9 different sports and within the 2007/08 – 2011/12 
academic years, 77% of all ACL injuries required surgery [3]. In the United 
Kingdom, the NHS (National Health System) performs approximately 11,000 ACL 
reconstructions every year, with failure rates up to 25%, which can lead to further 
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surgery and long-term issues [2], [19], [20]. ACL injuries are among the most 
economically costly sport injuries, frequently requiring expensive surgery and 
rehabilitation [3]. The cost of an ACL reconstruction in the UK varies from private 
hospitals being an average £6,000 per surgery [21], to NHS hospitals being between 
£3,000 and £3,500 per surgery [19]. In the United States more than 200,000 patients 
are diagnosed with ACL ruptures every year, of which 175,000 cases require surgery, 
with the cost of surgery estimated at $1 billion annually [22]. ACL reconstructions 
performed in the United States between 1990 and 2007 have been analysed in two 
main studies [23], [24]. Both studies concluded that the rate of ACL reconstructions 
increased dramatically by 37% across this time period between 1994 and 2006 [24]. 
This increase was seen across all age groups, but specifically in those aged between 
15 and 34 years old and the proportion of females undergoing ACL reconstruction 
increased by up to 47% [24]. Moreover, subsequent knee surgery was necessary in 
6.5% of the cases within 1 year after the ACL replacement [23] and 20% of the 
patients suffered re-injury within 2 years after the surgery [5].  
 
The use of autografts (grafts from the patient’s own body) are currently 
considered the “gold standard” in ACL surgery. However, this technique is 
associated with muscle weakness at the donor site, graft site morbidity, knee pain, 
infection, loss of sensitivity due to nerve damage and long operation and 
rehabilitation time [22], [25]. Allografts (grafts from a cadaver) and xenografts 
(tissue taken from an animal) have issues related with the possibility of transmitting 
diseases, risk of immunological response and the sterilization process [26], [27]. 
Synthetic ligaments have been also considered for ACL reconstruction but their main 
disadvantage is their poor long-term behaviour, due to fatigue of the material, laxity 
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and subsequent mechanical failure [28]. The use of tissue-engineered ACL implants 
is well received among British Orthopaedic Surgeons, where 86% of surgeons 
surveyed said they would consider the implantation of a tissue-engineered ACL 
implant if it showed biological and mechanical success, providing it significantly 
improved the patient satisfaction or shortened surgical time [29]. Moreover, 76% of 
surgeons felt that using tissue-engineered ACL implants would be more appropriate 
than autografts, due to less scarring at the donor site and a reduction in operative 
time [29].  
   
 All these statistics lead to the conclusion: 
  
 
This chapter provides the background necessary to analyse the current 
problem and determine the characteristics that an ACL implant has to possess to 
improve its performance and behave like the natural ACL. To this end, the anatomy 
of the knee and ACL, the mechanical function of the ACL and ACL loading, ACL 
Key Points: 
1. ACL injuries are increasing dramatically at all ages and especially among 
females. 
2. Current treatments for ACL injuries exhibit high failure rate, which causes issues 
in the quality of life of the patient and unnecessary extra costs.  
3. Other alternatives to the current treatments offering potential benefits should be 
studied. 
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injury mechanics, current ACL implants, manufacturing process and potential 
materials used to create ACL implants were studied. The important and relevant key 
points of all of these aspects cited above are explained. Moreover, the research 
questions of this thesis are included at the end of the present chapter. 
 
 
 
Literature review 
 
1.1. ANATOMY OF THE KNEE AND THE ACL 
 
Importance: 
1. The study of the anatomy of the knee aids understanding of where the ACL is 
located, its insertion sites, its environment and gives information about its function in 
the knee. 
2. Knowing the environment of the ACL is crucial in understanding its healing 
problem, designing mechanical tests with similar environments and so designing 
ligament implants that can bear loads comparable to the ones that the natural ACL 
has to bear.  
3. The study of the anatomy of the ACL is important in order to know the dimensions 
of the ligament, the materials that constitute the ACL and its structure. Hence 
allowing the mimicking of the dimension, the structure and to enable use of materials 
with similar mechanical properties as the ACL in new ligament implants.  
 
Chapter 1. Introduction and Literature Review 
 
 
30 
 
 
 
The knee joint is one of the largest and most important joints in the human 
body. It consists of four bones (femur, tibia, patella and fibula); four major ligaments 
(anterior cruciate ligament, posterior cruciate ligament, medial collateral ligament 
and lateral collateral ligament); tendons; muscles around the joint; cartilaginous 
tissue in the medial and lateral meniscus and in the articular cartilage; and a joint 
capsule with synovial liquid in it. Figure 1.1 shows the components of the knee joint 
and their location. 
 
Figure 1.1Diagram of the knee joint A) Coronal plane B) Sagittal plane. Adapted from [30] 
 
The anterior cruciate ligament (ACL) plays a key role in the articular 
mechanics of the knee connecting the tibia (anterior part of the intercondylar region) 
with the femur (slightly posterior to the medial surface of the lateral condyle) [31], 
[32]. It also plays a vital role in the stability of the knee and its biomechanics [33], 
restraining the anterior tibial translation and limiting the internal tibial rotation. 
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The ACL is an intra-articular and extrasynovial structure, located in the 
intercondylar notch of the knee (Figure 1.1 B) and enveloped by the synovial 
membrane [34]. The ligaments can be classified as extra-articular and intra-articular 
depending on their location. A membrane known as epiligament surrounds the extra-
articular ligaments. This membrane contains cells, vascular irrigation and neural 
innervation; therefore, it can be considered to heal after an injury. The intra-articular 
ligaments are surrounded by synovial liquid; these type of ligaments have a low cell 
content, and poor vascularity and innervation, severely limiting their healing after an 
injury. [35] Figure 1.2 shows the difference between both ligaments. 
 
 
Figure 1.2 Ligament classification depending on location 
      
The ACL is an intra-articular ligament with an abundance of collagen bundles 
but low vascularity and cellular activity [36], [37]. Therefore, the capacity of the 
ACL to regenerate itself is low and after a serious injury where the tissue is 
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damaged, surgery involving the use of an appropriate graft is often required to 
replace the ligament [22].  
 
According to most authors who have studied the anatomy of the ACL, the 
ACL consists of two bundles of fibres (Figure 1.3): anteromedial (thinner) and 
posterolateral (main portion). These bundles, in turn, are made up multiple groups of 
fibres where each has a single origin and insertion point; they are not parallel, do not 
have the same length and therefore they are not under the same tension [16]. The 
hierarchical structure of ligaments and the components are explained in section 1.1.1. 
 
 
Figure 1.3 Anteromedial (AM) and posterolateral (PL) bundles of the ACL. Reproduced from [33] 
 
Following on with the macrostructure of the ACL, the anteromedial bundle 
(AM) is formed by the fibres inserted into the proximal part of the femur and into the 
anterior and medial part of the tibia (Figure 1.4). Fibres that go from the most distal 
portion of the femoral insertion and are inserted into the posterolateral portion of the 
tibial anchoring constitute the posterolateral bundle (PL) [38]. The AM bundle 
restrains the anterior–posterior translation of the knee, while the PL bundle restrains 
the rotation of the knee [38]. This behaviour can be observed in Figure 1.4. 
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Figure 1.4  AM and PL bundle behaviour at 0º and 90º of flexion. Reproduced from [39]. 
 
A key point in the design of new ACL implants is to obtain the average 
dimensions of the natural ACL in order to replicate those dimensions in future 
implants. Therefore, before explaining the micro and nano structure of the ACL, it is 
important to present the mean anatomical dimensions of the human ACL. These 
values are shown in Table 1.1. 
 
 
Table 1.1 Mean anatomical dimensions of the human ACL 
 
ACL length men (mm) 29 
[40] 
ACL length women (mm) 26.8 
Mean diameter of the ACL at 
mid-portion (mm) 
6.1 
[41] 
ACL cross-sectional area 
(mm2) 
29.2 
Tibial insertion site 
length/width (mm) 
13.4/11.1 
Femoral insertion site 
length/width (mm) 
13.1/9.1 
Tibial footprint area (mm2) 117.9 
Femoral footprint area (mm2) 96.8 
 
The next section (section 1.1.1.) explains the general structure and 
components of the ligaments, and presents some morphological values of the human 
ACL relevant to the design of ACL implants. 
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1.1.1. STRUCTURE AND COMPONENTS 
 
As an overview, ligaments are composed of dense bundles of collagen and 
elastin fibres that follow a specific hierarchy. This defines their mechanical 
behaviour and biological properties, since it offers elasticity, stiffness and an 
optimum environment for cell growth, proliferation, migration and differentiation 
[25], [42]. This hierarchical structure is shown in the figure below (Figure 1.5) and is 
explained through this section (section 1.1.1.). 
 
 
Figure 1.5 Hierarchical structure of the ligament. Reproduced from [38], [39] 
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Ligaments are mainly comprised of fibroblasts and extracellular matrix, 
which is composed of collagen, elastin and ground substance [25] as shown in Figure 
1.6.  
 
 
Figure 1.6 Composition of the ligament 
 
 
Fibroblasts are few in number in ligaments, with approximately only 20% of 
these biological structures being composed of cells [43]. However, they are 
extremely important because they are involved in renewing both the ground 
substance and collagen fibres [25]. 
 
The extracellular matrix constitutes the major part of ligament volume and 
provides tensile strength and elasticity. Water is the principal component in 
ligaments forming 65-75% of the total volume. Considering the dry weight of the 
ligament, collagen is present in approximately 75% with a ratio of 9:1 between 
collagen type I and collagen type III. Fibrous elastin is found in values of between 10 
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and 15% and acid mucopolysaccharides (such as hyaluronic acid or chondroitin 
sulphate) are present in approximately 1% of the ligaments dry weight [25], [43].  
 
- Collagen is a fibrous protein responsible for tensile strength and rigidity of 
the tissue. This protein has the property of self-assembly, and is presented organized 
at all levels, from microscopic to macroscopic. The collagen structural unit is  
tropocollagen, which comes from procollagen composed of three α polypeptide 
chains. Five tropocollagen molecules are joined to form the smallest ligament 
structural unit, the microfibril [25], [43]. The structure of the collagen is shown in 
Figures 1.5 and 1.7. 
 
 
Figure 1.7 Collagen composition. Reproduced from [42] 
 
 
Microfibrils are joined to form collagen fibrils. Fibrils are joined in bundles 
to create fibres adopting a crimped planar structure; when these fibres are subjected 
to a tensile loading they lose their crimped pattern to be oriented in the direction of 
the load.  These fibres are joined in bundles to establish collagen fascicles, and the 
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bundles of fascicles constitute the ligament (Figure 1.5.). The connective tissue, 
which surrounds the fascicles, is called the endoligament. This tissue carries blood 
vessels, lymph vessels and nerves to the ligament and through it. The outer surface of 
the ligament is covered by a highly cellular fibrous layer called the epiligament [25], 
[43].  
 
The diameter of collagen fibrils is 40-150 nm, the diameter of the fibres is 
between 1 and 20 µm and the fascicles have a diameter of 360 - 1500 µm in the 
natural human ACL [33], [44]–[47]. A SEM image of the fibres of collagen in the 
ACL is shown in Figure 1.8. 
 
 
Figure 1.8 Collagen fibres of a natural human ACL reproduced from [48] 
 
- Elastin is a stable and insoluble protein responsible for ligament elasticity. 
Although it is present in small quantities in ligaments, between 10% and 15% of the 
ligament dry weight, it is crucial to add elastic mechanical behaviour to the 
ligament’s properties [25], [43] i.e. allowing the ligament to recover its original 
shape after being deformed. 
 
-  Ground substance is an amorphous matrix that surrounds the cells and 
fibres. It is mainly constituted of glycosaminoglycan chains (hyaluronic acid, 
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chondroitin sulphate 4 and 6) covalently bounded to different kinds of proteoglycans. 
Proteoglycans are present in small quantities, varying according to ligament location 
and load conditions. They are large negatively charged hydrophilic molecules that 
can store 50 times their weight of water and provide the collagen fibrils with a high 
capacity to resist large compressive and tensile forces. The proteoglycans also enable 
rapid diffusion of water soluble molecules and migration of cells [42] and give the 
viscoelastic behaviour of this tissue. Other important proteins that contribute to 
ligament and enthesis (connective tissue between ligament and bone) formation are 
tenascin-C and sox-9 which play a role in collagen fibre alignment and orientation 
[49]. 
 
Several growth factors (such as IGF-1, TGF-β, bFGF or GDF-5, -6 and -7)  
are involved in the activation, regulation of cellular response (such as cell 
proliferation, extracellular matrix elaboration or neovascularization) and in the 
expression of specific genes (Col I, Col III, Tenascin-C or Sox-9) that serve as 
markers for the detection of new ligamentous tissue generation [50]. The 
development and healing of ligaments can be checked through analysing the 
presence of these genes with a polymerase chain reaction (PCR) technique. 
 
 
Key points: 
1. The ACL is an intra-articular ligament with poor healing properties; therefore, 
once it is injured it is necessary to perform an ACL replacement to recover the 
stability of the knee, demonstrating the necessity of use of ACL implants.  
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2. The ACL is located inside the synovial capsule and surround by synovial liquid; 
therefore, in order to test new ACL implants in a similar environment to the natural 
ACL, mechanical tests should be done in wet conditions. These experiments will be 
shown in Chapter 6.    
3. The ACL has an average length of 29 mm in males and 26.8 mm in females. These 
values will be used to validate the length of the ACL calculated in Chapter 3 and 
create scaffolds with similar dimensions in Chapters 4, 5 and 6.  
4. The ACL consists of collagen fibrils of 40-150 nm in diameter, fibres of 1 and 20 
µm in diameter and fascicles of 360-1500 µm in diameter. The structure of the ACL 
and dimensions will be replicated in the new ligament implants created in Chapter 6.   
5. The main material that constitutes the ACL is collagen. Chapter 4 will focus on 
manufacturing scaffolds to be used as ACL implants with gelatin, a cheap polymer 
derivate from collagen and with similar mechanical and biological properties.  
 
 
 
1.2. MECHANICAL BEHAVIOUR 
 
Importance: 
1. A ligament implant should ideally mimic the mechanical behaviour of the natural 
ligament, therefore its understanding and knowledge of its mechanical properties is 
crucial. 
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2. Different techniques are used to analyse the mechanical behaviour of the ACL. 
Knowing their limitations helps to determine the optimum approach to evaluate in 
vivo ACL forces and strain during daily and high impact activities.      
 
 
Ligaments consist of a range of different proteins, which give them a 
heterogeneous character. Due to the orientation and the crimped pattern of collagen 
fibres they exhibit anisotropic and non-linear behaviour.  
 
Specific aspects of mechanical behaviour and properties, such as elasticity, 
residual stress, creep, relaxation and hysteresis in ligaments will be explained in the 
next section 1.2.1.    
 
 
1.2.1. GENERAL MECHANICAL BEHAVIOUR OF LIGAMENTS 
 
1.2.1.1. Elastic properties 
 
Ligaments act like “a spring” storing the motion energy, and efficiently 
transferring the force to the bone with minimal loss of energy [25]. However, they 
also have viscoelastic behaviour and their stress-strain curve shows three different 
areas, as it can be observed in Figure 1.9.   
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Figure 1.9 Stress-strain curve for ligaments. Reproduced from [51] 
 
- Toe region corresponds to the physiological range where ligaments 
normally operate and where the elastic behaviour allows a deformation of 4% [25], 
[52]. This behaviour is due to the crimped nature of collagen fibres (Figure 1.9), 
since the crimp pattern of the fibres in this region are straightened in the direction of 
the applied load and recover their structure once the load has been removed. 
 
- Linear region is the part of the curve where fibres lose their crimped pattern 
and if the stresses exceed the physiological range, the fibres begin to suffer micro-
breakages. The Young’s modulus of the ligament is calculated by taking the gradient 
from this linear region at certain strain values [25], [52].  
 
- Breaking region is the part of the curve where the relationship between 
stress and strain is no longer linear, causing disruption of the fibres in the fascicles 
and finally tissue disruption [25], [52].  
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1.2.1.2. Residual stress 
 
Ligaments are not free of stress at their unloaded configuration (when they 
are not subjected to any load), they present residual stress; this phenomenon can be 
observed when their insertion sites are dissected, since size and geometry of the 
ligament change to reach an equilibrium state free of tension (shortening and 
widening the fibres of the damaged ligament) [52].  
 
The origins of these stresses are growth, remodelling or damage of the 
ligament generated throughout life. 
 
   
1.2.1.3. Time dependent properties 
 
 Ligaments exhibit viscoelastic behaviour where the relationship between 
stress and strain is not constant but varies with the time, displacement and load [53]. 
Moreover, ligaments undergo phenomena of strain rate, creep, force relaxation and 
hysteresis due to the interaction between the viscous proteoglycan matrix and the 
collagen fibres [53]. 
 
 Some studies have demonstrated that if strain rate increases the Young’s 
modulus and maximum stress also increase and above the linear load point a 
maximum load, strain and energy to failure are observed [54], [55]. 
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 Creep is another phenomenon shown in ligaments. This can be observed 
when a constant force is applied to a ligament, since this force causes a progressive 
lengthening of the tissue over the time (Figure 1.10); in other words, the deformation 
of the ligament increases under constant load [53], [55]. 
 
 
Figure 1.10 Creep behaviour.  Reproduced from [56]. 
   
 
If the length of the ligament is fixed at the peak strain, the force applied 
decreases over time. The more rapid the strain rate is, the larger peak force and 
greater the relaxation is; in other words, the stress is reduced under a constant 
deformation. This phenomenon is called force relaxation and is characteristic of 
ligaments (Figure 1.11) [53], [55]. 
 
 
Figure 1.11 Force relaxation. Reproduced from [56]. 
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 Hysteresis is another time-dependent property of ligaments. This property can 
be observed when loading and unloading cycles are performed at a constant strain 
rate. The area between both cycles is the dissipated or lost energy during the test and 
indicates the viscoelasticity of the tissue (Figure 1.12) [53]. 
 
 
Figure 1.12 Hysteresis. Reproduced from [57]. 
 
 
1.2.2. ACL MECHANICAL PROPERTIES 
 
 
Few investigations have been performed in order to determine the ACL 
mechanical properties through tensile testing of isolated ACL specimens [58]–[61]. 
This point was underlined in a recent paper by Mclean et al. in 2015, where the 
paucity of ACL tensile data was reported in a literature review paper about ACL 
mechanical properties [62]. 
 
 Parameters such as strain at failure, ultimate tensile stress or Young’s 
modulus have been found in four studies [58]–[61]. Noyes et al., studied the 
mechanical behaviour of ACLs from humans and rhesus monkeys [59]. This study 
proved that the ACL mechanical properties vary between species; for example, the 
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ultimate tensile strength in young adult monkeys was 66.1 MPa and in young adult 
humans (age: 16-26 years) was 37.8 MPa. The ACL Young’s modulus in monkeys 
was reported as 186 MPa, but was reported as being lower in humans, at 111 MPa.   
 
Chandrashekar et al., studied the differences in the mechanical properties of 
the ACL between genders in 2005 [60]. 8 male ACLs (age: 26-50 years) and 9 
female ACLs (age: 17-50 years) were mechanically evaluated. The ultimate tensile 
strength of 26 ± 10 MPa was reported for male ACL and 23 ± 9 MPa reported for 
female ACL. Regarding male ACL Young’s modulus, this was reported as 128 ± 35 
MPa and for female 99 ± 50 MPa. Therefore, this study concluded that gender is an 
important factor for the study of these properties. 
 
A more recent study evaluated the ACL mechanical properties in a porcine 
model [61]. This study analysed 15 porcine ACLs and determined a modulus of 
elasticity of 148 ± 62 MPa and an ultimate tensile strength of 32 ± 16 MPa.  
However, as highlighted by Noyes et al. [59] the species influence on the mechanical 
properties of the ACL should be considered in the design of ACL implants for 
humans.  
 
 Currently, values for the mechanical properties of the ACL reported in 
Noyes et at. and Woo et al. [58], [59] in the 70’s and 90’s are still used as landmark 
papers to evaluate ACL implants [63]–[69]. Specifically, a Young’s modulus of 111 
MPa and ultimate tensile strength of 38 MPa are well recognised and used in many 
publications in the field [63]–[69], these values will therefore be used throughout this 
thesis to evaluate the the ACL scaffolds developed in this project.  
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Table 1.2 summarizes the mechanical properties of the ACL found in the 
studies previously cited [58]–[61]. 
 
Table 1.2 ACL mechanical properties 
 
Characteristics 
of the 
specimens 
Elongation 
at failure 
(mm) 
Strain at 
failure 
Load at failure 
(N) 
Stress at 
failure 
(MPa) 
Stiffness 
(N/mm) 
Modulus of 
elasticity 
(MPa) 
References 
Human n=6, 
age: 16-26 
years 
11.91 0.44±0.08 1730±66 38±9 182±56 111±25 [59] 
Human n=9, 
age: 22-35 
years 
9.99   2160   242   [58] 
Human n=17, 
age: 17-50 
years 
8.17±2.41 0.28±0.07 1526±658 24±9 250±102 113±45 [60] 
Porcine n=15 8.67±1.70 0.32±0.08 853±252 32±16 147±30 148±62 [61] 
 
 
1.2.3. ACL MECHANICAL BEHAVIOUR 
 
 
A substantial number of research studies have been performed to quantify the 
ACL mechanical forces and strain [40], [70]–[73], [73]–[105], when the ligament is 
subjected to specific knee angles, elongations, loads or different activities are 
performed.  
 
Hashemi et al. [40] developed multi-linear regression models  to predict ACL 
stiffness, energy, load and elongation at failure from anthropometrical parameters 
(ACL size, height, weight and body mass index), age and gender. This study used 
cadaveric knees to obtain information about the ACL size (length, minimal area and 
volume) and to test the ligament to failure in order to build the regression models. 
The conclusion of this study was that gender, age, weight, BMI, and height 
contributed (p<0.05) to all predicted structural properties. The smallest cross-
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sectional area of the ACL along its length was a contributor to elongation at failure, 
energy at failure and linear stiffness (p<0.05), but not to load at failure. ACL volume 
was also a contributor to elongation and energy at failure (p<0.05), but not to linear 
stiffness and load at failure models. However, ACL length was not a significant 
contributor to any structural property [40].  
 
Other techniques have used robotic technology to examine knee kinematics 
and estimate ACL tensile forces and strain by testing the specimen under certain 
conditions to mimic physiological knee positions [88], [89], [105]. This technique 
reproduced positions of physiological knee motion and calculated the change in 
forces experienced by the ligament [90]–[93]. Woo et al. (2000) [105] reported a 
maximum force in the ACL of 111 N when an anterior tibial load of 100 N is 
applied, and this ACL force decreased as the flexion angle increased. 10 Nm internal 
tibial torque and a combined 10 Nm valgus and 10 Nm internal tibial torque were 
applied to intact and the ACL-deficient knees for different flexion knee angles in 
Kanamori et al. [89]. This study concluded that the ACL plays an important role in 
restraining anterior tibial translation and internal tibial torque, especially when the 
knee is almost full extended [89]. Although robotic technology is very useful to 
estimate in vitro ACL forces and strain, limitations were exhibited in reproducing the 
in vivo mechanical behaviour of the ACL. The main issue with this technology was 
that these studies estimated the ACL forces by applying anterior tibial loads or 
rotational moments to the knee joint. However, the ACL is likely to bear higher 
forces during in vivo activities than the forces measured in vitro due to the muscle 
forces not being taken into account when determining the loading in the knee [94]. 
Other limitations of these studies include the difficulty in obtaining knee specimens 
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from healthy younger donors and consequently the difficulty in comparison between 
the in vivo ACL mechanical behaviour in younger and older donor [94]. 
 
 Recently, the interest in establishing the in vivo ACL mechanical behaviour, 
joint kinematics and ACL injury mechanisms has increased, and other methods using 
video, motion capture techniques, strain gauges, fluoroscopy and computational 
models have been developed in order to create new prevention programs or estimate 
in vivo forces and ACL elongation [70]–[79], [95]–[99]. 
 
Joint kinematics and ACL injury mechanisms have been studied by video and 
motion capture techniques [70], [71], [95]–[97]. A systematic review of video 
analysis of ACL injuries was performed in Carlson et al. [96] where it was identified 
that a combination of decreased ankle plantar flexion, decreased knee flexion, and 
increased hip flexion provoked high-risk of ACL injuries during landing. Video 
analysis leads to enhanced understanding of non-contact ACL injury; however, this 
technique was solely used to estimate kinematics and dynamics for the knee joint and 
they were not used to estimate in vivo ACL length, strain or tensile force.  
 
To evaluate the in vitro ACL strain [72] and in vivo ACL strain in cycling 
[73], stair climbing [106] and squatting [74], strain gauges were also employed. 
Fleming et al. (1998 and 1999) [73], [106] evaluated the ACL strain during cycling 
and climbing stairs for different machine powers and cadences. These studies 
concluded that strain values increased as the knee was moved from a flexed to an 
extended position [106] and no significant differences were found in peak strain 
values as a result of changes in power level or cadence [73]. This technique has the 
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limitation of being invasive, since it requires surgery for gauges to be implanted on 
the ACL, and the gauge is attached to only a small location of the ACL, not 
recording the strain across the whole ligament.  
 
Experiments with motion capture and biplanar fluoroscopy [75], [76] have 
been used to calculate the ACL length and knee kinematics during walking and 
jumping. Taylor et al. (2013) [75] concluded that the strain in the ACL peaked at 13 
± 2% during mid-stance walking when the knee was near full extension. The peak 
ACL strain was found at 12 ± 7% when knee flexion angles were lowest during 
jumping [76]. However, these models developed to estimate the ACL strain only had 
a 1 degree of freedom (DOF), therefore the results can be subjected to inaccuracies 
due to failure to take account of movement of the knee in other planes. One of the 
main concerns of the fluoroscopy technique, though, is the high radiation doses that 
the participants would be subjected to. Moreover, the activities that can be studied 
using this technique are limited, as its configuration only allows movements 
performed within a confined space to be analysed. 
 
    Studies with motion capture and musculoskeletal simulations studied the 
kinematics and dynamics of different joints [98], [99] and determined ACL length 
and strain during walking and jumping with both legs [77]–[79]. Kar et al. [77] 
found averaged peak strains of 12 ± 4% in the right and 12 ± 3% in the left ACL 
during jumping. Xu et al. developed a 3 DOF knee OpenSim model to simulate the 
mechanical behaviour of the knee ligaments differentiating between the anterior and 
posterior bundles of the ACL and PCL (posterior cruciate ligament) [78]. These 
studies moved the research in the field forward developing models with more than 1 
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DOF for the knee; however, they do not evaluate the ACL length and force for 
activities associated with high injury rates such as jumping with one leg or crossover 
cutting. Chapter 3 used these techniques to estimate in vivo ACL length, strain and 
forces for those activities, filling the gap existing in the literature. 
 
Table 1.3 summarizes the different existing methods u estimate the 
mechanical behaviour of the ACL with some of their limitations.  
 
Table 1.3 Techniques to evaluate the ACL mechanical behaviour with their limitations. 
 
Limitations
1. No in-vivo  mechanical behaviour evaluated.                                         
2. It is not possible to estimate ACL forces, just changes of ACL 
forces are estimated                                                                                                      
3. Little availability of knee specimens from healthy younger donors
1. Invasive and requires surgery.                                                                   
2. Gauge only measures the strain in a small location of the ACL. 
Video 1. Do not study in-vivo  ACL length, strain or tensile force.
Biplanar 
fluoroscopy
1. Fluoroscopy is an invasive technique that involves high radiation 
doses.                                                                                                                
2. Only movements performed within a confined space are studied. 
Therefore, these studies are limited to static trials or activities with 
short horizontal displacements.
Musculoskeletal 
simulations
1. No studies performed during cutting or jumping with one leg. 
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Some studies reported peak values of percentage of ACL strain of 2.8 % 
during climbing stairs [106], 2% during cycling [73], up to 4% for squatting [74], 
and up to 2% during a forward lunge [84]. Regarding peak values of ACL tensile 
force, Shelburne et al. (2005) reported 303 N during walking on level-ground [79] 
and 20 N for dynamic squats [86]; these values were calculated through a 2D 
dynamical model simulating muscle and ligament loading. Other investigations 
reported between 0 N [81] to 95 N [100] for dynamic squats, 253 N was recorded for 
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double foot drop landing [101] and 1294 N for single-leg landing from running to 
stop [87].  
 
Some studies reported peak ACL forces of 0.2 N/BW [102], however other 
investigations showed values higher than 1 N/BW [103], [104] during walking. 
Therefore, disparity of results was observed for the same activity. If different 
researchers reported varying values of ACL forces and strain, this introduces 
problems in comparing those values between different activities. This is due to the 
wide range of techniques used to determine in vivo ACL strain and force and the 
limitations associated with each technique.  
 
Therefore, it is necessary to develop and implement a reliable and easy 
methodology to investigate different activities in one study to allow valid comparison 
and so write new rehabilitation protocols, new prevention programs to avoid ACL 
injuries or design new ACL implants that can bear the in vivo ACL forces and strain 
estimated. Observing the limitations of each technique to estimate the in vivo ACL 
mechanical behaviour, a motion capture in combination with a musculoskeletal 
model was used for the development of this thesis and it was explained in Chapter 3. 
This technique allows calculation of the in vivo forces and strain for multiple 
activities, including high impact activities such as crossover cutting, sidestep cutting 
or jumping with one leg, activities for which in vivo ACL forces and strain have not 
been studied to date. The next following  sections (1.2.3.1 and 1.2.3.2) explain the 
basic concept of this technology.  
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1.2.3.1. Motion capture 
 
The movement of objects or people can be recorded through a motion capture 
technique, which is based on the use of retroreflective markers whose movements are 
tracked by infrared cameras such as the one shown in Figure 1.13.  
 
Figure 1.13 Vicon infrared camera. 
 
Before experimentation, a calibration process has to be performed. This 
process allows the software to calculate the location and orientation of each camera. 
There are two steps for the calibration, a first static calibration where the origin or 
centre of the capture volume and orientation is determined and second dynamic 
calibration where the relative positions and orientations of the cameras are calculated 
through the movement of a calibration wand throughout the whole volume of study 
[107]. 
 
Reflective markers are attached to the participants to record the movements 
of the different segments of their body (head, chest, arms, pelvis, legs, knees and 
feet). Each marker should be visible to at least two cameras to accurately calculate its 
position. The displacement can be recorded with one marker, the use of two markers 
allows the calculation of velocity and acceleration and the system can calculate joint 
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angles with three markers [108]. The location of the markers is given by protocols, 
the most commonly used being the Helen Hayes market set and the Cleveland Clinic 
marker set. In Chapter 3 a modification of the Cleveland Clinic marker was used 
following the recommendations of OpenSim (Sim TK, Stanford, CA) web page 
[109]. The model with the marker set used is shown in Figure 1.14 
 
 
Figure 1.14 Vicon/Nexus model for stair negotiation. 
 
 
Once the position of each marker is tracked, the coordinates of each marker 
were used to calculate the kinematics and dynamics with a musculoskeletal model 
implemented in OpenSim 3.3 (Sim TK, Stanford, CA).  
 
1.2.3.2. Musculoskeletal model 
 
OpenSim is a software capable of creating musculoskeletal models to analyse 
the in vivo behaviour of muscles, tendons and ligaments (Figure 1.15 shows the 
model during a static trial, stair negotiation and crossover cutting trials).  
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Figure 1.15 OpenSim models during A) Static trial, B) Stair negotiation and C) Crossover cutting. 
 
 
 
OpenSim contains different tools to enable calculation of kinematics and 
dynamics. An understanding of the theory behind these tools is fundamental in the 
development of Chapter 3 of this thesis; therefore, the function of each tool is 
explained below. It should be noted that this section 1.2.3.2 does not constitute a 
methodology of the studies performed in Chapter 3, but rather a background for the 
use and development of OpenSim models more generally. 
   
1.2.3.2.1. Scaling 
 
A model is scaled thanks to a combination of two methods, the “measured-
based scaling” where the distances between experimental and virtual marker 
positions are measured, and “manual scaling” where scale factors obtained from 
anthropometric measurements are used. Experimental markers are placed on specific 
landmarks of participants’ body and their x-y-z positions are obtained from static 
calibration with a motion capture system. For the “measured-based scaling” a non-
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scaled model with a set of virtual markers is required. These virtual markers are 
located at the same anatomical positions as the experimental markers, and the 
dimensions of each segment, muscles and ligaments are scaled matching the 
distances between virtual and experimental markers. Another alternative included in 
the scale tool implemented in OpenSim is to scale each segment of the model from 
anthropometric measurements; as it was indicated above; this technique is called 
“manual scaling” [110].  
  
1.2.3.2.2. Inverse kinematics 
    
With a motion capture system it is possible to track the experimental marker 
locations while the participants are performing an activity. The inverse kinematics 
(IK) tool is able to calculate joint displacements and angles from collected 
experimental data. For each time frame this tool computes the coordinates and 
positions the model in a pose that “best matches” experimental marker positions with 
the coordinate data, minimizing the sum of weighted squared errors of markers and 
coordinates [111] and obtaining the kinematics of the model.  
 
1.2.3.2.3. Inverse dynamics 
 
The inverse dynamics (ID) tool is necessary to validate the muscle function in 
the computational model. This tool is able to calculate joint forces and moments 
from the inverse kinematics file previously generated and a ground reaction forces 
(GRF) file obtained from force platform data, generated while the participants were 
performing the activities [112].    
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1.2.3.2.4. Static optimisation 
 
Once the joint forces and moments were calculated from inverse dynamics 
tool, these parameters feed into the model to determine muscle forces and activations 
at each instant in time through static optimisation [113].  
 
The activation of certain muscles obtained from the model can be 
qualitatively compared with the activation of these muscles recorded with 
electromyography sensors in order to validate the muscle function in the model. 
 
1.2.3.2.5. Analysis tool 
 
 
In order to calculate the ACL length at each instant in time and so to be able 
to calculate the ACL strain and force, an analysis tool implemented in OpenSim is 
used. This tool enables the users to perform muscle analysis to calculate parameters 
such as total muscle, fibre or tendon length; muscle, fibre or tendon force; velocities; 
pennation angles; moments or moment arms [114].  
 
With this tool it is possible to track the insertion points of the ACL obtained 
from kinematics data and estimate the in vivo ACL length modelling the ligament as 
a nonlinear elastic passive soft tissue based on Thelen2003 [115] muscle model. 
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Key points: 
1. The ACL exhibits a stress/strain curve with three very clearly defined regions: a 
toe region, a linear region and a breaking region. Different polymers will be used in 
Chapters 4 and 6 in order to replicate this behaviour. 
2. The Young’s modulus of the ACL is 111 MPa and the ultimate tensile stress is 38 
MPa. These values will be used in Chapters 4, 5 and 6 to assess the manufactured 
scaffolds. 
3. Hysteresis is a time-dependent property of the ligaments. This property will be 
tested in Chapter 6. 
4. Different techniques have been used to understand the ACL in vivo mechanical 
behaviour and calculate the elongation and forces acting over it while different 
activities are performed. However, there is not any reliable and easy methodology to 
investigate different activities in one study to allow valid comparison, and to produce 
mechanical specifications in order to design ACL ligaments according to the in vivo 
mechanical behaviour of the ACL. This gap in the literature will be covered in 
Chapter 3 following the motion capture in combination with a musculoskeletal model 
technique explained in this section. 
 
 
 
 
 
 
 
 
Chapter 1. Introduction and Literature Review 
 
 
58 
 
 
1.3. ACL INJURY MECHANICS 
 
Importance: 
1. The understanding of ACL injury and failure mechanics will help to design new 
ligament implants, new rehabilitation protocols and prevention programs to reduce 
the risk of injury. 
 
 
 The ACL has a fundamental role in the stabilization of the knee restraining 
the anterior tibial translation and internal rotation in the non-weight-bering knee [74], 
[116]. It has an estimated failure load of 2000 N, Young’s modulus 111 MPa and 
ultimate tensile stress of 38 MPa [59] as shown in section 1.2.4. 
 
 ACL injuries usually happen under dynamic loading, with 78% of the injuries 
occuring during non-contact activities such as crossover cutting, side step cutting or 
landing from a jump [4]. The highest rate of ACL rupture is registered during sports 
such as football, basketball and skiing. It is known that this type of injury occurs 
during sudden accelerations, changing directions, and when decelerating from 
running with change in direction or landing [4]. The typical ACL injury occurs when 
the knee is at 30° flexion in a valgus position and the participant internally rotates the 
knee with the planted foot, when suddenly changing direction [117], [118]. However, 
the ACL injury mechanisms are complex (since the accident that provokes injury is 
fast, dynamic and multiple factors are involved, and the knee is a complex joint that 
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allows compression, translation and rotation in different axes [119]) and further 
investigations have to be done.   
 
    Although nowadays the specific ACL injury mechanics remain unclear, 
ACL injury risk factors have been detected and studied [120]–[128]. The ACL injury 
risk factors are classified as intrinsic and extrinsic [120], [121] and the intrinsic in 
turn modifiable and non-modifiable. A scheme with all of the known risk factors is 
presented in Figure 1.16. The knowledge and identification of risk factors is 
important for the development of injury prevention programs, which could reduce 
the risk of ACL injuries. Certain studies considered as ACL risk factors the 
increment in knee valgus moment, quadriceps muscle activation or the anterior tibial 
shear force [123]–[125]. Specifically, Hewett et al. [121] reported that the knee 
valgus moment is a predictor of risk of ACL injury. However, it was demonstrated 
that knee the valgus moment on its own cannot injure the ACL when the medial 
collateral ligament is not damaged [129]. 
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Figure 1.16 ACL risk factors. 
 
 
 The ACL injury is commonly called a sprain and can be classified as a grade 
I, II and III, depending on the clinical symptoms. Grade I sprain exhibits a minimum 
loss of function, minimum pain and inflammation, the fibres are stretched but no 
tears are observed, the knee is still stable and there is no haemorrhage. Grade II 
sprain occurs when the fibres are partially torn, there is a moderate swelling with 
some loss of function; an increase in an anterior translation of the tibia and an 
unstable knee. Grade III sprain presents a complete rupture of the ACL, significant 
loss of articular function generating instability of the knee, severe inflammation and 
pain [53], [130], [131].  
 
 The tearing of the ACL from its bony insertion points is called avulsion. 
Avulsion is more common in children rather than adults, because it occurs between 
unmineralized and mineralized fibrocartilage layers shown in children. Midsubstance 
ACL ruptures commonly happens in adults [53].  
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ACL injuries are diagnosed through physical assessment (with Lachman’s 
test, anterior drawer test or pivot shift) to detect an abnormal anterior translation of 
the tibia; through radiographs, to check the presence of bone bruising, osteochondral 
fracture or to determine the notch width index (a person with ACL injury has smaller 
notch width index than normal) [132]; and through magnetic resonance imaging 
(MRI) to observe the damaged ACL.  
 
Not all ACL injuries are surgically treated. The choice of undergoing surgery 
highly depends on the severity of the rupture of the ACL, the patient’s symptoms, 
sport level and type of sport that the patient wants to keep doing [133]. Non-
operative treatment or conservative treatment is recommended in grade I and grade II 
injuries where the knee partially maintains its stability and the injured part of the 
ACL remains functional. This treatment is based on physiotherapy and many patients 
can have asymptomatic knees following rehabilitation programs [133]. 
 
 
Key points: 
1. The ACL is one of the most important stabilizers of the knee joint, restraining the 
anterior tibial translation and internal rotation of the knee. This fact was also verified 
with a computational model developed in Chapter 3. 
2. 78% of the ACL injuries occur during non-contact activities when sudden 
accelerations, changes in direction, decelerations when running with changes in 
direction or landing are present. Chapter 3 studied the ACL biomechanics during 
daily (walking, climbing stairs) and high impact activities (crossover and side step 
Chapter 1. Introduction and Literature Review 
 
 
62 
 
cutting, running, jumping or landing) to be able to understand more about ACL 
injury mechanics.  
 
 
 
1.4. STATE OF THE ART FOR ACL IMPLANTS 
 
Importance: 
1. It is known that the failure rate of current treatments for ACL replacement is still 
high; therefore, further study is needed to determine the causes of failure and create 
new ligaments that can address and solve these issues.  
2. Understanding the advantages and disadvantages of current treatments will help to 
design the new ligaments maintaining the advantages and reducing the disadvantages 
of current grafts. 
 
 
The “gold standard” to treat ACL injury is to reconstruct the ACL from 
autografts (grafts from the patient’s own body) [134]. More than 90% of the 
reconstructions are carried out with bone-patellar tendon-bone or hamstring tendon 
grafts but quadriceps tendon and iliotibial bands have been also used to replace the 
ACL [22]. Although the use of autologous grafts is the most common practice, this 
exhibits an important number of drawbacks among which are notable muscle 
weakness at the donor site, graft site morbidity, knee pain, infection, loss of 
sensibility due to nerve damage and long operation and rehabilitation time [22], [25].  
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Allografts (tissue taken from a cadaver) and xenografts (tissue removed from 
an animal) are also used for ACL reconstructions as an alternative to autografts when 
these are not available due to damage or from being used in a previous 
reconstruction. Due to the lack of young healthy cadaver donors, the Achilles tendon 
and the anterior tibialis and posterior tibialis tendons are also used to performed ACL 
replacements. Although some disadvantages of the autograft are solved through 
allografts such as the donor site morbidity and the necessity of a previous operation 
to harvest the tissue, other drawbacks are associated with the use of these specific 
grafts. Some of these limitations include: the possibility of transmitting diseases, risk 
of bacterial infection and an immunological response, limitations in the availability 
of donor tissue and difficulties with the sterilization of the graft, factors/conditions 
that could damage the graft and reduce its mechanical properties [135]. However, the 
major risk and disadvantage in allografts and xenografts is the transmission of 
infectious agents from donor to host [135], [136], therefore the sterilization technique 
plays a crucial role in the success of the ACL replacement. Techniques such as 
gamma irradiation, ethylene oxide gas, thermal treatment, beta-propiolactone, 
chemical processing, antibiotic soaks and Biocleanse have been used to sterilize 
allografts [136]. Ethylene oxide sterilization, however, is associated with high graft 
failure rates and persistent synovitis, therefore is not a suitable method for 
sterilization of allografts [135], [137]. Irradiation is the most frequently used 
sterilization technique; however, the use of this technique results in the loss of 
mechanical properties because it damages collagen fibres and causes changes in 
crosslinks of collagen [138]–[142]. An alternative to irradiation is the BioCleanse 
technique (Regeneration Technologies Inc., Alachua, FL), which involves chemical 
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sterilization of tissues. Conrad et al. reported that tendon allografts, treated them this 
way, exhibited higher ultimate stress and higher ultimate failure load than irradiated 
allografts [135]; however,  Indelicato et al. [143] studied this technique for bone-
patellar tendon-bone ACL allografts and concluded that non-significant differences 
were observed between allografts treated with BioCleanse and non-irradiated 
allografts. 
 
 Xenografts show the same advantages and disadvantages as allografts, but the 
risk of disease transfer is higher when the tissue is transferred from one species to 
another [144]. However, the main challenge for the use of xenografts is to deal with 
the immunological rejection [26], [27]. This immunological rejection is associated 
with the presence of α-galactose (α-Gal) found in the cellular and extracellular 
matrix of almost all mammals with the exception of humans and old world primates, 
who produce anti-α-Gal antibodies triggering the rejection of the graft [26], [27]. In 
order to reduce this risk of rejection and make them viable to be implanted in the 
body the tissue has to be cleaned, the α-Gal epitopes (part of the antigen recognized 
by the immune system) removed enzymatically, stabilized with 0.1% glutaraldehyde 
(GTA) and sterilized by electron beam radiation at 17.8 kGy [26], [27]. This 
increases the cost of the graft and incorporates toxic chemicals with possible residual 
components leaching into surrounding tissue. In 2014 Aperion Biologics Inc (San 
Antonio, Texas, USA) was granted the CE mark approval for Z-Lig®, the first 
porcine xenograft created for ACL replacement [27], [145]. The Z-Lig® xenograft 
was tested in skeletally mature monkeys with serological analysis to identify the 
immune response, by mechanical testing to assess performance, and through 
histopathological analysis to assess biological response and remodelling [27]. The 
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results from the preclinical performance and safety profile were promising after a 
twelve-month observation. The porcine xenograft was functional, the vascularization 
and synovial sheath were re-established, there were no signs of degenerative articular 
changes or adverse synovial reaction, bone consolidation was found inside the bone 
tunnels, the ultimate failure load increased over time at a similar rate to the allograft 
and no adverse findings emerged from standard clinical chemistry, serological, and 
haematological panels [27]. A first clinical trial was performed with humans and 
showed similar results. 
 
Synthetic ligaments were designed to overcome the disadvantages found in 
the biological grafts, eliminating issues such as donor site morbidity, transfer 
diseases and long operation times. However, this type of implants have shown a lack 
of biocompatibility and although they retained mechanical properties similar to the 
natural ACL at short-term, they failed long-term mainly due to fatigue of the graft, 
but also laxity, stiffness, infection, synovitis and tissue degeneration, mechanical 
failure and re-rupture of the graft [25], [28].  
 
Synthetic ligaments can be classified into three main groups: non-
biodegradable implants, which are not designed to have any soft tissue ingrowth; 
ligament augmentation devices (LADs), designed to protect the implanted autograft 
and enhance its revascularization and maturation; and tissue engineered scaffolds, 
designed to encourage/promote the ingrowth of native tissue.  
 
The first ACL reconstruction with synthetic grafts was performed in 1903 
with an implant based on braided silk attached to the semitendinosus [146]. A silver 
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filament was used for ACL replacement in 1914 [147]. Advances in the chemical 
industry and in biomaterials allowed the development of permanent ACL implants 
made with more suitable materials such as carbon fibre, polyester, 
polytetrafluoroethylene and polypropylene in the 1970s and 1990s [28], [146], [147]. 
These grafts exhibited superior mechanical characteristics in comparison with 
biological scaffolds, but their poor biocompatibility and long-term mechanical 
complications (implant degeneration due to fatigue and consequently implant failure) 
meant they were not feasible for ACL replacements [28]. Moreover, ligaments based 
on carbon fibre were abandoned in early clinical stages due to the fact that carbon 
fragments were found in lymph nodes and the carbon fibres abraded the knee bones 
[148], [149].  
 
Between 1986 and 1987 the Food and Drug Administration (FDA) approved 
the Gore-Tex ligament implant (W.L. Gore, Flagstaff, Arizona), the Kennedy LAD 
(3M, St. Paul, Minnesota) and the Stryker-Meadox Dacron ligament (Meadox 
Medical, Oakland, New Yersey; Stryker Corp., Kalamazoo, MI, USA) [28], [148], 
[150]. Although these implants showed satisfactory short-term results, longer-term 
monitoring revealed many complications such as implant degeneration and failure, 
synovitis and inflammation. Analysing these implants in more detail, Guidoin et al. 
[151] reviewed 117 cases of failed ACL reconstructions and found three key 
elements that contributed to the artificial ligament failure: inadequate fibre abrasion 
resistance against osseous surfaces, flexural and rotational fatigue of the fibres and 
loss of integrity of the textile structure due to unpredictable tissue infiltration during 
healing. An retrospective study of 123 patients with Gore-Tex implants showed that 
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26 of the implants resulted in re-rupture, 50% were loosened and the 63% of the 
patients had osteoarthritis after a follow-up of 5-11 years [152].  
 
The Leeds-Keio ligament (Xiros Ltd, Neoligaments ™, Leeds, UK) and the 
Ligament Advanced Reinforcement System (LARS) (Surgical Implants and Devices 
/ Corin, Arc-sur-Tille, France) were commercialized in Europe and Asia [28], [148], 
[150]. Murray et al. [153] studied 18 ACL Leeds-Keio replacements after 10-16 
years of the reconstruction and concluded that knee joint laxity was increased in 51% 
of the grafts and re-rupture of the implant was found in 28% of the cases. However, a 
more recent retrospective study with 50 of the same type of grafts showed that just 
12% of the replacements ended in re-rupture after 10-20 years of the operation [154]. 
LARS ligaments were designed in two parts, the intraosseous part and the intra-
articular part. In the intraosseous part longitudinal fibres were knitted together, while 
the fibres in the intra-articular part were pre-twisted at 90° [155]. This configuration 
provided more resistance to torsional fatigue and wearing and appears to be the most 
efficient synthetic scaffold to date [28]. Recently grafts such as ACLip® (Amplitude 
surgical, Valence, France) granted with the CE mark approval in 2017 or Jewel 
ACL™ and Hybrid System™ (both from Xiros Ltd, Leeds, UK) have been 
commercialized [156] but no long-term results have been reported in the literature.  
 
The following Table (1.4) summarises the materials, describes the grafts, and 
includes disadvantages of each commercial implant following different study cases 
[154], [157]–[163], the mechanical properties and companies for the commercial 
synthetic ACL implants (permanent implants and augmentation devices) found in the 
literature review.  
Chapter 1.  Introduction and Literature Review 
 
 
68 
 
Table 1.4 Commercial synthetic ACL implants [148], [150], [157], [164]–[179]. 
 
Implant Polymer Description Observations
Ultimate tensile strength 
(N)
Stiffness 
(N/mm)
Manufacturer
ABC Prosthetic ligament Carbon fibre and polyester
24 braided narrow ribbons wrapped 
at ends
Fragments of carbon fibres observed in lymph 
nodes. Rupture. High rates of creep
1400 * Surgicraft Ltd, Redditch, UK
Stryker-Meadox Dacron graft Polyethylene terephthalate 4-6 woven tapes in tubular shell
Instability of the knee. Elongation due to creep. 
Ruptures at the insertions and middle part of the 
graft
3631 420
Meadox Medical, Oakland, New 
Yersey; Stryker Corp., Kalamazoo, 
MI, USA
Gore-Tex graft
Expanded 
polytetrafluorethylene
24 braids of 3 yams wrapped at the 
end
Fragments observed. Synovitis. Rupture after 
cycling loading. Infection. Loss of tension of the 
graft. Poor long-term results
5300 322 W.L. Gore, Flagstaff, AR, USA
Leeds-Keio artificial ligament Polyethylene terephthalate Woven structures
No fatigue resistance. Tissue ingrowth not aligned 
to restore ligament function. High rates of rupture
2000 270 Xiros Ltd, Neoligaments ™, Leeds, UK
Kennedy LAD Polypropylene Braided narrow ribbons Synovitis. General inflammation of the knee 1500 280 3M, St. Paul, Minnesota
Ligament Advance 
Reinforcement System 
(LARS)®
Polyethylene terephthalate
Longitudinal fibres in two bundles 
orientated clockwise or anti-
clockwise for right and left knees
Infection. Synovitis
From  1,500N for 30 fibres to  
4,700N for 100 fibres
*
Corin/Surgical Implants and Devices, 
Arc-sur-Tille, France
Proplast ligaments Teflon and carbon fibre *
Extremely poor clinical performance at long-term. 
Carbon fibres abraded the bone in the knee. 
Carbon fragments were found out of the knee 
(liver). Imflamation. Poor torsion resistance
* * Vitex Inc, Houston, TX, USA
Polyflex Polypropylene
Intraosseous: 6.35 mm diameter and 
20 mm length each ending. 
Intraarticular: 4.76 mm diameter and 
35-40 mm length. Woven tubular 
structure
Rupture of the ligament due to ligament erosion 
and residual rotational stress
* 511 Richard, Memphis, TN, USA
Intergraft Carbon fibre *
Extremely poor clinical performance at long-term. 
Carbon fibres abraded the bone in the knee. 
Carbon fragments were found out of the knee 
(liver). Inflammation. Poor torsion resistance
660 230 x 109
Osteonics Biomaterials, Livermore, 
CA, USA
Proflex Polyester
15 concentric tubular braids of 32 
yarn
Infection. Swelling. Rupture. Synovial reactions 4500 * Protek Ltd, Bern, Switzerland
Trevira-hochfest Polyester
8 mm wide x 300 mm long flat woven 
structure
Free PET particles and multinuclear giant foreign 
body cells were observed in the knee
1866 68.3 Telos, SARL, Marburg, Germany
Lygeron Polyethylene terephthalate 6 ribbons in a woven tube
Low extensivity, axial splitting. Abrasive wear due 
to tight weaving
4500 *
Orthomed, Marsannay La Cote, 
France
Ligastic® Polyethylene terephthalate Tubular knit with polyurethane shell Rupture. Instability. Pain. Good flexibility 4200 *
Orthomed, Marsannay La Cote, 
France
Ligaid Polyacrylic acid Twisted cord braids wrapped at ends * * * Porth-Aid, France
Raschel
Ultra-high-molecular-
weight polyethylene 
Knitted structure rolled into tubular 
shape
Flexibility due to its knitted structure * * Cendis Medical, France
Braided PHP
Ultra-high-molecular-
weight polyethylene 
Double concentric tubular braids * 4900 * Cendis Medical, France
SEM graft Polyester Braid structure * 2500 *
Scince et Medecine, Montrouge, 
France
Apex ligaments Polyester * * * * DePuy International, Leeds, UK
Jewel ACL™ Polyester One tubular woven structure * 1250 310 Xiros Ltd, Neoligaments ™, Leeds, UK
Hybrid System ™ Polyester
Widths of 3-50 mm and 500-800 mm 
long tubular and single structures
* 300-2250 depending on size * Xiros Ltd, Neoligaments ™, Leeds, UK
ACLip® Polyester * * * * Amplitude surgical, Valence, France
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In conclusion, all of these commercial implants exhibited aceptable short-
term behaviour but they have complications at long-term due to creep, fatigue and 
implant abrasion in the bone tunnels which provoke debris deposits causing synovitis 
and pain [25], [28]. These disadvantages may imply a second surgery and they are 
the reason why commercial implants are not as popular as autografts [25], [28].  
 
Nowadays interest in manufacturing ACL implants through Tissue 
Engineering has increased due to the great appeal of producing a fully regenerated 
ligament with appropriate long-term mechanical properties. Manufacture of a tissue 
engineering ACL implant is based on producing a scaffold where fibroblasts or 
mesenchymal stem cells are seeded to allow neoligamentous (creation of new 
ligamentous tissue) growth. The main challenge of tissue engineering implants is to 
create a scaffold able to degrade progressively at the same rate as ligamentous tissue 
growth, maintaining the mechanical properties of the structure as a whole over time.  
An ideal scaffold must accomplish the following requirements: 
 
 Biocompatibility: It is the ability of a material to perform with an 
appropriate host response in a specific aaplocation. The term 
biocompatibility is related to different properties of materials, such as 
non-toxicity, tissues compatibility, blood compatibility 
(hemocompatibility), and biofunctionality properties [180].  
 Biofunctionality: It is the capacity of the ligament implant to perform 
the functions for which it has been designed, at the required period of 
time, effectively and with an appropriate host response [180].  
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 Tunable biodegradability degradation rate, while simultaneously being 
replaced by host tissue [181].  
 Maintain appropriate mechanical properties comparable to the natural 
ligament before, during and after its degradation  [63].  
 Appropriate porosity to allow the transport of nutrients, gases, waste, 
regulation factors and cells from the surface to the interior of the 
scaffold [182].  
 It should cause minimum inflammation or toxicity in vivo [182]. 
 Surgeon-friendly characteristics with easy shapes and sizes for 
implantation into the body [64].  
 
Further research regarding the development of tissue engineered ACL is 
shown in section 1.6.2. of the present chapter. 
 
A summary table showing the general advantages and disadvantages of these 
treatments is presented below (Table 1.5). This table was produced after analysing 
different case studies and demostrates the high potential of tissue engineered grafts 
and why they are nowadays increasingly popular.   
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Table 1.5 Advantages and disadvantages of current ACL implants [22], [25]–[28], [183], [184]. 
 
ACL grafts Advantages Disadvantages
Autografts
1. “Gold standard” to ACL replacement.                               
2.  Biocompatibility.                                                          
3. No transmission of diseasses.
1. Muscle weakness at the donor site.                                   
2. Graft site morbidity.                                                              
3. Knee pain.                                                                                    
4. Infection.                                                                                     
5. Loss of sensibility due to nerve damage.                                                 
6. Long operation and rehabilitation time.                               
7. Risk of infection during the surgery.  
Allografts
1.No availability problem.                                                                    
2. Biocompatibility.                                                               
3. Reduced operation and rehabilitation time.           
4. No donor site morbidity.                
1.Lack of young healthy cadaver donors.                               
2. Risk of transmission of diseases.                                       
3. Infection.                                                                                     
4. Difficulties with the sterilization of the graft, inducing  
an alteration of the mechanical properties of the graft 
or bacterial infections.                                                                              
5. Risk of infection during the surgery.                             
Xenografts
1. No availability problem.                                                                   
2. Biocompatibility.                                                          
3. Reduced operation and rehabilitation time.               
4. No donor site morbidity. 
1. Risk of transmission of diseases and risk of 
immunogenical response.                                                                                            
2. Infection.                                                                                       
3. Difficulties with the sterilization of the graft, inducing 
an alteration of the mechanical properties of the graft 
or bacterial infections.                                                                           
4. Risk of infection during the surgery.                      
Synthetic grafts (marketed)
1. No availability problem.                                             
2. Good short term mechanical properties.                                                              
3. Reduced operation and rehabilitation time.           
4. No donor site morbidity.                                               
5. No transmission of diseasses.
1. Lack of biocompatibility.                                                          
2. Poor long term mechanical properties.                                   
3. Laxity.                                                                                         
4. Increment of stiffness of the knee joint.                                                               
5. Infection, swelling and synovitis.                                                           
6. Tissue degradation.                                                                 
7. Particles of implant observed in lymphatic nodes.         
8. Rupture.                                                                                    
9. High rates of creep.                                                                  
10. Instability of the knee.                                                        
11. No fatigue resistance                                                                         
12. Risk of infection during the surgery.         
Tissue engineered grafts
1. No availability problem.                                             
2. Biocompatible                                                              
3. Good short and long term mechanical properties  
4. Neoligamentous growth.                                              
5. Tunable biodegradability.                                              
6. Appropriate porosity.                                                     
7. Reduced operation and rehabilitation time.            
8. No donor site morbidity.                                              
9. No transmission of diseasses.
1. In process. No tissue engineered ACL implants are 
currently commecialized.                                                        
2. Risk of infection during the surgery.  
 
 
 
Key points: 
1. Autografts are currently the “gold standard” for ACL replacement. However, they 
exhibit disadvantages that could be reduced with other type of grafts. 
2. Tissue engineered ACL implants have huge potential and they become 
increasingly popular among the scientific community. However, further work has to 
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be done to achieve the ideal graft. Chapters 4, 5 and 6 are focussed on the 
development of new tissue engineered implants for ACL replacements.  
 
 
 
1.5. MANUFACTURING PROCESS  
 
 
Importance: 
1. The study of all possible manufacturing processes to create scaffolds with their 
respective advantages and disadvantages helps to choose the best fabrication method 
to create tissue engineered ligaments.  
2. Understanding the electrospinning process and its parameters is necessary to 
optimise the process and to manufacture scaffolds with mechanical properties, 
morphology and topography comparable to the natural ACL. 
 
 
Nowadays there are numerous techniques to manufacture scaffolds for tissue 
engineering applications. Commonly they are classified as non-designed and 
designed techniques [185]. The first category includes techniques such as 
electrospinning, melt moulding, gas foaming, freeze drying or emulsion freezing, 
solvent casting or particulate leaching and phase separation [185]–[187]. The precise 
outcome cannot be completely pre-determined with these techniques; however their 
topography, morphology and with that their percentage of porosity can be controlled 
through different strategies depending on the manufacturing method [185]–[187]. 
For instance, the electrospinning technique is able to mimic the nano and micro 
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structure of the tissue being able to realistically represent the nanofibres of 
extracellular matrix, and this structure can be customized through varying solution, 
process or environmental parameters as will be explained in the next section (1.5.1).  
 
The second category of manufacturing techniques is called designed 
technique or rapid prototyping and includes techniques such as 3D printing, laser 
sintering and stereolithography. Rapid prototyping is characterized as being able to 
create a 3D structure that mimics the natural tissue through a computational model 
created from medical images such as computed tomography (CT) scans or magnetic 
resonance imaging (MRI).  
 
As explained in section 1.4 where tissue engineered implants were briefly 
presented, scaffolds should be biocompatible (coexisting with living tissues without 
causing harm), biofunctional, biodegradable, have appropriate mechanical properties 
(comparable to the natural ACL as shown in section 1.2) and an adequate porous 
structure to allow cells to proliferate, migrate and in the case of stem cells 
differentiate into fibroblasts. Therefore, the manufacturing process is crucial to create 
scaffolds with the appropriate morphology and mechanical properties. A brief 
explanation of the existing manufacturing methods is shown in section 1.5.1. 
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1.5.1. DIFFERENT TECHNIQUES TO FABRICATE SCAFFOLDS 
 
1.5.1.1. Solvent Casting and Particulate Leaching 
 
This technique consists of the dissolution of a polymer in a solvent. Then a 
porogenic agent (e.g. salt, sugar, gelatin or paraffin) soluble in water is added to the 
polymer solution to create a porous structure. The solution is poured into a mould 
with the desired shape and the solvent removed by evaporation or lyophilisation, then 
the porogenic agent is leached into the polymer. Finally, the mould is immersed in 
water to dissolve the porogenic particules immersed in the polymer, and a porous 
structure is created.   The pore size and porosity can be controlled by modifying the 
size and quantity of the porogenic agent. The main concern about this method is the 
difficulty of control over the internal structure of the polymer matrix; as the pores 
could be not interconnected or uniformly distributed [185]–[187] this would make 
the cell migration inside the scaffold difficult.    
 
1.5.1.2. Thermally Induced Phase Separation 
 
This technique consists of the dissolution of a polymer in a solvent with a 
high boiling point. The solution is heated to a high temperature and poured into a 
mould. Then the solidification of the solution is induced cooling it down, introducing 
the solution into a refrigerator set to the gelation temperature of the polymer, 
generating a phase separation with a polymer-rich phase and a polymer-poor phase. 
The final step is to remove the solvent by extraction, evaporation or sublimation. The 
space originally occupied by the solvent in the polymer-poor phase becomes pores of 
the polymer foam. This technique allows the creation of macro and microporous 
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structures with high porosity and it is commonly used for bone tissue engineering 
[185]–[187]. 
 
1.5.1.3. Gas Foaming 
 
In this technique a polymer is saturated with high-pressure (800 psi) N2 or 
CO2, creating intermolecular interactions between the gas and the polymer 
molecules. A fast depressurization of the polymer provokes thermodynamic 
instability creating pores in the polymer. The main disadvantage is the creation of a 
nonporous layer and closed pore matrix; however, this disadvantage can be improved 
through the addition of salt particles to the solution prior to the depressurization step. 
The salt particles have the characteristic of being leached away when the polymer is 
immersed in water, increasing the porosity of the structure [185]–[187]. The pore 
size and porosity can be controlled by modifying the size of the porogen particles 
and the salt/polymer composite ratio. 
 
1.5.1.4. Emulsion Freeze-Drying 
 
In this method, water is added to the polymer solution and the mixture homogenized 
to get an emulsion. The solution is frozen (−70°C to −80°C) and placed into a 
vacuum desiccator to remove the solvent and water. The porosity obtained with this 
method is above 90% and the scaffolds produced show interconnected pores with 
sizes ranging from few microns to 300 µm [185]. The porosity plays a critical role in 
biological tissue formation and the mechanical properties of the scaffold. The pore 
size has to be large enough for the cells to proliferate and migrate inside the scaffold 
and to enhance the interchange of nutrients and waste products. However, an 
increase in the pore size provokes a decrease in mechanical properties, therefore a 
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balance must be reached between tissue formation and mechanical properties [188] 
depending on the tissue to be grown. Some studies considered a minimum pore size 
requirement as ∼100 μm for enhancing new bone formation [188]. Andrews et al. 
[189] investigated how the morphology and topography of electrospun scaffolds 
effect fibroblast behaviour. However, no specific optimum pore size to grow 
fibroblasts over scaffolds has been found; therefore, further research has to be done. 
    
1.5.1.5. Rapid Prototyping (3D printing) 
 
This method uses a computer-aided design software to produce a 3D 
structure, by adding layers over layers of material. It allows customization of the 
model, creating the scaffolds with desired shapes faster than with other 
manufacturing techniques [190]. In addition, the pore size and distribution can be 
controlled modifying the model. However, it has the limitations of being a process 
that requires expensive technology and the use of high temperature, therefore only 
certain polymers are appropriate to this technique [185]–[187]. 
 
 
1.5.1.6. Electrospinning 
 
 
The electrospinning technique allows the creation of electrospun (non-
woven) scaffolds with high porosity and surface area, manufacturing a net of 
nanofibres and microfibres, which mimics the natural extracellular matrix (ECM) of 
biological tissue. The morphology of the scaffolds (including diameter of the fibres, 
inter-fibre separation, porosity, roughness) can be controlled by modifying the 
environmental, polymer and machine parameters.   
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Fibrous scaffolds are nowadays preferred against other structures for tissue 
engineering applications, as they provide an environment for the cells similar to the 
natural extracellular matrix. This fibrous structure favours the interactions between 
cells and between cells and matrix, which allows creating biological tissue with the 
same characteristics as the tissue that they replace. Moreover, the possibility of using 
biodegradable and biocompatible polymers makes for an attractive technique 
increasing its use day-by-day to create scaffolds for tissue regeneration [191].  
 
It is essential to undertake a study into the advantages and disadvantages of 
the different fabrication methods, to be able to decide which manufacturing method 
would be the most appropriate for creating tissue engineered ACL implants. Table 
1.6 summarises all the advantages and disadvantages found in the literature. 
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Table 1.6 Advantages and disadvantages of different manufacturing methods to create tissue 
engineered scaffolds [192]–[194]. 
 
ACL grafts Advantages Disadvantages
Solvent Casting and 
Particulate Leaching
1. Easy method.                                                 
2. Small amount of material required.     
1. Difficulty in controlling the internal structure (pore 
size and shape) of the polymer matrix.                                                                            
2. Use of organic solvents.                                                                  
3. Time-consuming washing step.                                               
4. Low thickness.                                                                           
5. Limited pore interconnection.                                           
Thermally Induced Phase 
Separation
1. Tunable mechanical properties.                  
2. Control over 3D shape.                                 
3. Control over pore size and shape.              
4. Simple and fast technique.                
1. Long continuos fibres can not be produced.                      
2. Difficult to control fibre dimension and orientation.                            
3. Only polymers with gelation capability can be used to 
produce nanofibrous structures. Limited to few 
polymers.                                                                                     
4. Low yield.                                                                                
5. Use of organic solvents.
Gas Foaming
1. Ease to create 3D structures.               2. 
No use of organic solvents.                          3. 
No high temperatures.
1. Low pore interconnetion.                                                     
2. Formation of a nonporous skin layer on scaffold 
surface.                            
Emulsion Freeze-Drying
1. No high temperatures required.                   
2. No washing steps.                                         
3. Easy technique.
1. Small pore size.                                                                         
2. Long fabrication times.
Rapid Prototyping
1. Control over 3D shape.                                 
2. Fast manufacturing process.                        
1. Limited to few polymers due to the high 
temparatures required in the process.                                                            
2. Expensive technology.                                                           
3. High level of expertise required.                                         
4. No features at the nanoscale.
Electrospinning
1. Well established and easy technique.                          
2. Easy functionalization                                 
3. Creation of long continuous fibres with 
diameters from micro-scale to nano-scale.   
4. Control over fibre diameter and 
orientation.                                                          
5. Tunable mechanical properties.                  
6. Possibility to work with a high range of 
polymers.                                                                
7. No high temperatures if melt 
electrospinning is not used.
1. Difficult to fabricate 3D structures.                                     
2. Difficult to control pore shape.                                          
3. Use of organic solvents for most of the polymers.
 
 
Electrospinning was the manufacturing technique selected for being used in 
this thesis due to its ease of use, tunable morphology, topography and mechanical 
properties of the scaffolds, the possibility to work with a high range of polymers and 
the ability to create a nanostructure comparable to the ECM. For this reason, the next 
section (1.5.2.) will focus on electrospinning, explaining briefly its physical principle 
and the way to optimise the different parameters that take part in the process.  
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1.5.2. MANUFACTURING PROCESS SELECTED: ELECTROSPINNING TECHNIQUE 
 
The main principle of electrospinning is the application of high voltage 
difference between a positively charged metallic needle and a grounded collector to 
project a polymeric solution or melt polymer creating fibres. The three major 
components are a high voltage power supply, a syringe connected to a flow control 
pump, and a metal collector (Figure 1.17) [195]. 
 
When the electrostatic force overcomes the cohesive force of the solution, an 
electrically charged jet emerges from the capillary creating the Taylor cone. Once the 
surface charge overcomes the surface tension of the polymer droplet, a polymer jet is 
initiated [43]. The fluid jet is accelerated and stretched by the external electric field 
and thins dramatically while travelling towards the collector, leading to the formation 
of continuous solid fibres as the solvent evaporates. Electrospinning products appear 
as highly porous nonwoven scaffolds made of nano/micro diameter fibres with large 
surface area to volume ratio. Fibre diameter, inter-fibre separation, roughness and 
fibre orientation can be controlled by changing the spinning parameters [195]–[197]. 
 
Figure 1.17 Schematic diagram showing the electrospinning set up. Reproduced from [198] 
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1.5.2.1. Optimisation of process parameters 
 
There are three different types of parameters in the electrospinning process: 
solution parameters (such as viscosity, concentration, molecular weight, surface 
tension or conductivity), process parameters (such as voltage, flow rate or distance 
between the needle and the collector) and environmental parameters (such as relative 
humidity or temperature). All of these parameters significantly affect the formation 
and morphology of the created fibres. Therefore, only with the control of all these 
parameters can a stable Taylor cone be obtained and nanofibres produced with the 
desired morphology [199].   
 
The qualitative effect of all of these parameters has been thoroughly studied 
[200]–[202] and certain parameters showed correlative relationships between them; 
however the exact values that allow obtaining the required scaffold, depend on the 
equipment, polymer and solvent used. Therefore, before starting with any experiment 
it is essential to find out a range of the parameters to obtain a stable Taylor cone that 
results in correct evaporation of the solvent and creation of non-beading fibres. Once 
a range of the parameters that creates good quality fibres is known, it is necessary to 
optimise those values to obtain the desired mechanical properties and morphology 
for the scaffolds.  
 
One of the biggest challenges with electrospinning is to find the optimal 
combination between viscosity of the polymer solution and flow rate, voltage and 
needle-collector distance [203]. Otherwise, the electrospinning will create beads or 
bead-strings (instead of fibres) if the combination of these parameters is not 
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optimised [199]. The creation of beads or beaded fibres reduce the quality of the 
fibres and consequently the quality of the electrospun mesh, decreasing its material 
properties (Young’s modulus and maximum tensile strengh) [204] and the pore size 
ending to issues in cell migration.  
 
The following Table (1.7) summarises the relationship between the 
manufacturing parameters and their effects on fibre morphology.  
 
Table 1.7 Electrospinning parameters/Fibre morphology [200]–[202] 
 
Fabrication parameters Effect on fibre morphology
Larger fibers and less defects
Bead formation
Difficulty in solution flow
Fiber breakage before reaching the collector
Uniform bead-free fibers, smaller fibers
Smaller fibers in general
Increased transport of charges, higher stretch and thinner fibers
Decrease transport of charges, lower stretch and thicker fibers
Surface tension No inclusive link
Polymer molecular weight/Viscosity Reduction in the number of beads and droplets
Dipole moment and dielectric constant Successful spinning 
Thicker fibers that were not dry upon reaching the collector, 
beads formation
Fibers with smaller diameters
Jet distortion, beading was observed and thicker fibers
Larger fibers 
The solution has a low impulse to reach the collector
Fibers may be broken, high stretch, longer and thinner fibers
Short and wet fibers, no evaporation of the solvent
Using a coaxial, 2-capillary spinneret, hollow fibers were 
produced
Multiple needle tips were employed to increase throughput
Smoother fibers resulted from metal collectors; more porous 
fiber structure was obtained using porous collectors
Aligned fibers were obtained using a conductive frame, rotating 
drum, or a wheel-like bobbin collector
Yarns and braided fibers were also obtained
Temperature caused a decrease in solution viscosity, smaller 
fibers
Humidity caused appearance of circular pores on the fibers
Solution concentration/Viscosity
Solution concentration
Conductivity/Solution charge density
Conductivity of solution
Collector geometry
Beads formation
Ambient parameters 
Flow rate
Field strength/Voltage
Distance between needle tip and collector
Needle tip design and diameter
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Key points: 
1. Fibrous scaffolds are preferred to other structures, since they provide an 
environment for the cells comparable to the natural extracellular matrix. 
2. Electrospinning is a manufacturing technique that presents many advantages in 
comparison to other fabrication methods. The most relevant advantage is the 
possibility of creating scaffolds with a nanostructure comparable to the ECM. 
Moreover, the natural ACL morphology, topography and mechanical properties can 
be mimicked by optimising the electrospinning parameters. Chapters 4 and 5 will 
optimise the process to be able to fabricate scaffolds comparable to the natural ACL.  
3. The ease of use of electrospinning, minimum cost and possibility to work with 
high range of polymers make this technique attractive and with high potential to be 
used in the development of new ACL implants. Chapters 4, 5 and 6 will use the 
electrospinning technique to create scaffolds for potential use as ACL implants. 
 
 
 
 
1.6. POLYMERS USED IN THE MANUFACTURING OF SCAFFOLDS   
 
 
Importance: 
1. The study of the different natural and synthetic polymers commonly used in 
electrospinning (with their advantages and disadvantages) helps to determine the 
most promising candidates to be used to manufacture ACL implants. 
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2. A literature review of the materials used for electrospun ACL scaffolds is needed 
to find the gaps in the current literature and to direct further investigations into 
promising materials and post-fabrication treatments. 
 
 
 
Polymers are the most suitable materials to develop scaffolds for tissue 
engineered applications, due to their mechanical properties (flexibility, strength) 
being comparable to biological tissue and their capacity for cell growth in 
biocompatible polymers. Depending on the origin of the polymer used to fabricate 
the scaffold, synthetic or natural scaffolds can be produced/used. Examples of natural 
polymers used in tissue engineering are collagen, silk, gelatin, hyaluronic acid, 
chitosan or alginate. The most studied synthetic polymers for tissue engineered 
applications are: polyglycolic acid (PGA), poly-L-lactic acid (PLLA), polylactic-co-
glycolic acid (PLGA), polycaprolactone (PCL), polyurethane urea (PUU) or 
polyvinyl alcohol (PVA) [22], [185], [205], [206]. 
 
It was demonstrated that materials such as collagen, hyaluronic acid, chitosan, 
alginate, polydioxanone (PDS) or polyglutamic acid used in tissue engineering 
exhibit lack or loss of mechanical strength compared to silk which exhibits good 
tensile strengh. Silk and chitosan present limited cell adhesion. PGA, PLLA, PCL 
and PLGA are biologically inert, therefore there are difficulties to growing cells on 
and in them [22], [185], [205], [206]. 
 
Tissue engineering uses biodegradable polymers to create new biological 
tissue while the polymer is degrading. Biocompatibility is one of the most wanted 
Chapter 1.  Introduction and Literature Review 
 
 
84 
 
characteristics in a polymer, since the rejection of the scaffold cannot happen as the 
material degrades in time. To customize mechanical properties, degradation rate or 
cell response, it is essential not only to choose the right polymer but also the right 
scaffold fabrication technique.  
 
 
 
1.6.1. MOST COMMON POLYMERS USED IN ELECTROSPINNING   
` 
 
The ideal electrospun scaffold should replicate the structure of the ECM, in 
order to provide not only appropriate mechanical properties to guarantee the integrity 
of the new tissue but also to favour cell adhesion and growth, differentiation and 
migration. 
 
The ECM consists of a 3D structure of polysaccharides and natural polymers 
such as collagen, elastin, proteoglycans and fibrinogen. Each polymer has a specific 
function in the ECM. For instance, collagen provides tensile strength and plays a key 
role in cell-matrix and matrix-matrix interactions [207], [208]. Elastin provides 
elasticity to the tissue and proteoglycans are crucial for cell proliferation, migration 
and cell-matrix and matrix-matrix interactions [207]. 
 
In order to replicate the ECM there are natural and synthetic polymers able to 
be used with the electrospinning technique. The most used natural polymers are 
collagen, gelatin, elastin and silk fibroin [209]. The most used synthetic polymers to 
manufacture electrospun tissue-engineering scaffolds are PCL, PLLA, PGA, poly 
PLGA, PVA and poly urethane (PU) [210], [211].  In general, it is known that 
natural polymers have the capacity to be biocompatible but they lack mechanical 
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strength. For instance the Young’s modulus for gelatin is reported as 1 MPa [212] 
and for collagen 14 MPa [213]. On the contrary, synthetic polymers are biologically 
inert but normally exhibit higher mechanical properties than the natural polymers 
[22], [205], for example the Young’s modulus for PCL is reported to be 158 MPa 
[214].  
 
The advantages and disadvantages of these most commonly used polymers 
are shown in Table (1.8). This table aided the decision of which polymers should be 
used for the experiments performed in this thesis, based principally on their 
biocompatibility, biodegradability, comparable stress/strain behaviour to the natural 
ACL, low cost and the need to avoid using harmful solvents.   
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Table 1.8 Advantages and disadvantages of natural and synthetic polymers [22], [185], [205], [206] 
 
Polymer Advantages Disadvantages
Collagen
1. Biocompatible.                                                
2. 90% of native ACL.                                       
3. Biodegradable.                                                
1. Expensive.                                                                            
2. Lack of mechanical strength.                                                 
3. Immunogenicity.                                                                    
4. Necessity of crosslinking the scaffold.
Gelatin
1. Inexpensive.                                                     
2. Higher tensile modulus than collagen.        
3. Bioactive.                                                        
4. Biodegradable.                                              
5. Biocompatible.                                              
6. Collagen derivative.                                         
7. Harmful solvents are not required.
1. Easy gelification in water.                                                  
2. Necessity of crosslinking the scaffold.
Elastin
1. Biocompatible.                                                
2. Component of the natural ACL.
1. Lack of mechanical strength
Silk
1.Good tensile strength.                                    
2. Viscolastic properties that prevents of 
damage due to fatigue and creep.
1. Limited cell adhesion.                                                       
2. Necessity to remove the sericin to be 
biocompatible.                                                                                 
3. Use of harmful solvents to produce the solution.
PCL
1. FDA-approved for sutures.                              
2. Easily manufactured
1. Use of harmful solvents to produce the solution.                             
2.Very slow degradation rate.                                             
3. Biologically inert.
PLLA
1. Slow degradation rate.                                   
2. Better cell adhesion than PGA or PLGA.    
3. Easily manufactured
1.Use of harmful solvents to produce the solution.                   
2. Hydrophobicity.                                                                          
3. Acidic degradation by product.                                                       
4. Biologically inert.
PGA
1. FDA-approved for sutures.                              
2. Easily manufactured.                                       
3. Technologically mature.
1.Rapid degradation and loss of mechanical 
strength.                                                                                          
2. Hydrophobicity.                                                                    
3. Use of harmful  solvents to produce the solution.               
4. Acidic degradation product.                                                    
5. Biologically inert.
PLGA
1. Controllable degradation rate by 
modifying the PLA:PGA rate.                           
2. Easily manufactured.
1. Use of harmful  solvents to produce the solution.                  
2. Acidic degradation by product.                                             
3. Biologically inert.
PVA
1. Inexpensive.                                                     
2. Water soluble.                                                  
3. Biodegradable.                                                  
4. Nontoxic.                                                            
5. Biocompatible.                                                  
6. Ease of use.                                                    
7. Normally used as baseline polymer from 
which the results can be extrapolated to 
other polymers
1. Necessity of crosslinking the scaffold
PU
1. Biocompatible.                                                
2. Flexibility.
1. Use of harmful solvents to produce the solution.                                                                                             
2. Low mechanical properties of electrospun 
scaffolds comparing to natural ACL.
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Following the tabulated information, it was determined that the two 
polymers with the desired characteristics for further investigation regarding ACL 
implant production were gelatin and PVA. Gelatin, is a natural polymer derivated 
from collagen (the most abundant polymer of the ECM), with similar properties to 
collagen and therefore hypothetically the cells would behave similarly on a gelatin 
scaffold compared to a collagen matrix. Gelatin is considerably cheaper than 
collagen, moreover gelatin exhibits higher tensile modulus than collagen fibres, 
biodegradability and similar bioactivity and biocompatibility to the collagen [215]. 
PVA is an inexpensive polymer with excellent physical, chemical and mechanical 
properties, during this thesis it was shown that 3 twisted/braided PVA scaffolds 
exhibited a maximum tensile stress of 38 MPa identical to the native ACL and 
displayed a Young’s modulus of 129 MPa, comparable to 111 MPa reported for the 
natural ACL [59]. PVA is a highly hydrophilic, water soluble, biodegradable, 
nontoxic and biocompatible polymer [216]–[219]. In addition, due to the ease of 
electrospinning high quality nanofibres, it is normally used as a baseline for 
experiments with other materials.   
 
 
1.6.2. MATERIALS USED FOR ELECTROSPUN ACL SCAFFOLDS 
 
Since 2005 a number of investigations have been performed to produce 
tissue-engineered ACL through the electrospinning technique [22], [44], [214], 
[220]–[233]. The words “ACL” and “electrospinning” have been searched and a total 
of 14 results have been shown in the research database Scopus. In addition to the 
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previous search performed, 3 additional articles of interest related to the 
manufacturing of electrospun tissue-engineered ligaments have been found and 
incorporated in the previous search. These last articles are taken into consideration 
due to their mechanical results (comparable to the mechanical properties to the 
natural ACL). Table 1.9 shows all these articles (17 articles) with the dissolution 
used, the mechanical properties and results achieved. Some conclusions obtained 
through the analysis of these articles will be shown at the end of section 1.6.2. 
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Table 1.9 Tissue engineered ACL produced with electrospinning techinque [22], [44], [214], [220]–[233] 
 
Paper Date Polymers Dissolution Mechanical properties Results
Synthesis and characterization of polycaprolactone 
for anterior cruciate ligament regeneration
2017 Poly(ε-caprolactone) (PCL)
A solution of PCL was prepared by 
dissolving 0.66 g of PCL in 1.6 mL of 
organic solvent mixture composed of 
DCM and DMF at a ratio of 1:1.
Ultimate stress=0.38MPa; Max 
load=0.89N; Elastic 
modulus=0.012MPa; Ultimate 
strain=62.57%
 Fibrous scaffolds generated with electrospinning showed 
weaker mechanical properties visa vis native ACL tissue in terms 
of ultimate stress, and elastic modulus. Also, the synthesized 
PCL can accommodate cell attachment when tested with 
hBMSCs. Put together, these observations reveal that the PCL 
synthesized in this study could be a good candidate as a 
biomaterial for ligament repair or regeneration
Microfibre-reinforced nanofibrous scaffolds with 
structural and material gradients to mimic ligament-
to-bone interface
2017
Poly(lactic-co-glycolic acid (PLGA) (15 wt%) , poly-
lactide acid (PLA) fibres with diameter of about 300 
mm used to o reinforce the
electrospun nanofibres and 50 nm nHA particles
PLGA (15 wt%) disolved in N,N-
dimethylformamide and acetone 1 : 1
Yield force=247.37±15.63 N; 
breaking force=500.11±54.17 N
Microfibre-reinforced nanofibrous scaffolds were 
manufactured with fibre orientation and nHA/BMP-2 gradients. 
The composite gradients were found to regulate cellular 
morphology as well as direct the zonal bone-specific 
differentiation in vitro . The mechanical property of the 3D 
nanofibrous scaffolds was improved by the incorporation of 
microfibres
Mechanical properties and cellular response of novel 
electrospun nanofibres for ligament tissue 
engineering: Effects of orientation and geometry
2016 Poly(ε-caprolactone) (PCL)
10% PCL electrospinning solution was 
a homogenous mixture with a 3:1 
chloroform to methanol
Young Modulus=158±32 Mpa; 
yield stress=57±23 Mpa; yield 
strain=0.38±0.08
Nanofibre orientation and geometry of electrospun PCL were 
modified to mimic the fascicles of native tendon and ligament. 
Aligned nanofibre bundles had the highest yield stresses and 
strains, while still maintaining a relatively high elastic modulus.
Use of Ultra-High Molecular Weight 
Polycaprolactone Scaffolds for ACL Reconstruction
2015
Ultra-high molecular weight polycaprolactone 
(UHMWPCL)
UHMWPCL is dissolved 10% w/w in 
1,1,1,3,3,3-hexafluoro-2-propanol
Peak load=24.6±4.7 N; 
stiffness=8.6±2.0 N/mm
This in vivo  study establishes the superiority of the higher 
molecular weight version of polycaprolactone over PCL as a 
scaffold material for ACL reconstruction.
In Vitro  and In Vivo Evaluation of Heparin Mediated 
Growth Factor Release from Tissue-Engineered 
Constructs for Anterior Cruciate Ligament 
Reconstruction
2015 Poly(ε-caprolactone) (PCL)
PCL 10% w/w in 1,1,1,3,3, 3-
hexafluoro-2-propanol
Graft with Heparin+ bFGF after 16 
weeks. Peak load= 15.32±8.5 N; 
stiffness=10.9±5.2 N/mm
Fibroblasts cultured on these scaffolds in vitro  demonstrated 
increased proliferation in the presence of bFGF immobilized 
using heparin. However, these results did not translate in a 
rodent model of ACL reconstruction, in which no differences in 
matrix deposition or mechanical properties were observed 
between grafts with and without bFGF.
In vivo  evaluation of electrospun polycaprolactone 
graft for anterior cruciate ligament engineering
2015 Poly(ε-caprolactone) (PCL)
PCL 10% w/w in 1,1,1,3,3, 3-
hexafluoro-2-propanol
Failure load=13.27±4.20N; 
stiffness=15.98±5.03 N/mm at 12 
weeks postimplantation
PCL elicits a minimal inflammatory response in the rodent 
model, due to the biocompatibility and successful deposition of 
an aligned collagen matrix.
Electrospun Poly(L‑lactide-co-acryloyl carbonate) 
fibre Scaffolds With a Mechanically Stable Crimp 
Structure For Ligament Tissue Engineering
2014 Poly(L-lactide-co-acryloyl carbonate) (P(LLA-AC))
P(LLA-AC) in 3:1 solution of 
dichloromethane/dimethylformamide 
(DCM/DMF)
Young's modulus of the dry 
uncross-linked fibre scaffolds was 
86 ± 5 MPa and that of the dry 
cross-linked scaffolds was 222 ± 
28 MPa. The average modulus of 
the hydrated scaffolds was 26 ± 
1.4 MPa.
Copolymerizing an acryloyl carbonate monomer with L-lactide 
yielded a copolymer with an acryloyl pendant group along its 
backbone that was effectively utilized to cross-link electrospun 
microfibres possessing an appropriate crimp structure. The 
cross-linked and crimped fibre scaffolds had a Young’s modulus 
approximating that of the modulus of human anterior cruciate 
ligaments. Fibroblasts seeded onto these fibres
effectively attached and proliferated.
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The Influence of Braiding Angle Variation in Braided-
Twisted fibre Scaffold Based Poly L-Lactic Acid for 
Anterior Cruciate Ligament Reconstruction 
Application
2014 Poly L-lactid acid (PLLA)
PLLA 7% wt chloroform and toluene 
3:1
Tensile strength=1.318 MPa for 
braided-twisted fibre scaffold 40°, 
60° 0.22 MPa and 80° 0.024 MPa 
Bigger braiding angle of braided twisted fibre scaffold has high 
degradation rate, bigger pore size, and lower mechanical 
strength.The braided-twisted fibre scaffold exhibited a 
porcentage of living cell of more than 60%.
Current tissue engineering strategies in anterior 
cruciate ligament reconstruction (Review)
2014
There is a true clinical need f or a tissue-engineered ACL graft. 
Tissue-engineered alternative to autografts and allografts may 
help to circumvent some of the complications associated with 
these traditional therapies. There is a lack of understanding of in 
vivo ACL development. To date, there is no tissue-engineered 
ACL construct that has been successfully implanted in humans. 
Updates in biological therapies for knee injuries: 
Anterior cruciate ligament
2014
Biological therapies are being developed and analyzed to 
optimize ACL injury treatment. Under the concept of biological 
therapy, remnant preserving ACLR seems to be the most simple, 
easily available, and economically viable strategy to improve 
ACL treatment.
Effect of fibre orientation of collagen-based 
electrospun meshes on human fibroblasts for 
ligament tissue engineering applications
2014
Poly(lactic-co-glycolic acid (PLGA), collagen I 
(ColI),and polyurethane (PU) 
15 w/v %PLGA(85:15), 10 w/v % ColI, 
and 5 w/v % PU and 15 w/v% 
PLGA(50:50), 10 w/v % ColI, and 5 w/v 
% PU
Aligned fibres and PLGA (50:50): 
Young's 
modulus=348.38±12.5MPa; Max 
strain=98.61±12.28; Tensile Stress 
at Yield=8.98±0.68                  
Aligned fibres and PLGA (85:15): 
Young's 
modulus=63.12±18.22MPa; Max 
strain=91.36±17.31; Tensile Stress 
at Yield=7.09±1.9
The experiments were carried out with coaxial electrospinning 
with a core of PU and a shell of collagen and PLGA with two 
different ratios of PLGA (50:50 and 85:15). The Young’s 
modulus, tensile stress at yield, and ultimate tensile strain of 
aligned fibre PLGA(50:50)-Coll-PU scaffolds demonstrated 
similar tensile properties to that of ligaments found in the knee 
such as anterior cruciate ligament (ACL), posterior cruciate 
ligament (PCL) and medial cruciate ligament (MCL). Moreover, it 
was demonstrated that human fibroblasts were attached and 
proliferated with no need for additional surface modifications
a promising base material for tissue-engineered
ligament in that they are a biomimetic structure, and
provide the mechanical environment ligament fibroblasts
encounter in vivo .
Cellularized Cylindrical fibre/Hydrogel Composites for 
Ligament Tissue Engineering
2014
Poly(lactic-co-glycolic acid (PLGA)/polyethylene 
glycol diacrylate (PEGDA) and poly(ester urethane) 
urea elastomer (PEUUR)/ PEGDA
95/5% (w/w) PLGA/PEGDA or 95/5% 
(w/w) PEUUR/ PEGDA polymer 
mixture was dissolved in HFIP to a final 
polymer/solvent concentration of 
11/89% (w/w)
Young's modulus of
the PLGA/PEGD composites=11.6 
MPa and PEUUR/ PEGDA 
composites= 1.05 Mpa
They obtained cellularized elastomeric composites for ligament 
tissue engineering that could support cyclic mechanical loading 
and cell viability. However, they did not have enough 
mechanical properties for ligament replacement and the cells 
are not able to proliferate, due to the limited ability for the cells 
to adhere to and migrate through the PEG hydrogels. Moreover, 
a 40% decrease in the Young’s modulus was observed when 
PLGA meshes were combined with a PEG hydrogel, the reason 
could be related to poor mesh/hydrogel bonding. In conclusion, 
the use of hydrogels for ligament tissue engineering could be 
very useful to get cellularized 3D scaffolds but must be studied 
deeper.
Review
Review
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In vivo  study of ligament-bone healing after anterior 
cruciate ligament reconstruction using autologous 
tendons with mesenchymal stem cells affinity peptide 
conjugated electrospun nanofibrous scaffold
2013 Poly L-lactid acid (PLLA)
1.0 g of PLLA powders in 10mL 
tetrafluoroethylene
Failure load (N)=82.59 ± 3.33
After implantation of grafts for 3 months, the regenerated 
ligament-bone insertion exhibited abundant ECM (collagen I, II, 
and III) and fibrocartilage growth. The tensile strength of the 
implant was shown to be better than the control. The findings 
of this study imply that nanofibrous scaffold with specific MSCs 
affinity peptide has great potentials in accelerating ligament-
bone healing process after ACL reconstruction.
Biomimetic poly(lactide) based fibrous scaffolds for 
ligament tissue engineering
2012
Poly(L-lactide-co-D,L-lactide) (PLDLA), poly(D,L-
lactide) (PDLLA) and poly(L-lactide) (PLLA)
PLDLA, PDLLA and PLLA are dissolved 
in 3:1 (volume ratio) of 
dichloromethane:dimethylformamide
Yield strain (cm/cm) from 0.21 ± 
0.03 until 0.15 ± 0.01; Ultimate
load (N) from  1.5 ± 0.2 until 0.23 
± 0.02; Modulus (MPa) from 19 ± 
4 until  3 ± 0.3 depending on the 
polymer used.
Of the poly(lactide) based polymer fibres investigated in this 
study, the 250 kDa PLDLA fibre mats possessed the highest 
modulus, and were the most resistant to degradation. The 250 
kDa PLDLA fibres were successfully treated in a heated aqueous 
environment to possess a crimp-like pattern. However, the
crimp-like pattern was not completely recoverable upon 
repetitive loading. Cells and the presence of collagen 
accumulation were observed at the surface and interior regions 
of the construct, demonstrating the potential of crimp-like 250 
kDa PLDLA fibres as a biomimetic scaffold for ligament
tissue engineering.
Preliminary investigation of airgap electrospun silk-
fibroin-based structures for ligament analogue 
engineering
2011
Silk fibroin (SF), polydioxanone (PDO), 
polycaprolactone (PCL), SF+PDO (50:50) and SF+PCL 
(50:50)
SF, PDO and PCL were dissolved in 
1,1,1,3,3,3 hexafluoro-2-propanol at 
concentrations of 100 mg/ml. 
Solutions were both electrospun 
individually and in 50:50 blends by 
volume of SF/PDO (SPDO) and SF/PCL 
(SPCL).
Wound SPCL structures: Young's 
modulus of 113±45 MPa, peak 
stress of 24.36±9.38 MPa and 
strain at break of 0.28 ± 0.07 
mm/mm
Structures made of high rotating speed are more compact, with 
more aligned fibres and less porous than structures made with 
low rotating speed or created through airgap electrospinning. 
The airgap electrospun scaffolds present the most porosity and 
thereby they are more conducive to cellular infiltration. In 
addition, although they not possess the same degree of fibre 
alignment or mechanical properties as highly aligned structures, 
its alignment is enough to induce a preferential direction of 
alignment in the fibroblasts seeded. Wound structures reach 
values of Young modulus and peak stress very similar to native 
anterior cruciate ligament, so they present good mechanical 
properties but poor level of porosity therefore inadequate 
cellular penetration. The authors of this paper suggest creating 
structures with a wound center core of aligned fibres to get the 
mechanical properties desired and a high porosity outer layer to 
enhance cellular infiltration. 
Electrospun degradable segmented polyurethane 
elastomers for ligament tissue engineering (abstract 
conference)
2005 Plyurethane (PU)
They present preliminary results demonstrating that they can 
control the diameter and degree of orientation of electrospun 
polyurethane fibres, and that electrospun substrates alter cell 
spreading, orientation, and the expression of extracellular 
matrix proteins.
Nanofibre alignment and direction of mechanical 
strain affect the ECM production of human ACL 
fibroblast.
2005 Plyurethane (PU)
PU 20 wt% N,N-dimethyl formamide 
(DMF)
Aligned fibres: Young's 
modulus=2500±63KPa; Max 
strain=1.08±0.17; Ultimate 
strength=3520±30KPa
HLFs cultured on aligned nanofibres had a similar morphology to 
ligament fibroblasts in vivo , and the aligned structure led to 
increase ECM production. Aligned nanofibres can constitute
a promising base material for tissue-engineered
ligament in that they are a biomimetic structure, and
provide the mechanical environment ligament fibroblasts
encounter in vivo .
Not shown
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Approximately 35% of the articles found developed their ACL implants with 
PCL [214], [220], [222], [223], 41% of the articles worked with derivates of PLA 
and PGA [224], [225], [227], [230]–[233] and approximately 24% of the articles 
produced their ligament implants with derivates of PU [228]–[230].  
 
It was observed that mechanical properties highly depend on the 
manufacturing process of the scaffold and its morphology, and not only on the 
specific material, as it was proved that modifying the structure of scaffolds made 
from the same polymer provides completely different mechanical properties [214], 
[220], [222], [223]. For instance, a solution of PCL dissolved in 1:1 DCM and DMF 
created a randomly distributed nanofibre scaffold with an elastic modulus of 0.012 
MPa [220]; however, a solution of 10% PCL dissolved in 3:1 chloroform and 
methanol produced aligned nanofibre bundles exhibiting an elastic modulus of 158 
MPa [214] much closer to the natural ACL (approx. 111 MPa [59]). Full et al. (2014) 
[230] also demonstrated that aligned fibre scaffolds present higher tensile properties 
than scaffolds with random fibre orientation; the tensile yield stress of aligned PLGA 
(50:50) fibres was reported to be 8.98 MPa, however the tensile stress at yield of 
randomly distributed PLGA (50:50) fibres was reported 0.86 MPa. 
 
From Table 1.9, it was shown that three articles reported mechanical values 
similar to the ACL [214], [224], [230], two of them achieving those values through 
aligned fibres [214], [230] and the other using a crosslinker agent [224]. Just one 
article studied 3D structures based on twisted/braided electrospun scaffolds, although 
its mechanical properties were not comparative to the native ACL [225]. From those 
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articles, it was concluded that to produce electrospun scaffolds with mechanical 
properties similar to the ACL, it is important to understand three issues:  
 
 The differences in terms of mechanical properties between randomly 
distributed and aligned fibres of the polymer.  
 How a crosslinker agent can affect the mechanical properties of 
electrospun scaffolds. 
 Evaluation of different 3D configurations such as twisted/braided or 
just twisted structures in order to understand how those configurations 
affect the mechanical properties of the scaffold. 
 
Following these last conclusions, the studies in Chapters 4 and 5 addressed 
the evaluation of the distribution of the fibres and the crosslinking process for gelatin 
and PVA respectively, and Chapter 6 studied different 3D configurations to 
determine the optimum for producing 3D tissue engineering ligaments. 
 
 
Key points: 
1. Gelatin, is a natural polymer derivated from collagen, with similar properties but 
considerably cheaper, is biodegradable and has similar bioactivity and 
biocompatibility to collagen. Gelatin was used in Chapter 4 to develop new ACL 
implants. 
2. PVA is an inexpensive polymer, with better mechanical properties than other 
polymers used for tissue engineered applications, highly hydrophilic, water soluble, 
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biodegradable, nontoxic and biocompatible. This polymer was used in Chapter 5 and 
6 to create 2D and 3D scaffolds for ACL replacement. 
3. Mechanical properties highly depend on the manufacturing process of the scaffold 
and its post-fabrication process. Therefore, aspects such as fibre distribution, 
crosslinking process and 3D electrospun structures have to be investigated. 
4. The mechanical evaluation of random and aligned distributed fibres of gelatin and 
PVA was respectively addressed in Chapters 4 and 5. 
5. The mechanical properties of crosslinked gelatin and PVA scaffolds were 
investigated in Chapters 4 and 5. 
6. The study of different 2D and 3D electrospun structures was performed in Chapter 
6 to determine the optimum structure to produce 3D tissue engineering ligaments. 
 
 
 
1.7. RESEARCH QUESTIONS   
 
Once the background study and literature review of the field had been 
performed, it was necessary to define the current gaps and determine the research 
questions that this thesis needed to answer. The research questions are presented 
below: 
 
 How can one develop a reliable and easy methodology to investigate 
the in vivo ACL mechanical behaviour for a large number of activities 
(in one study to allow comparison) and define mechanical 
specifications to design new biomimetic ACL grafts? (Chapter 3). 
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 Seeing that 25% of the ACL reconstructions lead to a further surgery 
and/or long-term issues, is this due to the current standardized 
procedure to design ACL implants not accounting for all of  the 
loading that the natural ACL has to bear? (Chapter 3). 
 Are gelatin and PVA suitable polymers to be used for the production 
of ACL electrospun grafts? In other words, could 2D electrospun 
gelatin and PVA scaffolds mimic the nano/micro morphology and the 
mechanical behaviour of the natural ACL once the solution and 
process parameters are optimised? (Chapters 4 and 5). 
 Which 2D/3D electrospun structure is optimum to replicate the 
morphology and the mechanical properties of the natural ACL? 
(Chapter 6). 
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2. Aims and thesis structure 
 
 
2.1. AIM AND OBJECTIVES 
 
The aim of this PhD was to design and manufacture biomimetic electrospun 
prototypes with comparable mechanical properties and morphology to natural ACL. 
These prototypes produced proof of concept for the design and manufacture and will 
be used as the baseline for cell testing, animal models and at the final stage clinical 
trials.  
 
In order to achieve this aim several objectives were worked through different 
studies.  
  
Objective 1 - Understanding current treatment technologies  
Identification of the research questions and current gaps in the field had to be 
defined through the study of the ACL background and literature review.  
  
Objective 2 - Quantify ACL Biomechanics 
This study was focussed on the understanding of in vivo ACL biomechanics 
to obtain the mechanical specifications to design and assess ligament 
implants; to that end a novel methodology was developed.   
  
Objective 3 - Material Evaluation 
Determination of the suitability of two different polymers (gelatin and PVA) 
to be used in the manufacturing of ACL prototypes and optimisation of the 
Chapter 2. Aim and Thesis Structure  
 
  97        97 
  
process in order to obtain mechanical properties and morphology comparable 
to the natural ACL. 
  
Objective 4 - Implant Structure for Optimal Mechanical Performance  
The last study identified the optimum prototype able to reproduce the 
mechanical behaviour (under cyclic tensile and shear loading and dry and wet 
conditions) and the nano and micro morphology of the natural ligament.  
  
A scheme of the thesis with the aims and novelties of each study are 
presented in Figure 2.1.4 
   
 
Figure 2.1 Aims and novelties of each study performed in this thesis. 
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2.2. THESIS STRUCTURE 
 
This thesis consists of ten chapters. The first Chapter describes the 
background and literature review regarding the ACL including topics such as 
anatomy of the knee and the ACL, mechanical behaviour, ACL injury mechanics, 
state for the art of ACL implants, the manufacturing process and the polymer used in 
the manufacturing of scaffolds. Research questions are included at the end of Chapter 
1.  
 
Chapter 2 presents the aim and objectives of this PhD thesis and briefly 
explains the thesis structure.  
 
Chapter 3 focusses on the in vivo mechanical behaviour of the ACL for 
consideration as mechanical specifications in the prototype designs. This chapter 
presents two different studies, the first (Biomechanics Study 1) developed a novel 
methodology to understand the in vivo mechanical behaviour of the ACL; and the 
second study (Biomechanics Study 2) calculated the in vivo strain and tensile forces 
on the ligament for different activities to be used in the design specifications and for 
assessing the prototypes.  
 
Chapter 4 evaluates the suitability of gelatin to manufacture ACL implants. In 
this Chapter two studies are performed, the first study (Gelatin Study 1) focusses on 
the understanding of how changes in the solvent concentration affect the mechanical 
and structural properties of the scaffold; and the second study (Gelatin Study 2) 
examines the use of a crosslinker agent and any corresponding changes to the 
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morphology of the nanofibres and their network. The optimisation of the solution and 
process was also determined at the beginning of this chapter.  
 
Chapter 5 studies the suitability of PVA for use as ACL implants. This 
chapter consistes of three studies. PVA Study 1 optimised the solution and process 
parameters achieving 2D electrospun scaffolds with morphology comparable to the 
natural ACL morphology. PVA Study 2 was focussed on the mechanical 
characterization of different scaffolds to identify the optimum i.e. with mechanical 
and morphological properties comparable to the native ACL. PVA Study 3 
determined the degradation of the optimum scaffold. 
 
 Chapter 6 studies morphologically and mechanically different 2D and 3D 
PVA structures under cycles of tensile and shear loads in dry and wet conditions. The 
optimum prototype to move forward to cell testing and animal models was 
determined. 
 
 Chapter 7 presents a discussion of all the studies done with their limitations 
and future work.  
 
Chapter 8 explains the conclusions obtained during this thesis. 
 
Chapter 9 conteins the references for the thesis as a whole. 
 
And finally, Chapter 10 presents the appendix. 
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3. Biomechanical specifications for designing 
ACL implants 
 
 
3.1. ABSTRACT 
 
The anterior cruciate ligament (ACL) plays a key role in the stability of the knee 
joint restricting the rotation and anterior tibial translation. However, there is a lack of 
knowledge of the in vivo ACL mechanical behaviour during high impact 
manoeuvres. This study aimed to understand and calculate the tensile forces while 
the anterior cruciate ligament (ACL) is subjected to loading during different 
activities. The motion of participants with healthy knees while they performed the 
following activities was investigated: walking, running, negotiating stairs, cross-over 
cutting, sidestep cutting, jumping and jumping with one leg. The in vivo ACL length 
and strain were calculated using experimental kinematic data and a three degree of 
freedom (DOF) knee model implemented in OpenSim. The in vivo ACL tensile 
forces were determined with a well-established force/strain relationship obtained 
through ACL tensile tests. Statistical regression models of ACL lengths with respect 
to angles for each activity have been performed in order to better understand the 
ACL failure mechanisms. The results determined that the forces experienced by the 
ACL of women during stair negotiation were highly significant compared to ACL 
forces in men and the ACL forces in aged people were significantly higher than in 
younger people. For the remaining activities, the maximum ACL tensile force was 
observed during jumping vertically at maximum effort and landing with both legs 
(1.076±0.113 N/BW). Surprisingly, the peak tensile ACL force for all participants 
during crossover cutting (0.715±0.2647 N/BW) was lower than during walking 
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(0.774±0.064 N/BW). Regression coefficients for crossover cutting indicated that 
excessive knee rotation and abduction angles contribute more significantly to the 
ACL elongation than in activities such as walking or running. These findings 
indicated that the ACL is subjected to multidirectional loading; further studies will 
be performed to investigate torsion and shear force on the ligament.  
 
 
 
3.2. INTRODUCTION 
 
The ACL is a key component in the stabilization of the knee joint, 
restricting the rotation and the anterior tibial motion and has the higher rates of injury 
of the human knee ligaments [1]. It is estimated that 78% of ACL injuries occur 
during noncontact activities, where sudden decelerations, landing from a jump, cross-
over cutting or pivoting are present [4]. The majority of these injuries were recorded 
in young athletes [234]. Anatomical (femoral notch distance or laxity), hormonal and 
biomechanical factors have been researched to understand the important factors 
contributing to these higher rates of injury [118], [235]; however the key factors 
contributing to ACL mechanical behaviour during high-risk activities and ACL 
rupture remain unclear.  
 
Experiments using cadaveric knees [40] determining anthropometrical 
parameters (ACL insertion points locations or femoral notch distance), or 
understanding the behaviour under mechanical loading, exhibited limitations in 
reproducing the in vivo mechanical behaviour of the ACL. Video and motion capture 
Chapter 3. Biomechanical Specifications 
 
  102        102 
  
techniques [70], [71] were also used to understand ACL injury mechanisms through 
the study of joint kinematics but disregarded the ACL length, strain or force. Strain 
gauges have also been employed to assess the in vitro ACL strain [72] and in vivo 
ACL strain in cycling and squatting [73], [74], but in the last case is invasive, 
requires surgery and the gauge is attached to only a small location of the ACL, not 
recording the strain across the whole ligament. Experiments with motion capture and 
biplanar fluoroscopy [75], [76] and studies with motion capture and musculoskeletal 
simulations [77]–[79] determined ACL length and strain during walking and jumping 
with both legs but activities with a high injury rates such as jumping with one leg or 
cutting have not been evaluated.  
 
Due to the wide range of techniques used to determine in vivo ACL strain 
and force and the limitations associated with each technique, there are differences in 
the results obtained, and comparison between activities is complicated. During 
walking for example, there is a large disparity with some studies reporting peak ACL 
forces of 0.2 N/BW [102] and others of more than 1 N/BW [103], [104]. Therefore, it 
is necessary to develop and implement a reliable and easy methodology to 
investigate different activities in one study to allow valid comparison, and to have 
mechanical specifications to design ACL ligaments according to the in vivo 
mechanical behaviour of the ACL.  In this chapter two different biomechanical 
studies were performed (biomechanics study 1 and biomechanics study 2). For the 
first study a  musculoskeletal model with 23 DOFs (1 DOF at the knee joint) [236] 
was developed and in the second study the model was improved incorporating a total 
of 27 DOFs (3 DOF at the knee joint) [237]–[239].  Motion capture was used to 
determine the ACL length, strain and tensile force at all ranges of motion for eight 
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different activities: ascending stairs, descending stairs, walking, running, sidestep 
cutting, crossover cutting, jumping with one leg and drop landing and jumping with 
maximum effort with two legs. Stair negotiation was evaluated in the first study and 
the rest of the activities in the second study. 
 
Nowadays, many researchers are developing new tissue engineered ligament 
and tendon implants. However, regarding mechanical characterization, only material 
properties such as Young’s modulus, ultimate tensile strain or tensile stress at yield 
are considered to determine if the scaffold has the appropriate characteristics to be 
implanted. Currently, no link has been created between mechanical behaviour at all 
ranges of motion and the design and development of tissue engineering based 
ligaments.  
 
The novelty of this Chapter 3 was in trying to understand how this ligament 
behaves while different activities are performed to study the failure mechanisms of 
the ACL and so be able to design improved implants relating to the forces 
experienced on these natural fibrous connective tissues.  
 
Different aims are associated with the two different studies developed in this 
chapter. The first study aimed to create a novel methodology easy to implement in a 
large range of activities to calculate in vivo ACL strain and tensile force; moreover, 
pilot studies for gender and different ages to analyse the in vivo ACL mechanical 
behaviour were performed. The second study aimed to develop an improved 
musculoskeletal model with which to compare the ACL behaviour between activities 
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and to use to design ligaments relating to the in vivo ACL strain and forces 
experienced by the natural ACL.  
 
 
 
3.3.  METHODS 
 
As was mentioned in the introduction (section 3.2.), this chapter aimed to 
understand and calculate in vivo forces while the ACL was subjected to loading. To 
achieve this goal three steps were followed:  
 
a) Recruitment of participants with healthy knees in order to capture their 
motion (though a VICON system) while they were performing different 
activities.  
 
b) Development of an OpenSim model to calculate the in vivo ACL length 
from kinematic data and with it be able to calculate the in vivo ACL strain 
at each moment of time. 
 
c) Implementation of a Matlab code to calculate in vivo ACL tensile forces 
using a force/displacement relationship given by Blankevoort. et al. [240], 
to be used as mechanical specifications for the design of the ACL 
implants.  
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The in vivo ACL mechanical behaviour was analysed by capturing the motion 
of participants while different activities were performed and then creating a 
musculoskeletal model in order to estimate the in vivo ACL length, strain and tensile 
forces in each moment of time. The results of this chapter helped in the 
determination of safety thresholds for the scaffold design. 
 
This chapter shows two different studies. Although both methods were 
similar, the computational models and tasks for each study were different; therefore, 
in order to clarify the content of each study, the method followed in each one was 
presented separately in sections 3.3.1 and 3.3.2.  
 
 
3.3.1. BIOMECHANICS STUDY 1 
 
The following Figure (3.1) represents the performed steps as needed in the 
methodology of this first study. An explanation of each task performed with 
OpemSim (Sim TK, Stanford, CA) was presented in Chapter 1 section 1.3.3.2. 
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Figure 3.1 Flow chart with the performed tasks in the first study 
 
 
3.3.1.1. Recruitment of healthy participants  
 
Nine participants (6 men and 3 women; mean±SD age: 41.4±13years, height: 
1.7±0.09 m and mass: 69.3±13.7 kg) were recruited for the first study, the number of 
participants was determined following previous studies [241]–[244]. Each participant 
was asked to read an information sheet, sign a consent form and to complete two 
questionnaires prior to beginning any activity. The questionnaires were the Knee 
Injury and Osteoarthritis Outcome Score (KOOS) and the Hip Injury and 
Osteoarthritis Outcome Score (HOOS), and they allow the assessment of knee and 
hip pain/symptoms and to only include in the study the participants with no history 
of knee injury, surgery or pain. Ethical approval was provided for the project by 
Science and Engineering Faculty Ethics of the Manchester Metropolitan University 
(ethics code: SE141530). 
Chapter 3. Biomechanical Specifications 
 
  107        107 
  
 
3.3.1.2. Motion capture 
 
A 10-camera motion capture system (Vicon 612 system, Oxford Metrics, UK) 
was used to collect kinematic data sampled at 100 Hz for both studies. A 
modification of the Cleveland Clinic marker set [109], consisting of 33 reflective 
markers placed on specific anatomical landmarks of the lower and upper body of the 
participants, was utilized to collect the kinematic measurements. The locations of the 
markers can be seen in Figure 3.2. 
 
Figure 3.2 Reflective markers locations. 
 
 
In addition, in the first study a set of 16 wireless surface electromyography 
(EMG) sensors (Delsys Inc. Boston, MA, USA) were placed on each participant, 
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recording the activation of the muscles quadriceps vastus medialis, quadriceps rectus 
femoris, quadriceps vastus lateralis, tibialis anterior, peroneus longus, gluteus 
medius, medial hamstrings and gastrocnemius medialis of both legs. The locations of 
these EMG sensors are shown in Figure 3.3. The purpose of EMG recordings was to 
validate the behaviour of the muscles in the first musculoskeletal model. 
 
 
Figure 3.3 EMG sensors locations. 
 
 
Before starting the experiment, the 10-camera motion capture system (Vicon 
612 system, Oxford Metrics, UK) was calibrated in order to calculate the location 
and orientation of all the cameras, and the correct operation of the EMG electrodes 
was checked on each participant. 
 
As mentioned in the introduction (section 3.2.), the first study was performed 
over an 8-step experimental staircase. The majority of experimental stairs used in 
biomechanical studies have only 1 or 2 steps [245]–[248], however this is one of the 
Chapter 3. Biomechanical Specifications 
 
  109        109 
  
first studies investigating ACL loading over a realistic staircase with an appropriate 
number of steps to simulate a real-life scenario. Therefore, a staircase with an 
optimum number of steps considering the resources (space, laboratory height and the 
number of Vicon cameras available) and the repeatability of the motion was used. 
This staircase had standard dimensions and contained four force platforms (Kistler, 
Switzerland) embedded into the middle steps. This staircase can be seen in Figure 
3.4.  
 
 
Figure 3.4 8-step experimental staircase. 
 
 
The force plates, in the first study, were used to help inform the static 
optimisation solver implemented in OpenSim for the calculation of the muscle 
activation. An initial static trial for participant calibration (scale body segments and 
align joints) was performed with each participant. This first trial was considered 
successful when all markers were visualized. Then, the participants were asked to 
perform the tasks up to a total of three successful trials following previous studies 
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[247], [248], while kinematic data were captured and EMG signal and reaction forces 
were recorded.  
 
For the first study, the participants were asked to ascend and descend the 
staircase at a normal self-selected speed in a step-over-step manner. 
 
 
Once the data were collected, they were processed in Vicon Nexus 1.8.5. 
(Vicon Motion Systems Ltd, UK) software and exported to OpenSim 3.3 (Sim TK, 
Stanford, CA) for the kinematics analysis. 
 
3.3.1.3. Determination of ACL elongation 
 
The in vivo ACL length at each timepoint was determined by tracking the 
coordinates of the ACL insertion points from the processed kinematic data derived 
from motion capture and a musculoskeletal model scaled for each participant 
according to their anatomy. 
 
A musculoskeletal model was developed based on the Gait 2392 model [249] 
implemented in OpenSim software, a lower extremity with back and torso model 
created by the developers of OpenSim. For the first study a model with 23 DOFs (1 
DOF at the knee joint), with 12 elements representing the bones and 92 
musculotendon actuators was developed.  
 
The anterior cruciate ligaments were modelled as an elastic passive soft tissue 
that follows a straight-line path between the insertion points in the femur and tibia. A 
Thelen2003 muscle [115] model implemented in OpenSim and based on Hill’s 
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model [250] was used to simulate the ACL. In order to mimic its passive character, 
the fibre length was set to zero and the contractile element activation was annulled.    
 
The attachment sites were studied and incorporated in this model using the 
average values reported in Xu et al. [78] and the placement was verified through Lee 
et al. [31] and Jordan et al. [251]. The coordinates for femur and tibia insertion 
points are shown in Table 3.1. 
 
 
Table 3.1 ACL insertion points. 
 
 
Insertion at femur (m) Insertion at tibia (m) 
 
X Y Z X Y Z 
Right leg -0.0111 -0.4051 0.00705 0.00955 -0.0313 -0.00035 
Left leg -0.0111 -0.4052 -0.00705 0.00955 -0.0313 0.00035 
 
 
The two ACL fibre bundles (anteromedial and posterolateral) were not 
considered in this model, since it was demonstrated [252] that the behaviour of both 
bundles is similar. Both bundles are stretched when the knee is extended and 
shortened when the knee is flexed. In addition, most surgeons prefer to perform a 
single bundle surgery to minimize loss of bone, risk of infection, time, and favour 
healing.    
 
The ACL length was calculated from kinematics due to the fact that the 
OpenSim model allows tracking of the coordinates of the attachment sites and 
calculation of the elongation at each moment of time with an analysis solver.  
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The strain at each instant was calculated from the ligament length change at 
each timepoint and the unloaded length. The in vivo unloaded length of the ACL for 
each participant was determined from a reference length (ACL length at knee full 
extension calculated, with the coordinates of the attachment sites, for each 
participant) and reference strain (taken from literature [240]) following previous 
studies [240]. 
 
3.3.1.4. ACL Force Estimation 
 
It is well known that ligaments have a viscoelastic character and follow a 
non-linear force/displacement curve due to the crimping pattern of their fibres. This 
chapter used the force/displacement curve defined by Blankevoort and Huiskes et al. 
[240] where a ligament was simulated by a non-linear spring, and its viscoelastic 
behaviour was mimicked with a damping element in parallel to the spring (Figure 
3.5).  
 
Figure 3.5 Sketch of the viscoelastic behaviour of the ACL. 
 
 
The estimation of the tensile force exerted by the spring (F1) was performed 
following the equations presented in [240]: 
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F1 = ¼ k ɛ2/ ɛl              0 ≤ ɛ ≤ 2 ɛl  
F1 = k (ɛ-ɛl)              ɛ  > 2 ɛl   
F1 = 0               ɛ  < 0   
 
Where: 
ɛ  Strain of the ligament  
ɛl  Linear range threshold 
k  Stiffness of the spring 
 
The strain is calculated from the ligament length (L) at each position and the 
zero-load length (L0).  
 
ɛ = (L-L0) / L0    
 
The unloaded ligament length is difficult to obtain; therefore, it was 
calculated by the length (Lr) and strain (ɛr) of the ligament at full extension, the 
reference position in the experimental trials.  
 
L0 =  Lr / (ɛr+1)    
 
The force exerted by the damper (F2) was calculated using the equation: 
 
F2 = D v     
 
Where: 
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D  Damping coefficient 
v Ligament velocity calculated by the central difference method. 
 
The parameters to model the ligaments are shown in Table 3.2.  
 
Table 3.2 Stiffness, threshold strain, reference strain and damping coefficient. 
 
 
 
 
Subsequently the calculated forces were normalized for Body Weight (BW) 
allowing comparison between participants. 
 
It is worth noticing that although the behaviour of both ACLs were collected, 
for the sake of simplicity only right-handed participants were considerated and only 
the results for the right knees are presented in the second experiment.  
 
Similar approaches to determine the ACL elongation and tensile force were 
used in Debski, Darcy and Woo et al. [255] when testing cadaveric knees.  
 
3.3.1.5. Muscle validation 
 
In order to validate the correct muscle function of the first model, the 
activation of certain muscles around the knee were recorded with EMG sensors and 
this activation was qualitatively compared with the forces of that muscles estimated 
from the OpenSim model. Figure 3.6 shows how the peaks of recorded activation for 
vastus lateralis are in the same instant of time as the peaks of force for the same 
muscle. 
k (N) ɛl ɛr D (N s/m) 
5000 [240] 0.03 [240] 0.08 [240] 500 [253], [254] 
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Figure 3.6 Vastus lateralis activation given by EMG and forces calculated by OpenSim model. 
 
 
3.3.1.6. Statistical analysis 
 
For the first study, no outliers in the data were observed from visual 
inspection. Moreover, differences between estimated ACL forces on both knees for 
sex, age and activities groups were compared using a one-way and two-way analysis 
of variance (ANOVA) with a 95% confidence interval, for the first experiment. 
 
All statistical analyses were conducted using SPSS (IBM Inc., Chicago, 
Illinois). 
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3.3.2. BIOMECHANICS STUDY 2 
 
The following Figure (3.7) represents all the performed steps needed in the 
methodology of this second study. 
 
 
Figure 3.7 Flow chart with the performed tasks in the second study 
 
 
3.3.2.1. Recruitment of healthy participants  
 
Twelve young adults with no previous ACL injuries (7 men and 5 women; 
mean ± SD age: 27.3 ± 3.3 years, height: 1.7 ± 0.1 m and mass: 71.6 ± 15.5 kg) were 
recruited for the second study following the number of participants in Morisson et al. 
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[102]. Test participants gave informed consent and the study was approved by the 
University’s Faculty Ethics committee as was explained for the first study in section 
3.2.1.1.  
 
3.3.2.2. Protocol  
 
As in the first study, a 10-camera motion capture system (Vicon 612 system, 
Oxford Metrics, UK) was used to collect kinematic data sampled at 100 Hz. A 
modification of the Cleveland Clinic marker set [109], consisting of 33 reflective 
markers placed on specific anatomical landmarks of the lower and upper body of the 
participants, was utilized to collect the kinematic measurements. 
 
All activities involved in the second study were performed over level ground 
and the participants were asked to perform them at their self-selected speed in order 
to eliminate interference with the correct execution of the task. Activities were: 
walking, running in a straight line, crossover cutting turning suddenly, sidestep 
cutting running straight then stepping at the right side with the right leg and keeping 
running straight, dropping from a 30 cm height jumping box and performing a 
vertical maximum effort jump with both legs, and jumping horizontally three times 
with one leg. The setup of this experiment can be seen in Figure 3.8. 
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Figure 3.8 Setup of Vicon cameras and force plates for the experiment over level ground 
 
 
Tape was placed on the floor for the purpose of all participants undertaking 
the activity in the same manner; moreover three force plates were used, in the second 
study, just for reference points to perform the tasks. The tape was used to indicate the 
starting and ending point of all the activities and the trajectories of the cutting tasks. 
Once the participants were familiarised with the activities (performing them until 
their execution were correct) the kinematic data was collected for each participant 
over three successful repeated trials. 
 
For this second study, they were asked to walk straight as normally as 
possible and step over the second force plate (FP2), as shown in Figure 3.9. 
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Figure 3.9 Walking trial. 
 
 
Afterwards, the participants run straight as normally as possible, stepping 
over one force plate (FP2) (Figure 3.10). 
 
Figure 3.10 Running trial. 
 
 
 
For the next task, they were asked to run at a certain angle and step over the 
FP2 force plate with the right leg and then turn and step over the FP3 with the left leg 
to perform a crossover cutting maneuver (Figure 3.11). 
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Figure 3.11 Crossover cutting trial. 
 
Immediately after, they performed a sidestep cutting maneuver, running 
straight, stepping over the FP2 force plate with the right leg and keeping running 
straight (Figure 3.12).  
 
Figure 3.12 Sidestep cutting trial. 
 
 
In the next activity, the participants were asked to drop from a 30cm height 
jumping box to the force plates (FP1 and FP2) and then jump as high as possible 
(Figure 3.13).  
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Figure 3.13 Jumping trial. 
 
 
The last activity for this second study was to jump with one leg. For this 
activity they were asked to jump with one leg to the FP2 then to the FP3 and finally 
to the floor (Figure 3.14). 
 
 
Figure 3.14 Jumping with one leg trial. 
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The data were processed in Vicon Nexus 1.8.5. software (Vicon Motion 
Systems Ltd., UK) and exported to OpenSim 3.3 (Sim TK, Stanford, CA) for the 
kinematics analysis.  
 
3.3.2.3. ACL elongations and force calculation  
 
The in vivo ACL length at each timepoint was determined by tracking the 
coordinates of the ACL insertion points from the processed kinematic data derived 
from motion capture and a musculoskeletal model scaled for each participant 
according to their anatomy. The initial model developed for the first study was 
improved incorporating a total of 27 DOF of which 6 corresponded to the knee joints 
(3 DOF for each knee), 12 segments represented the bones and 92 the musculotendon 
actuators. The anterior cruciate ligaments were modelled as an elastic passive soft 
tissue as previously described in Roldán et al. [236] and in section 3.3.1.3 of the 
present thesis. 
 
The strain at each instant was calculated from the ligament length change at 
each timepoint and the unloaded length. The in vivo unloaded length of the ACL for 
each participant was determined from a reference length (ACL length at knee full 
extension calculated for each participant) and reference strain (taken from literature 
[240]) following previous studies [236], [240]. The equations used to calculate the 
ACL length and strain can be found in Section 3.3.1.4.  
 
ACL tensile forces were calculated from a force/strain relationship reported 
in Blankevoort and Huiskes [240] where the ligament was simulated by a non-linear 
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spring, and its viscoelastic behaviour was mimicked with a damping element in 
parallel to the spring following the method implemented in previous studies [236] 
and section 3.3.1.4 of this chapter. Subsequently these calculated forces were 
normalized for Body Weight (BW) allowing comparison between participants. 
 
Notice that although the behaviour of both ACLs were collected, for the sake 
of simplicity only the results for the right knees are presented. Similar approaches to 
determine the ACL elongation and tensile force were used in Debski et al. [255] 
when testing cadaveric knees. 
 
3.3.2.4.  Statistical analysis 
 
For the second study, multiple linear regressions were performed to calculate 
the relationship between the right ACL length and the right knee angles for each 
activity (considering positive sign to knee flexion, external rotation and abduction 
angles). The coefficient of determination (R2) decreases considerably when the 
sample size increases. In this case, the sample size for each activity was very large, 
reaching 3410 degrees of freedom for the two-legged jumping activity. Therefore, in 
order to verify the goodness of fit it was necessary not only to consider the R2 value, 
but also to have low standard error of the calculation, a highly significant F test with 
a value of F above unity, highly significant regression coefficients (P value < 0.001) 
with short confidence intervals, non-colinearity between independent variables with 
a condition index below 15, and the normal distribution of the residuals. The Pearson 
coefficient signs indicated the behaviour of the ACL length when one of the knee 
angles varied. The sign of regression coefficients and Pearson coefficients could be 
different, since Pearson coefficients measure how an independent variable is related 
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to the dependent variable and the regression coefficients indicate how all 
independent variables are related to the dependent variable.   
 
All statistical analyses were conducted using SPSS (IBM Inc., Chicago, 
Illinois). 
 
 
 
3.4. RESULTS AND DISCUSSION 
 
The first study was focussed on the development of an easy to implement 
methodology to estimate the tensile forces experienced by the ligament, and the 
differences in the ACL mechanical behaviour between genders and ages were 
analysed through a pilot study. This first study will allow understanding of the 
feasibility of manufacturing ACL implants according to patient’s needs. 
 
The second study was focussed on the comparison between 6 daily and high 
impact activities in order to obtain the tensile forces experienced by the ligament and 
with them the mechanical specification for the ACL implant. 
 
The results of both studies were shown in the next section 3.4.1. 
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3.4.1. BIOMECHANICS STUDY 1 
 
3.4.1.1. Stair negotiation 
          
The same pattern of knee flexion/extension angle and ACL length was 
observed for each participant. Since an 8-step staircase was used to perform the 
experiment, four cycles for each leg were obtained. This model showed that the 
length of the ACL increased when the knee was extended and decreased as the 
flexion angle was increased regardless of the performed activity, this pattern is 
shown in Figure 3.15. Analysing the motion during climbing stairs, the maximum 
ACL length was recorded at full extension of the knee (stage A in Figure 3.15). The 
first ACL minimum length was at 90 degrees of knee flexion (stage B), then the ACL 
length increased at peak knee flexion due to the position of the insertion points (stage 
C). The second ACL minimum length was recorded at full strike (stage D) and 
finally the length increased again at the stance phase.  
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Figure 3.15 Flexion knee angle (º) versus ACL length (m) ascending stairs. 
 
 
The mean of the maximum ACL length recorded was 0.0289±0.0017 m 
corresponding to a full extension position and the mean of the minimum ACL length 
was 0.027±0.0016 m. Therefore, the maximum elongation recorded was 
0.0019±0.0001 m, which is approx. 19% of the reported elongation at failure of the 
ACL [253], [254]. Differentiating between genders, the mean ACL length for men 
was 0.0294±0.002 m and for women 0.0258±0.004 m. 
 
Previous studies with 20 human cadaveric knees determined that the average 
of ACL length in men is 0.029±0.0025 m and in women 0.0268±0.0028 m [40]; 
following these findings it can be concluded that the calculated ACL length were 
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within the same range and therefore they could be considered as anthropometrically 
valid.   
 
Analysing the ACL strain, a maximum strain of 0.084±0.0047 and a 
minimum strain of 0.012±0.0048 were observed.  
 
The maximum force experienced by the ACL was observed at full extension 
of the knee. The average of the peak ACL force/body weight (BW) while the 
participant was ascending stairs was 0.409±0.058 N/BW and descending stairs was 
0.416±0.089 N/BW. The peak ACL force was calculated to be 325.43 N for 
descending stairs, which is around 18% of the reported failure strength of the 
ligament [58], [59]. 
 
The most statistically significant values of force are shown in Table 3.3. 
Moreover, the values of peak ACL strain and forces for men versus women and 
young (<40 years old) versus older adults (≥40 years old) are shown in Tables 3.4 
and 3.5. 
 
 
Table 3.3 ACL forces during stair negotiation (mean±SD). ANOVAs for groups of sex, age and 
activities. 
 
Men Women P value Young (<40) Older (>40) P value Ascending Descending P value
Right ACL 0.181±0.131 0.248±0.181 0.000 0.191±0.141 0.217±0.165 0.000 0.187±0.149 0.217±0.150 0.000
Left ACL 0.176±0.135 0.251±0.188 0.000 0.192±0.143 0.208±0.176 0.000 0.199±0.153 0.197±0.160 0.424
Age ActivityTotal ACL force 
(N/BW)
Sex
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Table 3.4  Peak ACL strain and forces (mean±SD) during stair negotiation in men and women. 
 
Maximum Minimum
Men 0.085±0.006 0.012±0.005
Women 0.083±0.001 0.012±0.006
Men 0.084±0.003 0.013±0.005
Women 0.086±0.007 0.015±0.006 0.497±0.109
0.002±0.0005
0.003±0.0007
0.003±0.0005
0.004±0.001
Strain Maximum Force/BW
Ascending stairs
Descending stairs
Total Force (N/BW) Damper Contribution Force (N/BW)
0.383±0.037
0.462±0.061
0.375±0.044
 
 
 
Table 3.5  Peak ACL strain and forces (mean±SD) during stair negotiation in young and older adults. 
 
Maximum Minimum
Young 0.081±0.001 0.011±0.005
Older 0.088±0.004 0.012±0.006
Young 0.081±0.001 0.013±0.004
Older 0.089±0.004 0.017±0.003
Descending stairs
0.416±0.047 0.0036±0.0012
0.416±0.135 0.0033±0.0009
Strain Maximum Force/BW
Total Force (N/BW) Damper Contribution Force (N/BW)
Ascending stairs
0.415±0.049 0.0025±0.0004
0.403±0.075 0.0024±0.0009
 
 
From Tables 3.3, 3.4 and 3.5 the following conclusions can be deduced. 
Women’s anterior cruciate ligaments were subjected to significantly higher tensile 
forces compared to men’s ACLs and in general these forces were higher when the 
participant was descending stairs. This conclusion agrees with a previous study 
which reported that female athletes suffer ACL injuries from 4 to 6 more times than 
male athletes [17]. 
 
For this study and in order to determine how the age contributes to the ACL 
forces, the participants below 40 years old were considered as young people and the 
participants above 40 as older aged people. The ANOVA test regarding age showed 
that the ACL forces in both legs were significantly higher for older people compared 
to young people. This phenomenon can be explained since the tissue loses water and 
gets stiffer with increased age, therefore the ACL forces are expected to be higher as 
following Hooke’s law, where the force is directly proportional to the stiffness. 
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To date there is no OpenSim model to estimate ACL force during stair 
negotiation. Therefore, the values of ACL force obtained in this study are difficult to 
compare with other models. However, some studies reported that the peak ACL 
forces during gait are between 0.2 N/BW and more than 1 N/BW [79].The estimation 
in this study was around 0.41 N/BW, therefore it was comparable to the ACL loads 
previously reported. 
 
 The viscoelastic contribution in the force, quantified by the ACL velocity 
and the damping coefficient, was negligible compared to the ACL total force. 
Moreover, in neither case were significant differences observed after performing 
different analyses of variance.  
 
Several studies have been published to determine the ACL length and strain 
based on motion capture and biplanar fluoroscopic images, while certain activities 
such as walking and jumping are performed [75], [76]. These studies reported a peak 
ACL strain of up to 13%. In the present study the peak ACL strain was up to 8.9% 
descending stairs, therefore it can be said that this model provides a realistic 
calculation of ACL strain. 
 
 
3.4.2. BIOMECHANICS STUDY 2 
 
The peak ACL force and strain, position of the maximum ACL length and 
elongation of the ACL for each activity are presented in Table 3.6. The maximum 
ACL tensile force and elongation were seen during jumping with two legs.  
 
Chapter 3. Biomechanical Specifications 
 
  130        130 
  
 
Table 3.6 Peak right ACL tensile forces, elongation, strain and position of the maximum right ACL 
length for each activity (mean±SD). 
 
 
 
Every participant exhibited a similar pattern of knee angles and ACL length 
when performing the same activity, therefore changes in ACL length for both sexes 
(considering sex as a categorical variable with 0 for men and 1 for women) can be 
predicted for changes in the three knee angles (quantitative variables) through multi-
linear regression models. The models performed in this study were highly significant 
with a high Fisher’s F, highly significant regression coefficients (P value < 0.001) 
with short confidence intervals demonstrating the precision of the calculation, a low 
standard error of the calculation, non-colinearity of the independent variables and 
normal distribution of the residuals. The signs of Pearson correlation coefficients 
(Table 3.7) indicate that the ACL length is longer in males, when the knee is 
extended, as the knee internal rotation and the  valgus angle increase. 
 
 
Table 3.7 Multiple linear regression parameters. 
 
Sex   Flexion Ext. Rotation Abduction 
Walking 615.27* -0.446* -0.526* -0.483* 0.206* 0.002 0.61
Jumping with two legs  359.44* -0.313* -0.209* -0.435* 0.06* 0.0028 0.3
Running    136.02* -0.542* -0.6* -0.391* 0.137* 0.0025 0.36
Sidestep cutting  60.63* -0.398* -0.07* -0.414* 0.083* 0.0029 0.24
Crossover cutting 91.43* -0.469* 0.098* -0.424* 0.221* 0.0027 0.31
Jumping with one leg 891.81* -0.574* -0.414* -0.646* 0.146* 0.002 0.66
Activity     
 Pearson Coefficients 
Fisher’s F    
 Standard error 
of estimation 
R2
 
* Highly significant P value < 0.001 
 
 
 
Activity       Max. Force (N)  Max. Force (N)/BW Max. Elongation (mm)  Max. Strain   Max. ACL Length Position 
Walking  513.068±8.337  0.774±0.064   6.15±0.28   0.132±0.002   Heel off 
Jumping with two legs   726.003±64.222  1.076±0.113  7.32±1.21     0.175±0.013  Flight phase of the jump 
Running     368.243±113.627  0.624±0.216    5.28±0.05  0.097±0.002  Heel strike 
Sidestep cutting   472.703±168.209  0.836±0.323  5.33±0.01   0.107±0.040 Heel strike 
Crossover cutting 425.869±147.602  0.715±0.265  5.36±0.15  0.107±0.032 Heel strike 
Jumping with one leg 149.352±55.474 0.243±0.092 3.86±0.17  0.047±0.016 Flight phase of the jump 
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3.4.2.1. Walking 
 
Analysing the walking motion, the maximum ACL length was recorded at 
full knee extension (stage C in Figure 3.16) at heel off. The ACL minimum length 
was at 50º of knee flexion (during the swing phase). A maximum was observed at 
maximum knee flexion (around 65º) due to a decrease of knee rotation angle. 
 
Figure 3.16 Knee angles and ACL length walking. 
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The following function (1) predicts the ACL length for walking. 
ACL length (m) = 0.03317 – 0.002415*Sex - 0.00009*Knee flexion angle (º) - 
0.000144*Knee external rotation angle (º) + 0.00006*Knee abduction angle (º) (1) 
 
 
3.4.2.2. Jumping with two legs 
 
Five ACL length peaks were found in all participants. Figure 3.17 shows the 
stages for this activity, where A corresponds to the moment just before reaching the 
force plates where the knees are extended or almost extended, B is the maximum 
flexion of the knee after the drop where the valgus and internal rotation angles 
increase, C is when the participant completely extended the knees during the jump 
(flight phase of the jump), D is the moment where the participant reached the highest 
height jumping and E is the maximum flexion of the knee after the jump.   
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Figure 3.17 Knee angles and ACL length for jumping and landing with two legs. 
 
Regression coefficients were used to determine the relationship (2) between 
gender, knee angles and ACL length at each stage for this activity:  
ACL length (m) = 0.02932 – 0.000675*Sex - 0.000036*Knee flexion angle (º) - 
0.000168*Knee external rotation angle (º) - 0.000054*Knee abduction angle (º)   (2) 
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3.4.2.3. Jumping with one leg 
 
A total of six ACL length peaks were found in all participants; the first (stage 
C), third (stage G) and fifth (stage J) peaks corresponded to the moment of toe off, 
the second (stage E), fourth (stage H) and sixth (stage K) peaks were when the 
participants were jumping with their leg extended. Stages F and I corresponded with 
the moments when the participants were landing flexing their knee. Stage B was the 
moment when the participant flexed the knee to gain momentum for the jump and D 
was the moment when the participants were jumping with the knee slightly flexed.  
Figure 3.18 shows all these stages for the ACL length versus the knee angles. 
 
Figure 3.18 Knee angles and ACL length for jumping and landing with one leg. 
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The relationship between gender, knee angles and ACL length is shown in the 
equation (3):  
 
ACL length (m) = 0.03149 – 0.00224*Sex - 0.000087*Knee flexion angle (º) - 
0.000159*Knee external rotation angle (º) - 0.00005*Knee abduction angle (º)   (3) 
 
 
3.4.2.4. Running 
 
Three ACL length peaks were found in all participants, the first peak 
corresponded to heel strike being the highest of the three peaks (stage A), the second 
peak is at toe off (stage B) and the third is at maximum knee flexion (stage C). This 
situation can be observed in Figure 3.19. 
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Figure 3.19 Knee angles and ACL length for running. 
 
 
In the regression model for running, the constant, sex and rotation angle were 
highly significant; contributing to the prediction of the dependent variable. However, 
the coefficients of knee flexion and abduction angles were not significant (P value 
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0.55 and 0.18 respectively), which means that these angles do not contribute 
significantly to the model. The predicted function for running was:  
 
ACL length (m) = 0.02999 – 0.00306*Sex - 0.0000019*Knee flexion angle (º) - 
0.000084*Knee external rotation angle (º) - 0.000022*Knee abduction angle (º)   (4) 
 
 
3.4.2.5. Sidestep cutting 
 
Similar to the previous activity (running) three ACL length peaks were found 
in all the participants, the first peak corresponded to heel strike (stage A), the second 
peak was at toe off (stage B) and the third at maximum knee flexion (stage C) 
(Figure 3.20). 
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Figure 3.20 Knee angles and ACL length for sidestep cutting. 
 
As was observed running, the constant, sex and rotation angle provided 
important information for predicting the dependent variable in the regression model, 
however the coefficients of knee flexion and abduction angles were not significant (P 
value 0.55 and 0.62 respectively), meaning that these angles do not contribute 
significantly to the model. The function model obtained was:  
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ACL length (m) = 0.0282 – 0.001997*Sex + 0.000002*Knee flexion angle (º) - 
0.000086*Knee external rotation angle (º) - 0.0000096*Knee abduction angle (º)  (5) 
 
3.4.2.6. Crossover cutting 
 
As observed in the activities of “running” and “sidestep cutting” the pattern 
of the ACL length showed three peaks for all participants in the same stages. The 
first peak corresponded to heel strike (stage A), the second peak is at toe off (stage 
B) and the third is at maximum knee flexion (stage C), as shown in Figure 3.21.  
 
Figure 3.21 Knee angles and ACL length for crossover cutting. 
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The function that predicted the ACL length for crossover was:  
ACL length (m) = 0.02775 -0.00239*Sex + 0.000019*Knee flexion angle (º) - 
0.000666*Knee external rotation angle (º) + 0.000058*Knee abduction angle (º)   (6) 
 
The novelty of this study was the calculation of in vivo ACL length and 
tensile forces during different dynamic activities, which could provide an insight into 
high-risk activities for ACL injuries and rehabilitation protocols or provide 
mechanical specifications for ACL implants. 
 
As was shown in section 1.2.3 the peak ACL forces were previously reported 
to range between 0.2 N/BW and 1 N/BW during walking [79], [102]–[104]. In 
biomechanics study 2 a peak ACL tensile force of 0.774±0.064 N/BW during 
walking was observed corresponding to 28.5% of the reported failure strength of the 
ACL [58], [59]. Therefore, the value reported is in the same range as the ACL loads 
previously reported. All these studies used computational models to calculate ACL 
forces; however, they exhibited different limitations that make the results non-
identical. For instance, the previous studies [79], [102]–[104] developed a 1 DOF 
knee model; however, a 3 DOF knee model is created in biomechanics study 2, 
therefore the accuracy in the calculation of ACL length with this new model is higher 
than in previous studies. 
 
The peak strain observed in biomechanical study 2 during walking was 13%, 
which agrees with a previous study based on motion capture and biplanar 
fluoroscopic images during the same activity [75]. 
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The highest peak of ACL tensile force was recorded for jumping with both 
legs (1.076±0.113 N/BW) and their values were around 4 times higher than jumping 
with one leg (0.774±0.064 N/BW); the knees were more flexed during the execution 
of one-legged jumping in all participants, decreasing the ACL elongation and 
consequently the estimated ACL tensile force.  
 
From this study (biomechanics study 2) it was observed that non-contact 
activities with high ACL injury rates such as crossover cutting or sidestep cutting are 
surprisingly associated with lower tensile forces in the ACL than daily activities such 
as walking. This evidence indicates that the failure mechanisms for these activities 
are likely due to a combination of loads, not just tensile loading. This is a novel 
finding not reported in the literature before. However, it was proved that the highest 
risk of ACL injury is when the knee is at a low degree of knee flexion (inferior to 30 
degrees), in a valgus position and internal rotation with the planted foot for suddenly 
changing direction [117], [119]. This involves the ligament being subjected to 
multidirectional forces, and therefore the failure mechanisms are due to 
multidirectional loads.  
 
The Pearson correlation coefficients obtained in biomechanics study 2 for 
cutting activities revealed a more significant linear relationship between rotation and 
abduction angles with the ACL length than with the flexion angle, therefore knee 
rotation and abduction angles contribute greatly to the elongation of the ACL for 
these activities as was predicted by Mc Lean et al. [256]. It is known that small knee 
flexion angles generate higher ACL tensile forces; the greater the valgus (abduction) 
angle the higher ACL loading is observed [77], [257], [258] and so with the greater 
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the rotation angle, the ACL could be subjected to a higher torsional load. Therefore, 
this study demonstrated for the first time that to understand the mechanical behaviour 
of the ACL a study of its tensile, shear and torsional loading is needed. Future work 
should calculate shear and torsion loads for each activity. 
 
There are two main limitations in this Chapter. The first limitation is the 
assumption of having 3 DOF per knee instead of 6 DOF, in future studies a model 
including 6 DOF for each knee will be performed to incorporate the translation in the 
three axes. However, the translation of the knee joint is very small and can be 
negligible in comparison with the knee angles; therefore, this improvement will not 
greatly increase the accuracy of the model. The second limitation is that the ACL 
tensile forces were calculated from the ACL strain and this was calculated by 
tracking the coordinates of the ACL insertion points and considering the ACL as a 
single straight bundle; however, it is known that the fibre bundles of the ACL are 
twisted and wrapped around the bones. The purpose of this study was to calculate the 
ACL length, strain and force for healthy ACLs (with no issues of knee joint laxity), 
to enable development of grafts with similar characteristics; therefore, the length for 
the twisted bundles of the ligament was not considered and is considered to be 
negligible compared to the length between the insertion points of the ligament. 
Moreover, 3D structures based on twisted bundles of fibres were created in Chapter 
6. These structures mimic the nano and micro morphology of the natural ligament, 
consequently this second assumption (considering the ACL as a single straight 
bundle) did not contribute significantly to the accuracy of the results, since the 
twisted structure of the ligament is taken into account in Chapter 6. 
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Despite the limitations of this study, the approach followed is more accurate 
than other studies mainly for two reasons: 
 
 The first reason is that other studies considered the knee as a 1DOF 
joint [75], [76]; however this study developed a 3DOF knee model 
able to determine the angles not only in the sagittal plane but also in 
the axial and coronal planes, contributing to a more accurate of the 
calculation of the length of the ligament. 
 
 Computationally checking the model uploaded in OpenSim platform 
[259] and published in Kar et al. [260], it was noticed that the scale of 
the model, the insertion points of the ACL and the way the ACL 
length had been measured were erroneous, since the model was not 
anatomically correct and the ACL length indicated was not 
physiological. However, the configuration of the scale tool, the 
placement of the insertion points and the measurement of the ACL 
length have been meticulously studied in this project and the results 
verified from literature. 
 
Moreover, this study is novel given that it was the first one that aims to 
understand the in vivo ACL length, force and strain while activities such as 
“climbing stairs”, “jumping with maximum effort”, “run”, “crossover cutting”, 
“sidestep cutting”, “climbing stairs” and “jumping with one leg” were performed. 
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 The values of maximum ACL force and strain were used as safety thresholds 
for the design of new ACL implants. 
     
 
     
3.5. CONCLUSIONS 
 
Biomechanics study 1 established a methodology to calculate in vivo tensile 
forces on the ACL during different dynamic activities. This study proved that there 
are significant differences between genders and ages, therefore it is feasible to create 
an ACL implant dependent on these variables.  The forces experienced by the ACL 
in women and in aged people were significantly higher compared to men and young 
people respectively. 
 
Biomechanics study 2 determined and compared in vivo ACL length and 
tensile forces during dynamic activities using a viscoelastic ligament model for a 
wide range of activities. The results of this study can inform research into ACL 
injury mechanisms and provide mechanical specifications for manufacturing 
improved ACL implants, which is the aim of the project. It established highly 
significant regression models between ACL lengths with respect to knee angles for 
the different activities enabling prediction of the behaviour of the ligament according 
to given angles for each activity. Finally, the peak tensile ACL force during cutting 
or running was lower than walking, suggesting that the failure mechanisms are due to 
multidirectional (including shear and torsion) loading instead of simply tensile 
loading in isolation. Therefore, new scaffolds have to be designed and tested to 
ensure they are able to bear multidirectional forces. 
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The results from Chapter 3 will be used as biomechanical specifications for 
the design and development of the scaffolds produced in Chapters 4, 5 and 6.  
 
Chapters 4 and 5 go on to study the suitability of two different polymers 
(gelatin and PVA respectively) to be used for ACL replacements. To achieve the aim 
of these chapters, the scaffolds created were mechanically and morphologically 
tested. The results obtained from the mechanical tests were compared with the results 
found in Chapter 3 to be able to determine if those polymers would be mechanically 
suitable for use as ACL replacements. 
 
Chapter 6 focusses on the study of 2D and 3D electrospun structures. The 
scaffolds built in this study were mechanically tested to determine which structure is 
more faithfully able to mimic the mechanical behaviour of the ACL.  
 
 
 
Key Points: 
1. A novel methodology was developed to calculate the in vivo ACL length, strain, 
forces and angles for a wide range of activities and allowed comparison between 
them. 
2. This study proved that ACL failure mechanisms are due to a combination of loads 
and it is the first that emphasized the importance of taking into account the 
multidirectional loading of the ACL to develop implants able to bear the same 
loading as the natural ligament. Therefore, the author encourages changing the 
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current standard procedure for the design of ACL implants to one that incorporates 
multi-planar loading.  
3. This study is a significant forward in the field, as to date no studies have been 
performed to create scaffolds that can replicate the in vivo loading and can bear the 
multi-planar loading of the natural ACL. 
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4. Suitability of gelatin electrospun scaffolds for 
the development of ligament implants from a 
morphological, topographical and 
mechanical perspective  
 
 
When the in vivo mechanical behaviour of the ACL and the mechanical 
specifications for the scaffolds are known, scaffolds that morphologically, 
topographically and mechanically mimic the ACL can be designed and 
manufactured.  
 
This chapter evaluates the suitability of gelatin electrospun scaffolds for use 
as ACL grafts. These scaffolds are then mechanically tested and compared with the 
natural ligament in order to determine their suitability for this purpose. 
 
 
 
4.1. ABSTRACT 
 
Electrospinning enables mimicking of the native extracellular matrix (ECM) 
through the creation of a nano- and micro-scale fibrous network.  
 
Gelatin exhibits high biocompatibility and a biodegradability similar to 
collagen making it attractive for use in biomedical applications [215]. However, this 
polymer has a number of disadvantages such as poor mechanical properties or high 
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degradation rate, requiring the use of crosslinker agents in order to increase the 
stiffness and the lifespan of the material. Moreover, its easy gelation in aqueous 
solution complicates the manufacturing of scaffolds through the electrospinning 
process, making the use of harmful solvents necessary. It is well known that the 
ability to electrospin gelatin heavily depends on the selection of solvent and its 
concentration [215], [261], [262], therefore an initial study of the solvents was 
needed.  
 
The novelties of this work are two-fold: to understand how changes in the 
solvent concentration affect the mechanical and structural properties of the scaffolds, 
and how the use of a crosslinker changes the morphology of the nanofibres and their 
network.  
 
This chapter aims to evaluate the suitability of gelatin electrospun scaffolds 
for use as tissue engineered ligaments. 
 
 
 
4.2. INTRODUCTION 
 
Electrospinning is a manufacturing technique capable of mimicking the 
collagen and elastin fibres in the ECM by creating a fibrous mat with fibre diameters 
ranging from 1-20 µm down to approximately 10 nm. This capability makes 
electrospinning a suitable technique for biomedical applications and more 
specifically for the fabrication of tissue engineering scaffolds to be used as implants 
[263] with a comparable nanostructure to the natural ACL.  
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Biocompatibility and cell responses on scaffolds depend greatly on factors 
such as microstructure (fibre diameter, inter-fibre separation, void fraction and fibre 
orientation) and topography of the scaffold [189]. Some researchers reported that the 
structure and topography of the scaffold could be more important in the attachment, 
proliferation and gene expression than the nature of the polymer itself [264], i.e. if it 
is a synthetic or a natural polymer.  Specifically, Ghanavati et al. concluded that PCL 
nanofibres with high surface area had better surface properties than natural collagen-
chitosan film, therefore the structure and topography of a matrix seemed to be more 
important in wound healing than its material substance [264]. 
 
Gelatin is a natural polymer derived from the hydrolysis of collagen, the most 
abundant protein of the ECM. It is commonly used in biomedical, pharmaceutical 
and food packaging applications [265]. Its low cost, high biocompatibility, 
biodegradability and bioactivity make it attractive for the development of tissue 
engineered implants and they are essential properties for the development of 
scaffolds in this thesis. The original idea for the design of the scaffolds was to use a 
shell-core structure, where the polymer in the inner part of the fibre provides the 
main part of the mechanical properties to the structure and the outer part provides the 
biocompatibility. Due to its biocompatibility, low cost, better mechanical properties 
then collagen and similar degradation rate to collagen, gelatin was selected in the 
first instance to constitute the outer part of the scaffold.  
 
However, despite its advantages this polymer has three main disadvantages 
that must be faced during its manufacturing process. The first disadvantage is the 
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difficulty of working with electrospun aqueous gelatin solutions at room temperature 
[215], [266], due to gelatin solutions with high Bloom value gelling easily at 
temperatures below 30ºC restricting the flow of solution through the needle and 
consequently the Taylor cone and fibre formation. The second disadvantage is its 
high degradation rate that complicates the biological characterization of the scaffold 
and its use as an implant. The third disadvantage is its poor mechanical properties 
with lower tensile stress and strain at rupture than the native ACL.   
 
In order to overcome these limitations, two studies were performed in this 
chapter (Gelatin study 1 and Gelatin study 2). To avoid the gelation process during 
the electrospinning, different approaches with different solvents have been proposed 
in the literature. Fluorinated alcohols such as 2,2,2-triefluoroethanol (TFE) [266], 
[267] or 1,1,1,3,3,3-hexafluoro-2-propanol (HIPF) [268]; dilutions of phosphate 
buffer saline (PBS) in ethanol [261], [269]; carboxylic acids such as formic acid or 
acetic acid (HAc) [215], [270]–[275]; mixtures of different solvents such as HAc and 
TFE [262], HAc and dimethyl sulfoxide (DMSO) [262], HAc and ethylene glycol 
[262], HAc and formamide [262] or HAc and ethyl acetate [274] are the most 
common solvents used with gelatin. However, the use of organic solvents could 
affect the protein structure of the polymer; the cytotoxicity due to residual solvent in 
the scaffold; and the morphology, topography and mechanical properties of the 
scaffolds and their relation with the cell viability, response and proliferation. 
Therefore, after a previous investigation into the optimum solution and process 
parameters, the first part of the chapter (Gelatin study 1) studied how different 
concentrations of solvents affect the morphology, topography and mechanical 
properties of the scaffolds [276]–[279]. 
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To address the limitations of having a high degradation rate and poor 
mechanical properties, the electrospun gelatin scaffolds must be crosslinked to create 
bonds between the proteins chains and provide more stability and stiffness to the 
material. Many chemical crosslinking agents have been investigated in the literature, 
including glutaraldehyde, formaldehyde, glyceraldehyde, genipin, oxygen species, 
carbodiimide, diepoxy compounds, diisocyanates and dextran aldehydes [280]. 
However, these crosslinkers reduce the number of free cell binding sites and with it 
the capacity of cell adhesion [281]. The second part of the Chapter (Gelatin study 2) 
studied how different concentrations of crosslinking agent (glutaraldehyde) affect the 
degradability, morphology and topography of the scaffold.    
 
 Currently, electrospun gelatin scaffolds have been developed for wound 
healing applications [282], [283], nervous system [284]–[286], dental applications 
[287], bone tissue [288]–[291] and skin tissue [292], [293], tendon implants [294] 
and vascular grafts [295]. However, no studies of electrospun gelatin scaffolds have 
been done with the purpose of manufacturing ligament implants. The only 
electrospun gelatin scaffolds found in the literature for tendon replacements [294] did 
not reach the mechanical strength needed for their application and they were far from 
obtaining values comparable to those exhibited for the natural ACL. That study [294] 
used co-electrospinning of PCL and methacrylated gelatin to manufacture tendon 
implants through use of 5 sheets of cell seeded aligned scaffolds. The cell growth, 
tensile mechanical properties and degradation were studied; however, no evidence of 
optimisation of the solution and process parameters nor morphological and 
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topographical characterization of the scaffolds to obtain biomimetic tendon implants 
were observed. 
 
The novelties of this work lie in understanding how changes in the solvent 
concentration affect the mechanical, morphological and topographical properties of 
the gelatin scaffolds and so induce associated cell behaviour in order to mimic the 
structural, mechanical and biological properties of the natural ECM. In addition, how 
the use of a crosslinking agent changes the morphology of the nanofibres and their 
network will be evaluated to check the suitability of the polymer and crosslinker to 
manufacture improved connective tissue (i.e. ACL) implants. 
 
The aim of this work was to assess the morphology, topography and 
mechanical behaviour of the gelatin with different solvent and crosslinker 
concentrations to determine its suitability to manufacture tissue engineering 
implants.  
 
 
 
4.3. METHODS 
 
4.3.1. POLYMER SOLUTION 
 
Gelatin powder type B from bovine skin (Bloom ~ 225 g) was purchased 
from Sigma Aldrich (UK). Glacial acetic acid (Sigma Aldrich, UK), DMSO (Sigma 
Aldrich, UK) and distilled water (dH2O) were used as solvents, dissolving the gelatin 
by stirring until homogenous solutions were obtained. The reasons for selecting these 
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solvents were: HAc enables optimisation of the electrospinning process avoiding 
gelation, it is not as harmful as the normal organic solvents used with gelatin and a 
recent study has demonstrated that the  cell viability is higher than 90% [215]; and  
DMSO favours the creation of smoother fibres free of defects [262], able to promote 
cell migration.  
 
 Initial experiments performed during this thesis determined that the optimum 
concentration of gelatin was 25% w/v, concentrations above this value increased the 
viscosity of the solution making it difficult to electrospin; below this concentration, 
bead formation and beaded fibres were observed, reducing the mechanical properties 
of the scaffold and impeding cell migration. Further details about the initial 
experiments and their results are presented in section 4.4.1 where the optimisation of 
the solution and process parameters are explained. 
 
4.3.1.1. Gelatin Study 1 
 
For this study, nine solutions were prepared with 25% w/v of gelatin 
dissolved in concentrations of HAc and dH2O of 3:1, 1:1 and 1:3, adding 0%, 5% 
and 10% of DMSO.  
 
4.3.1.2. Gelatin Study 2 
 
A gelatin solution was prepared with 25% w/v of gelatin dissolved in 1:1 
HAc/ dH2O and 5% DMSO following the mechanical results of the previous study 
(Gelatin study 1) [276]. The scaffolds manufactured with this solution exhibited a 
greater tensile strength than the scaffolds manufactured with different concentrations 
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of solvents; they showed an appropriate Young’s modulus for tissue engineered 
ligament implants with comparable values as the natural ACL; and they presented 
fibres with uniform diameters and free of defects (all the mechanical results obtained 
in gelatin study 1 can be found in section 4.4.2).  
 
4.3.2. SCAFFOLD PRODUCTION 
 
 All the scaffolds used in these two studies (Gelatin study 1 and Gelatin study 
2) were fabricated with an electrospinning device (TL-01, NaBond, China) under the 
same set up of parameters, which allowed production of a stable Taylor cone and 
optimisation of the quality of the scaffold manufacturing fibres free of defects.  A 10 
ml syringe was loaded with the polymer to pump it with a flow rate of 2 ml/h through 
a 15 G needle. An electrostatic field was created applying high voltage (for this study 
26 kV) between the tip of the needle and the collector. The fibres were projected 
from the tip of the needle over a sheet of aluminium foil attached to a 15 cm diameter 
rotating collector working at 1300 rpm. The distance between the needle and the 
collector was set up to 11 cm. Each scaffold was manufactured at room temperature 
(25ºC) and for 3 hours spin time.  
 
 
4.3.3. CHEMICAL CROSSLINKING 
 
Chemical crosslinking was used solely in Gelatin study 2, where two 
crosslinking techniques were evaluated: immersion and vapour deposition.  
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For crosslinking the samples by immersion, three 0.5 x 0.5 cm samples were 
placed in a 6 well plate with 2 ml of 25% GTA in wells for 2 hours.  
 
For the crosslinking by vapour deposition, samples of 0.5 x 0.5 cm were cut 
from the scaffold manufactured for Gelatin study 2; air-dried and placed over a 
metallic mesh in a sealed desiccator to be crosslinked. The effect of the crosslinker 
over the electrospun fibres was tested with three different concentration of GTA 
diluted in distilled water 2.5%, 5% and 25%. 25 ml, these solutions were poured 
separately in a Petri dish at the bottom of the desiccator and the samples were placed 
over a metallic mesh on top of the Petri dish to be exposed to glutaraldehyde vapour.    
  
 
4.3.4. DEGRADATION ASSAY 
 
Two samples of each concentration of GTA were dried-air for 24 hours and 
the rest of the samples were placed in 6 well dishes with 4 ml of phosphate-buffered 
saline buffer (PBS) in each well and left in an incubator at 37ºC and 4% CO2 in order 
to test their degradability with time in an environment similar to the human body. A 
total of 42 samples, two samples for each concentration, were left for 1, 5, 7, 14, 21 
and 28 days in PBS and then dried-air for 24 hours in a fume hood. This assay was 
performed for Gelatin study 2. 
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4.3.5. SCAFFOLD/FIBRE CHARACTERIZATION 
 
4.3.5.1. Morphology of the fibres 
 
A SC7640 sputter coater (Quorum Technologies Ltd. Kent, UK) was used to 
coat the samples with gold prior to their visualization with a field emission scanning 
electron microscope Zeiss Supra 40 (FE-SEM, Carl Zeiss SMT Ltd., Cambridge, 
UK). The intensity used for coating the samples was 20 mA, the voltage 0.8 kV and 
the duration of the coating was 120 seconds, which provides a coating thickness of 
32.6 nm, following equipment specifications. Scanning electron microscope (SEM) 
images were taken at approx. 6 mm working distance, 3 kV and with x 50000 
magnifications. Fibre diameter (Ø fibre) and inter-fibre separation (Int.sep.) were 
determined with AxioVision SE64 Rel. 4.9.1 (Carl Zeiss SMT Ltd., Cambridge, UK) 
by measuring 20 fibres per sample for the two studies (Figure 4.1). The inter-fibre 
separation was defined as the maximum horizontal distance between two fibres that 
belong to the same pore. A pore was defined as the void space constituted by fibres 
(normally four fibres) that intersect one with each other and are located on the same 
layer of fibres.  
 
Chapter 4. Suitability of Gelatin Electrospun Scaffolds for ACL Replacement  
 
  157        157 
  
 
Figure 4.1 SEM image with fibre diameter (Ø fibre) and inter-fibre separation (Int. sep.). 
 
 
4.3.5.2. Topography of the scaffold 
 
The average roughness of the scaffolds was measured by taking 6 white light 
interferometry images per sample using an interferometer from ZeGage (Zygo 
Corporation, US) (Figure 4.2) following a previous study [296]. This equipment 
allowed high-precision 3D metrology of surface features to be obtained, determining 
the topography of scaffolds through measuring characteristics such as maximum 
peak-to-valley profile height or average roughness. The average roughness was 
compared between samples with different GTA concentrations and days in PBS in 
order to understand how the crosslinking and the incubation in PBS affected to the 
topography of the samples. The same procedure was followed in both studies. 
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Figure 4.2 White light interferometry image showing the scaffold topography. 
 
 
4.3.5.3. Mechanical behaviour of the scaffold 
 
4 samples were mechanically analysed for each scaffold in Gelatin study 1 
following a previous study [266]. The samples were removed with a dog-bone 
cutting die (25 x 4 mm, test length x width), and their thickness measured three times 
with a digital and an analogical calliper in order to check the consistency of the 
measurements; samples were attached to a cardboard frame to aid in the alignment of 
the sample in the tensometer (Instron H10KS, US) and tensile tested until failure 
with a 100 N load cell and 1 mm/min test speed [297]–[299]. Mechanical properties 
such as Young’s modulus, tensile strength and strain at break were determined for 
each sample and statistically analysed in order to find a relationship between 
mechanical and morphological properties. 
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4.3.5.4. Chemical characterization of the scaffold 
 
A Fourier Transform Infrared Spectrometer (PerkinElmer Spectrum two, US) 
was used to investigate any chemical changes in the gelatin samples. Non-significant 
results were observed when varying the crosslinker concentration (data shown in the 
appendix Figures 9.1 and 9.2).  
 
 
4.3.6. STATISTICAL ANALYSIS 
 
Mean and standard error of the mean (Std Error) were calculated for each of 
the structural and mechanical properties. 
 
In order to compare these properties between scaffolds made with different 
solvents concentrations, one-way analysis of variance (ANOVA) with a 95% 
confidence was performed.  
 
Linear regressions were performed to calculate the relationship between 
morphological, topographical and mechanical properties of each scaffold and solvent 
concentrations.  
 
All statistical analyses were conducted using SPSS (IBM Inc, US). 
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4.4. RESULTS AND DISCUSSION 
 
 
4.4.1. OPTIMISATION OF THE SOLUTION AND PROCESS PARAMETERS 
 
Before the two studies were performed (Gelatin study 1 and Gelatin study 2), 
optimisation of the solution and process parameters was conducted. Set up of the 
electrospinner included determination of: 
 
 The optimum voltage, which has to be high enough to overcome the 
cohesive force of the solution in order to start creating the Taylor 
cone for formation of the jet of fibres. If the voltage were not high 
enough, no fibres would be created and if the voltage is too high, 
beads are created. A series of experiments were performed where the 
voltage was varied between 15 kV and 28 kV. In this study, a stable 
Taylor cone and an electrospun structure free of beads were observed 
with 26kV. 
 Flow rate: This parameter is related to the viscosity of the polymer, its 
concentration and the temperature of the chamber.  It was observed 
that at higher polymer concentrations, less flow rate is needed to 
obtain a stable Taylor cone; the same phenomenon happened when 
increasing the temperature of the chamber. After a systematic series 
of experiments varying the flow rate from 1ml/h until 2ml/h and 
keeping the rest of the parameters constant, it was determined that the 
optimum flow rate was 2ml/h. 
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 Distance between collector and needle: enough distance is required to 
facilitate complete evaporation of the solvent; however if the distance 
is too high, in this case ≥ 15 cm, an unstable Taylor cone from which 
no fibres are projected can be observed. For the experiments 
performed for this study, an optimum distance of 11 cm between 
collector and needle was determined, which allowed creating fibres 
free of defects.  
 Revolutions of the mandrel: Experiments with 1000, 1300, 2000, 
3000, 4000, 5000 and 6000 rpm were performed in order to 
understand how the morphology of the scaffold changed with altered 
revolutions. It was observed that with revolutions of 3000 and 4000 
rpm the fibres were longitudinally aligned; with lower revolutions, 
the fibres were randomly distributed; and with revolutions higher 
than 4000 rpm, the revolutions were too high increasing the vibration 
of the equipment and aligned fibres were not created.  The rest of the 
experiments were performed with 1300 rpm there revolutions 
generating smooth fibres without defects.  
 Temperature: The temperature was varied from 22º C to 30º C to 
obtain the ideal temperature with which to create high quality fibres 
with no beads. After systematic evaluations of how the temperature 
affected to the fibres, it was concluded that 25º C was the temperature 
that favoured the formation of high quality electrospun scaffolds. 
Below that temperature, the viscosity of the solution increased, 
making it difficult to spin and higher to that temperature beads were 
observed in the scaffolds. 
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 Size of the needle: Needles with 15G, 20G, 21G, 22G and 23G were 
evaluated to obtain an electrospun scaffold with high quality fibres 
and with appropriate diameter. The most optimal needle was 15G, 
following the criteria that it was the easiest to spin with, no 
occlusions were caused and smooth fibres free of beads were 
produced.         
 
A resume of the optimal parameters observed is given in Table 4.1. 
  
Table 4.1 Optimum process parameters. 
 
Collector Voltage Flow rate
Distance between 
collector and needle
Needle
Revolutions of 
the mandrel
15 cm 26 kV 2 ml/h 11 cm 15G 1300 rpm  
 
 In order to optimise the solution parameters several experiments were 
conducted: 
 
 Experiments to determine the ideal solvent and polymer 
concentration: dH2O, PBS, ethanol 70%, HAc, fetal bovine serum 
(FBS) and DMSO were used as solvents. The following experiments 
were performed to determine the most suitable solvent and the 
concentration (Table 4.2). 
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Table 4.2 Experiments to determine the ideal solvent and concentrations. 
 
Dissolving solution Collector Concentration Voltage Flow rate Distance Needle
Revolutions of 
the mandrel
Temperature Time
dH2O Rot 15 cm 12% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
dH2O Rot 15 cm 9% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
dH2O Rot 15 cm 7% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
dH2O Rot 15 cm 5% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
dH2O Rot 15 cm 3% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
PBS (x1)/IMS 70% 2:3 Rot 15 cm 15% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
PBS (x1)/Ethanol 70% 2:3 Rot 15 cm 12% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
PBS (x1)/Ethanol 70% 2:3 Rot 15 cm 6% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
PBS (x10)/Ethanol 70% 2:3 Rot 15 cm 12% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
100% Acetic acid Rot 15 cm 20% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
75% Acetic acid Rot 15 cm 30% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
50% Acetic acid Rot 15 cm 30% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C unspinnable
50% Acetic acid Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
25% Acetic acid Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
23.75% Acetic acid/71.25% dH2O/DMSO 5% Rot 15 cm 20% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
47.5% Acetic acid/47.5% dH2O/DMSO 5% Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
47.5% Acetic acid/47.5% dH2O/DMSO 5% Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
25% Acetic acid/75% FBS Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
50% Acetic acid/50% FBS Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
75% Acetic acid/25% FBS Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C Occlusion
75% Acetic acid/25% FBS Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
23.75% Acetic acid/71.25% FBS/DMSO 5% Rot 15 cm 20% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
47.5% Acetic acid/47.5% FBS/DMSO 5% Rot 15 cm 20% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
71.25% Acetic acid/23.75% FBS/DMSO 5% Rot 15 cm 20% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
47.5% Acetic acid/47.5% FBS/DMSO 5% Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
71.25% Acetic acid/23.75% FBS/DMSO 5% Rot 15 cm 25% Gelatin 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes
Acetic Acid Rot 15 cm 10% Gelatin+10% PCL 26 kV 2 ml/h 11 cm 15G 1300 rpm 25° C 10 minutes  
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After experiments with 3%, 5%, 7%, 9% and 12% gelatin and distilled water 
at 25°C it was concluded that gelatin is not spinnable when dissolved solely in 
distilled water.This was due to low concentrations not having appropriate viscosity 
for electrospinning and higher concentrations provoking gelation of the polymer 
blocking the tube and needle. 15%, 12% and 6% gelatin was dissolved with PBS (x1 
and x10) and ethanol 70%, but it was unspinnable in PBS and ethanol. 20%, 25% 
and 30% gelatin was dissolved with 100%, 75%, 50% and 25% HAc, resulting in the 
optimum gelatin concentration of 25%. These last experiments were also performed 
with FBS instead of distilled water to make the dilutions of the HAc, and fibres and 
ribbons with higher diameter were produced. Experiments with HAc diluted in 
distilled water or FBS and DMSO were then performed. Table 4.3 shows the 
appearance of the scaffolds depending on the solvents and polymer concentrations in 
order to obtain conclusions and determine which was the best scaffold in terms of its 
morphology. 
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Table 4.3 Experiments to determine the ideal solvent and concentrations. 
 
 
Sample Dissolving solution Concentration 
Bead  
Formation 
Fibre Defects Heterogeneous Fibres "Ribbons" "Spiderweb" "Spitting" 
R21 PBS (x10)/Ethanol 70% 2:3 12% Gelatin Yes 
R22 100% Acetic acid 20% Gelatin Yes Yes No No Yes No 
R23 75% Acetic acid 30% Gelatin No Few No No Yes No 
R24 50% Acetic acid 25% Gelatin No Few No No Yes No 
R25 25% Acetic acid 25% Gelatin No Few No No Yes No 
R26 23.75% Acetic acid/71.25% dH 2 O/DMSO 5% 20% Gelatin Few Few No No Yes No 
R27a 47.5% Acetic acid/47.5% dH 2 O/DMSO 5% 25% Gelatin No Few No No Few No 
R27b 47.5% Acetic acid/47.5% dH 2 O/DMSO 5% 25% Gelatin No Few No No Few No 
R28 25% Acetic acid/75% FBS 25% Gelatin No No Yes No Yes No 
R29 50% Acetic acid/50% FBS 25% Gelatin Few No Yes No Few No 
R30a 75% Acetic acid/25% FBS 25% Gelatin No No Yes Yes Yes No 
R30b 75% Acetic acid/25% FBS 25% Gelatin Yes Yes Yes No 
R31 23.75% Acetic acid/71.25% FBS/DMSO 5% 20% Gelatin Yes No Yes No Yes No 
R32 47.5% Acetic acid/47.5% FBS/DMSO 5% 20% Gelatin Yes No Yes No Yes No 
R33 71.25% Acetic acid/23.75% FBS/DMSO 5% 20% Gelatin Yes No Yes Yes No No 
R34 47.5% Acetic acid/47.5% FBS/DMSO 5% 25% Gelatin Few No Yes Yes No No 
R35 71.25% Acetic acid/23.75% FBS/DMSO 5% 25% Gelatin Few No Yes No No No 
R36 Acetic Acid 10% Gelatin+10% PCL No No Yes No Yes Yes 
Unspinnable 
Fused fibres 
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From these initial experiments, the following general conclusions were 
obtained: 
 
a) No electrospun scaffolds could be manufactured with just 
gelatin and distilled water, or gelatin and PBS/ethanol due to its 
tendency to gelate and so obstructing the tube before reaching the 
needle.  
b) Bead formation was reduced when increasing the gelatin 
concentration. 25% gelatin was observed as the optimum gelatin 
concentration. 
c) It was demonstrated that the higher the gelatin concentration, 
the larger the fibre diameters were observed. 
d) Acetic acid was used as a solvent to avoid gelation. If the 
scaffolds are rinsed with PBS, prior to seeding with cells the 
cytotoxicity will decrease; therefore the viability of the cells would 
increase, and as this solvent is non-aggressive, the protein chemical 
structure would remain intact [215], [270], [271].  
e) It was demonstrated that the higher the acetic acid (HAc) 
concentration, the larger the fibre diameters were observed for the same 
gelatin concentration. 
f) The addition of DMSO increased the viscosity of the solution; 
therefore, it was expected to enhance the free-beads fibres formation. It 
was observed that when adding DMSO, the beads and “ribbons” 
formation decreased.  
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g) For the same gelatin concentration, larger fibre diameters were 
observed in the scaffolds through the addition of DMSO.  
h) FBS was considered as a solvent because it could increase the 
cell viability, bio-affinity and reduce the osmotic stress [267], [300]. 
From these experiments, it was demonstrated that a combination of 
acetic acid with FBS can be used to spin gelatin fibres, however ribbons 
were also observed and for this reason, this solvent was initially 
rejected for further investigations. The fibres were more heterogeneous 
and with a larger diameter when the gelatin was dissolved in acetic 
acid/FBS comparing to acetic acid/dH2O. 
i) The addition of PCL to the gelatin can improve the degradation 
process of the gelatin, moreover the mechanical properties would also 
improve [301], [302]. It was proved that PCL can be dissolved 
moderately well in acetic acid [303], [304], therefore both polymers 
could be dissolved in acetic acid, reducing the cytotoxicity and avoiding 
damage in the polymer structure. Extremely heterogeneous fibres had 
been created with a mix of gelatin and PCL. However, an inappropriate 
performance of the electrospinner (no creation of a stable polymer jet) 
and very low fibre density were observed.  
j) More experiments with 25% w/v of gelatin dissolved in 
concentrations of HAc and dH2O of 3:1, 1:1 and 1:3, adding 0%, 5% 
and 10% of DMSO must been done in order to understand how the 
solvent concentration modifies the morphology, topography and 
mechanical properties of the scaffolds. Therefore, a second study was 
performed with this aim.  
Chapter 4. Suitability of Gelatin Electrospun Scaffolds for ACL Replacement  
 
  168         
  
 
4.4.2. GELATIN STUDY 1: HOW DIFFERENT CONCENTRATIONS OF SOLVENTS AFFECT 
THE MORPHOLOGY, TOPOGRAPHY AND MECHANICAL PROPERTIES OF THE 
SCAFFOLDS. 
 
After an initial study to optimise the solution and process parameters, a 
subsequent study to evaluate how the concentration of the solvents affect the 
morphology, topography and mechanical properties of the scaffolds was performed.  
 
As described in the methods (section 4.3), nine solutions were prepared with 
25% w/v of gelatin dissolved in concentrations of HAc and dH2O of 3:1, 1:1 and 1:3, 
adding 0%, 5% and 10% of DMSO.  
 
Fibre diameter, inter-fibre separation and average roughness were significantly 
affected by the concentration of HAc, DMSO and their interaction (p < 0.001), with 
significant differences found between scaffolds manufactured with different solvents 
concentrations and the scaffold parameters. Regression models revealed that fibre 
diameter and inter-fibre separation increased significantly (p < 0.001) when the 
concentration of HAc and DMSO increased. The concentration of HAc provides 
more variability than the DMSO concentration, to the dependent variable (partial ɳ2 = 
0.66 and 0.41 respectively); therefore, the concentration of HAc is more relevant 
than the concentration of DMSO in the contribution of the morphology of the 
scaffolds. This phenomenon can be observed in Figures 3 and 4 where the 3:1 
HAc/dH2O concentration provided greater fibre diameter and inter-fibre separation to 
all DMO concentration. This was also corroborated by Erencia et al. [215] in 2015 
where solutions of gelatin with concentrations of 200, 250, 300, 350, and 400 mg/mL 
(kg/m3) were prepared using acetic acid at different concentrations (25, 50, and 75% 
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(v/v)) as solvent. Erencia et al. [215] proved that the viscosity of the polymer and 
consequently the thickness of the fibres increased when the HAc concentration was 
increased.  
 
Another outcome observed from an increase of the polymer viscosity was that 
the fibres were more aligned when the HAc and DMSO concentration was increased.  
 
The regression models obtained for predicting the diameter of the fibres and 
inter-fibre separation were: 
 
Fibre diameter (µm) = -0.155 +  0.197 * DMSO concentration + 0.108 * HAc 
concentration 
 
Inter-fibre separation (µm) = -0.693 +  0.877 * DMSO concentration + 0.487 
* HAc concentration 
 
A relationship between fibre diameter and inter-fibre separation was also 
observed; the greater the fibre diameter, the greater the inter-fibre separation was 
obtained. This fact agrees with the thesis of Joseph Lenning Lowery (Massachusetts 
Institute of Technology, 2009) [305] where it was proved that the packing of the 
fibres was more dense when the fibres were thinner. 
 
Figures 4.3 and 4.4 show the relationship between diameter of fibres and 
inter-fibre separation with respect to the concentration of HAc and DMSO. The 
Chapter 4. Suitability of Gelatin Electrospun Scaffolds for ACL Replacement  
 
  170         
  
scaffolds with the largest fibre diameter and inter-fibre separations were those 
manufactured with 3:1 HAc/dH2O and 10% DMSO. 
 
 
 
Figure 4.3 Fibre diameter (μm) for different concentrations of HAc and DMSO. 
 
 
 
Figure 4.4 Inter-fibre separation (μm) for different concentrations of HAc and DMSO. 
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Analysing the roughness in relation to the acetic acid concentration, the 
minimum roughness was shown as 1:1 HAc/dH2O and the maximum as 3:1 
HAc/dH2O (Figure 4.5).  
 
The average roughness of the scaffold tended to decrease when the DMSO 
concentration was increased, allowing the creation of smoother fibres with an 
absence of beads, a fact that was also observed by Choktaweesap et al. [262]. 
Choktaweesap et al. [262] studied the effect of a single solvent system (glacial acetic 
acid) and mixed solvent systems (glacial acetic acid in combination with different 
solvents: 2,2,2-trifluoroethanol (TFE), dimethyl sulfoxide (DMSO), ethylene glycol 
(EG) and formamide (F)) on the morphology and fibre diameter. Choktaweesap et al. 
concluded that the addition of TFE, DMSO, EG, or F as co-solvent helped to 
improve the electrospinnability of the resulting gelatin solution. Moreover, DMSO 
and EG contributed to the formation of smooth gelatin fibres with reduced diameters 
in comparison to fibres created with acetic acid as the sole solvent. 
  
In this case, the regression model that predicts the average roughness related 
to the solvent concentration was: 
 
Average roughness (µm) = 1.756 - 0.014 * DMSO concentration - 0.242 * 
HAc concentration 
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Figure 4.5 Average roughness (μm) for different concentrations of HAc and DMSO. 
 
 
 
Mechanical properties were significantly affected by the concentration of 
DMSO (p < 0.001). Scaffolds with 1:1 HAc/ dH2O exhibited the greatest tensile 
strength and strain at break at each DMSO concentration (Figure 4.6 and 4.7), due to 
the fact that the inter-fibre separation was the lowest allowing the creation of denser 
packing of fibres.  
 
The tensile strength can be predict with the following regression model:  
 
 Tensile strength (MPa) = 2.456 - 0.166 * DMSO concentration + 0.788 * 
HAc concentration 
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Figure 4.6 Tensile strength (MPa) for different concentrations of HAc and DMSO. 
 
 
Figure 4.7 Strain at break (%) for different concentrations of HAc and DMSO. 
 
 
Stress-strain curves were plotted for each tested sample. The J-shape 
characteristic of gelatin electrospun scaffolds [266] and biological soft tissue such as 
ligaments [306] was found in each sample. This J-shape is tipically shown to have a 
toe-region where the fibres start to straighten in the direction of the applied load and 
recovere their structure once load has been removed, a linear region where the 
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Young’s modulus was calculated for each sample, and the yield region. A typical 
stress-strain curve shown in Figure 4.8.  
 
Figure 4.8 Stress-Strain curve for a 1:1 HAc/dH2O and 5% DMSO scaffold. 
 
 
The natural anterior cruciate ligament (ACL) has a Young’s modulus of 
approx. 111 MPa [59]. All scaffolds manufactured for this study exhibited a higher 
Young’s modulus than the natural ACL but not too high to cause stress shielding 
once implanted into the body (as can be observed in Figure 4.9); therefore, they have 
an appropriate value for tissue engineered implants.  
 
 
Figure 4.9 Young’s modulus (MPa) for different concentrations of HAc and DMSO. 
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A maximum average tensile strength of 4.639±0.883 MPa, Young’s Modulus 
of 300.961±32.603 MPa and strain at break of 2.243±0.292% were observed with 
tensile tests of the virgin scaffold with concentrations of 25% w/v of gelatin 
dissolved in 1:1 HAc (glacial acetic acid)/dH2O (distilled water) and 5% DMSO 
(dimethyl sulfoxide).  
 
Previous studies revealed that the maximum tensile strength in a daily activity 
such as walking is approximately 17.57 MPa [237] and the maximum strain for that 
same activity is approx. 13% [237]. Therefore, the material properties of the gelatin 
electrospun scaffolds did not reach the specifications needed for daily activities such 
as walking. 
 
Moreover, no significant relationships between strain at break and Young’s 
modulus and the different concentration of solvents were obtained. 
 
Despite not obtaining the desired mechanical properties, these values were 
significantly higher than the values reported in the only study for tendon replacement 
found in the literature [294], corroborating the importance of performing an iterative 
optimisation for both solution and process parameters. Yang et al. [294] reported 
values of maximum tensile strength of 1 MPa; however, in the study performed for 
this thesis the optimum gelatin scaffolds reached values of maximum tensile strength 
of 4.6 MPa. The differences between both studies lies in the type of solvent and its 
concentration used to perform the gelatin solution; in the case of Yang et al. the 
solvent used was TFE and its concentration 20% w/v. 
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Once the solvent concentration effects on the morphology of gelatin scaffolds 
were known, the next step was the study of the degradation of the scaffolds. As 
gelatin is soluble in water it is predicted that these scaffolds would be dissolved in 
synovial liquid existing around the knee joint, therefore a process of crosslinking has 
to be performed in order to slow down its biodegradation process. The following 
section 4.4.3 focusses on the crosslinker agent and how it affects the degradation, 
morphology and topography of the scaffolds. 
 
 
4.4.3. GELATIN STUDY 2: HOW CROSSLINKING AFFECTS THE DEGRADABILITY OF THE 
SCAFFOLD, ITS MORPHOLOGY AND TOPOGRAPHY 
 
As was explained in section 4.3.4, the degradation of 42 samples was 
analysed. Non-crosslinked samples exhibited total dissolution within 1 hour of 
incubation in PBS making the use of any biological assay and therefore the 
manufacturing of any implant prototype invalid. Samples crosslinked by immersion 
were found inviable, since they partially dissolved within two hours of immersion in 
GTA.  Samples crosslinked by vapour deposition with 2.5% GTA were dissolved 
after 3 days of incubation in PBS. 5% GTA crosslinked samples (vapour deposition) 
lasted 7 days before being completely dissolved. Samples exposed to 25% GTA in 
vapour deposition remained undegraded until day 28. Figure 4.10 shows the 
scaffolds after being crosslinked by immersion and vapour deposition with 2.5%, 5% 
and 25% GTA. 
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Figure 4.10 Scaffolds after the crosslinking process. A) Immersion, B) Vapour deposition with 2.5% 
GTA, C) Vapour deposition with 5% GTA, D) Vapour deposition with 25% GTA. 
 
Due to only the samples exposed to 25% GTA being capable of use as 
potential ACL implants, only those samples are presented.   
 
The values for diameters of the fibres and inter-fibre separations for the 
samples exposed to 25% GTA versus the days in PBS are presented in Figures 4.11 
and 4.12. 
 
 
Figure 4.11 Fibre diameter (μm) with 25% GTA 
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Figure 4.12 Inter-fibre separation (μm) with 25% GTA. 
 
 
After a statistical analysis, it was obtained that there was a moderate negative 
correlation (-0.512) between the diameter of the fibres and days in PBS; therefore 
when the incubation days increased, the diameter of the fibre decreased. A very weak 
positive correlation was found between the days in PBS and the inter-fibre separation 
(0.1076). Regression models were performed for both parameters but neither the 
model nor the coefficients were significant. 
 
The average roughness and days in PBS showed a significant positive 
correlation (0.8364). Therefore, the roughness of the scaffold tended to increase with 
the presence of PBS. The regression model between those parameters and its 
coefficients proved to be significant (p < 0.05) and it is shown below:  
 
Average roughness (µm) = 1.423 - 0.026 * days in PBS 
 
This phenomen could be due to the exposure of the fibres to salts dissolved in 
the PBS modifying their original topography. Figure 4.12 shows the values of 
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average roughness versus days in incubation in PBS and SEM images of each 
scaffold.  
 
 
Figure 4.13 Average roughness (μm) for crosslinked scaffolds with 25% GTA. 
 
 
No tensile tests were performed for crosslinked samples due to them being 
found to be visually more brittle and stiffer than the non-crosslinked samples (Figure 
4.10), therefore it was obvious that the mechanical properties did not improve once 
the samples were crosslinked. 
 
 
 
 
 
 
 
Chapter 4. Suitability of Gelatin Electrospun Scaffolds for ACL Replacement  
 
  180         
  
 
4.5. CONCLUSIONS 
 
Acetic acid (HAc) and distilled water (dH2O) in 3:1, 1:1 and 1:3 
concentrations and dimethyl sulfoxide (DMSO) in 0%, 5% and 10% were used as 
solvents for electrospinning 25% w/v gelatin scaffolds. 
 
From Gelatin study 1 it was concluded that the diameter of the fibres, inter-
fibre separation, roughness and tensile strength were significantly affected by the 
concentration of HAc and DMSO (p < 0.001). The optimum concentration was found 
to be 25% of gelatin dissolved in 1:1 HAc and dH2O with 5% DMSO added; the 
optimum parameters to create the scaffold were: 26kV, flow rate of 2 ml/h, 11 cm 
distance between needle and collector, 15 G of size of the needle and 1300 rpm of 
the mandrel.   
 
Morphologically and topographically, it was observed that the diameter of the 
fibres and inter-fibre separations increased when the solvent concentration increased 
and the roughness decreased when the concentration of DMSO increased.  
 
Regarding mechanical properties, despite all manufactured scaffolds 
exhibiting higher Young’s modulus than the natural ACL, the maximum average 
tensile strength was 4.639±0.883 MPa and its strain at break was recorded as 
2.243±0.292 %; values much lower than the native ACL (reported as having an 
ultimate tensile of 38 MPa and strain at failure of 44%) [59].  
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From Gelatin study 2, it was concluded that only the samples exposed to 25% 
GTA remained undegraded until day 28. However, the original morphology of the 
scaffolds was modified, increasing in most of the cases all the fibre parameters 
(diameter, inter-fibre separation and roughness) when the incubation time in PBS 
increased. Additionally, crosslinked samples were visually found to be more brittle 
and stiffer than the non-crosslinked samples, therefore their mechanical properties 
did not improve after the crosslinking process. 
 
Therefore, both studies (Gelatin study 1 and Gelatin study 2) demonstrated, 
for the first time, that gelatin is not suitable for use as the sole polymer for the 
manufacture of ACL implants and further investigations must be focussed on the 
study of novel polymers and combinations of polymers for optimal ACL 
replacement.  
 
Chapter 5 evaluates the suitability of PVA electrospun scaffolds for use as 
ACL replacements. The morphology, topography and mechanical behaviour of these 
scaffolds is studied and compared with the properties of the natural ACL. 
 
 
 
Key points: 
1. This study evaluated the suitability of gelatin electrospun scaffolds to develop 
biomimetic ACL grafts, since no studies with these type of scaffolds have previously 
been performed for the purpose of manufacturing ligament implants. 
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2. To date, no studies for any polymer have focussed on an iterative optimisation of 
solution (with different polymer and solvent concentrations) and process parameters, 
with the goal of achieving mechanical and morphological properties that mimic the 
desired biological tissue.  
3. This chapter also studied how the use of crosslinking agents change the 
morphology of the nanofibres and their network, and how this influenced the 
suitability of this polymer to be used for ACL grafts. 
4. The optimised gelatin scaffolds achieved mechanical properties (maximum tensile 
strength 4.6 MPa) significantly higher than gelatin-based electrospun scaffolds 
reported for tendon applications (maximum tensile strength 1 MPa [294]).  
5. It was demonstrated that optimised gelatin scaffolds are not suitable to be used as 
the sole polymer for the manufacturing of ACL implants. This finding increases 
knowledge of the mechanical limitations of gelatin and moves the field forward to 
investigate other alternative polymers for new ACL grafts. 
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5. Suitability of polyvinyl alcohol (PVA) for the 
manufacturing of electrospun tissue 
engineered ligament implants: 
morphological, topographical and 
mechanical study 
 
 
The lack of appropriate suitability of gelatin electrospun scaffolds for their 
use as ACL grafts was demonstrated in Chapter 4. Therefore, it was necessary to test 
the suitability of a new polymer for use as a potential ACL graft. The suitability of 
polyvinyl alcohol electrospun scaffolds is studied in Chapter 5 comparing the 
morphology, topography and mechanical behaviour of the scaffolds created in this 
chapter with the characteristics of the natural ACL. 
 
 
5.1. ABSTRACT 
 
Polyvinyl alcohol (PVA) is an inexpensive, biodegradable, nontoxic and 
biocompatible polymer [65], [217], [218], [307]. This polymer is commonly used as 
a baseline for experiments with other materials, because it is easily electrospinnable 
due to its water solubility and nontoxicity.  
 
Recent studies used electrospun PVA mats for different applications such as 
food packing, tissue engineering, antibacterial, osmosis membrane, air filtration or 
drug delivery [307]–[312].  In these studies scaffolds were characterized in different 
ways (morphologically, chemically or mechanically, depending on the study) but 
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they were not characterized morphologically, topographically and mechanically at 
the same time.  
 
The use of PVA-based electrospun scaffolds for the manufacturing of 
ligaments implants has not been reported to date and only one study was found 
where PVA-base electrospun scaffolds were used for tendon substitutes [313].  
 
However PVA hydrogel cords were evaluated for use as ligament 
replacements [65], [314]–[316]. These 3D structures resulted in good 
biocompatibility [316] but low mechanical properties in comparison with the ACL 
[314]. 
 
The novelty of this work was to establish appropriate process and solution 
parameters in order to produce electrospun scaffolds with comparable mechanical 
behaviour and morphology as the native ACL. 
 
As in the previous study with gelatin (Chapter 4), the aim of the work was to 
evaluate the suitability of PVA electrospun scaffolds for use in creating new tissue 
engineered ligaments. The results of this research will increase the understanding 
about the type of material needed to achieve this objective. 
 
The work from this PhD revealed that a specific electrospinning setup could 
create 2D electrospun PVA scaffolds with a tensile strength of 30 ± 1 MPa close to 
that of the natural ligament (38 MPa [59]) and superior to 24.8 MPa reported during 
a jumping at maximum effort (activity which exhibited the highest tensile force) in 
Chapter 5. Suitability of PVA Electrospun Scaffolds for ACL Replacement 
 
  185         
  
Chapter 3 [237]. Apart from investigating the suitability of the PVA to be used for 
manufacturing new tissue engineering ligaments, this study was an initial 
investigation to manufacture 2D scaffolds and then use them to create 3D scaffolds 
for ACL replacement. 
 
 
 
5.2. INTRODUCTION 
 
As demonstrated in the previous chapter (Chapter 4), solution and process 
parameters directly affect the morphology, topography and mechanical properties of 
the electrospun mats, therefore the optimisation of those parameters will be critical to 
customize the scaffolds and obtain the desired properties. This novel study focusses 
on a systematic optimisation of these parameters to achieve PVA electrospun 
scaffolds with comparable morphology and mechanical properties to the natural 
ACL. A number of studies reported induced changes in the morphology of the fibres 
from modifying solution or process parameters [217], [218], [317]; however, none of 
them used a consistent optimisation process to select those parameters in order to 
achieve the desired objective. This study optimised the process and was the basis for 
the development of 3D tissue-engineered ligament implants produced in the 
following chapter of this thesis (Chapter 6). 
 
PVA is an inexpensive, highly hydrophilic, biodegradable, nontoxic and 
biocompatible polymer with excellent physical, chemical and mechanical properties. 
These properties make the PVA a promising polymer to create nanofibrous 
electrospun scaffolds for tissue engineering applications [65], [217], [218], [307] but 
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its use as a potential material for ligament implants still has to be proved 
mechanically and morphologically.  
 
Following a literature review of the PVA-based electrospun scaffolds created 
for tissue engineering, it was observed that most of them were used for skin and 
wound dressing applications [318]–[322], as well as bone tissue [309], [323]–[326] 
and vascular grafts [327]–[331]. No studies were found for the development of PVA-
based electrospun ligaments and only one study was found for tendons [313]; 
however in that article, PVA was used as sacrificial polymer with the aim of, once 
the PVA is dissolved in warm water, producing polyurethane hollow yarns. 
Therefore, the suitability of PVA electrospun scaffolds to be used for ligament 
implants is yet to be assessed. 
 
PVA hydrogels are commonly studied for tissue engineered cartilage 
substitutes [332]–[335]. Only four articles were found with the aim of creating 
ligaments [65], [314]–[316]. However, none of them studied the morphology of the 
scaffold or assessed their mechanical behaviour under shear loading. 
 
Bash et al., used ultrahigh molecular weight polyethylene thread braided with 
PVA hydrogel cords to create the prototypes [65]. They reported an ultimate load in 
tension of their constructs of approx. 2000 N identical to the value reported for the 
natural ACL [58], [59]; however, they did not report any evaluation of the 
degradation, morphology or topography of the scaffold to be compared to the native 
ligament.  
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Cai et al., studied twisted collagen I fibres with PVA hydrogel cords in order 
to manufacture ACL hydrogel scaffolds [314]. The maximum tensile strength 
reported for these constructs was 29.7 MPa, inferior to 38 MPa observed in the 
natural ACL.  
 
Moreau et al., (2014 and 2017) evaluated the in vivo influence of coating 
PVA hydrogel cords with hydroxyapatite to promote osteogenesis in rabbits [315], 
[316]. The results of these studies revealed that no bone tunnel osteolysis was 
observed and new bone tissue started to grow from the cortical bone [316]; however, 
the addition of the hydroxyapatite coating did not significantly improve the 
osseointegration of the implant [316].    
 
Other studies demonstrated that crosslinked PVA hydrogels exhibited 
excellent biocompatibility [336] and a water-swollen network similar to the 
extracellular matrix of the native ligament [65]. However, they cannot mimic the 
morphology of the extracellular matrix and therefore non-biomimetic ligament 
scaffolds can be produced with hydrogels.  
 
PVA electrospun scaffolds exhibit a network of nanofibres that mimics the 
extracellular matrix [337] and provides an optimum environment for cell 
proliferation. This polymer is easily electrospinnable due to its water solubility, 
nontoxicity of the solvent, the solution is ease to prepare and the production of high 
quality nanofibres free of defects. All of these advantages makes PVA an excellent 
polymer to be used as a baseline for experiments with other materials. More detail 
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about the advantages and disadvantages of currently used materials can be found in 
Section 1. 6.  
 
The novelty of this work is in understanding how changes in the process and 
solution parameters affect the morphology and maximum tensile strength of PVA 
electrospun scaffolds. This study allowed the creation of structures with similar 
morphology and mechanical behaviour to the natural ACL. The relationship between 
the process and solution parameters that provide morphology and mechanical 
behaviour comparable to the ACL are not fully documented in the literature. 
Moreover, this study will help to determine the type of material needed to create 
scaffolds with comparable structure to the natural ACL and that can bear high impact 
loading.  
 
As in the previous study with the gelatin (Chapter 4), the aim of this work 
was to assess the morphology, mechanical behaviour and degradation of the PVA 
electrospun scaffolds to determine its suitability to manufacture tissue-engineering 
implants [338].  
 
 
 
5.3. METHODS 
 
5.3.1. POLYMER SOLUTION 
 
For the initial optimisation of the polymer solution, different concentrations 
of PVA (Sigma Aldrich, UK) diluted in distilled water (dH2O) were prepared by 
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heating and stirring until a homogenous solution was achieved (see section 5.3.2.). 
After achieving the optimum concentration of PVA (12% w/v), different ranges of 
experiments with this solution were performed to determine the structure that 
provides the closest maximum tensile strength to the native ACL (38 MPa [59]) and 
that is capable of bearing a tensile strength of 24.8 MPa, reported during a jumping at 
maximum effort [237].  
 
Crosslinked samples were fabricated with 25% glutaraldehyde acquired from 
Sigma Aldrich (UK). 
 
 
5.3.2. SCAFFOLD PRODUCTION 
 
 An electrospinning device (Spraybase®, Ireland) was used to 
manufacture all the electrospun scaffolds.  As in the last study with gelatin (section 
4.4.1), it was necessary to perform an initial study (PVA study 1) to optimise the 
process and solution parameters, in order to produce the scaffold with the closest 
properties to the natural ligament. For that study different experiments were 
performed: 
 Optimisation of the polymer concentration. Four different 
concentrations were studied: 10%, 12%, 14% and 16%. The rest of 
the parameters were fixed as shown in Table 5.1. With these first 
experiments, an optimum morphology of the fibres (comparable to 
the diameter of the collagen fibrils of the natural ACL) with 
appropriate diameter was obtained.  
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Table 5.1 Fixed process parameters to determine optimum polymer concentration. 
 
 
 
 Optimisation of flow rate. 0.5 ml/h, 1 ml/h, 2 ml/h and 5 ml/h were 
tested until a stable Taylor cone was visibly obtained.  
 
 Optimisation of voltage. The voltage was varied until a stable Taylor 
cone and jet was produced. The spinnability with voltages 18 kV, 20 
kV, 22 kV and 25 kV was observed. 
 Optimisation of the distance between needle and collector. The 
morphology of the fibres was studied with three different distances 
50 mm, 80 mm and 110 mm. The rest of the parameters were fixed at 
the values shown in Table 5.2. 
 
Table 5.2 Fixed process parameters to determine distance between needle and collector. 
 
Concentration Voltage Flow rate
Revolutions of the 
mandrel
Needle Time
12% 20 kV 1 ml/h 2000 rpm 18G 20 min  
 
 Optimisation of the size of the needle. The morphology of the fibres 
manufactured with needle sizes of 15G, 18G, 20G, 21G, 22G and 
23G in diameter were studied to determine the size that provides the 
best morphology (with diameter of fibres comparable to the collagen 
fibrils of the native ACL) with mats free of any kind of defect. Table 
5.3 shows the rest of the parameters used for creating the scaffolds. 
 
Table 5.3 Fixed process parameters to determine the size of the needle. 
 
Concentration Voltage Flow rate
Distance between 
collector and needle
Revolutions of 
the mandrel
Time
12% 20 kV 1 ml/h 80 mm 2000 rpm 20 min  
Voltage Flow rate 
Distance between  
collector and needle 
Needle 
Revolutions of  
the mandrel 
Temperature Time 
25 kV 1 ml/h 11 cm 18G 1000 rpm 23 ° C 15 min 
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 Optimisation of the revolution of the mandrel. The changing 
orientation of the fibres was observed with different revolution 
speeds of the mandrel: 500 rpm, 1000 rpm, 2000 rpm and 3000 rpm. 
The other parameters were fixed as in Table 5.4. 
 
Table 5.4 Fixed process parameters to determine the revolutions of the mandrel. 
 
Concentration Voltage Flow rate
Distance between 
collector and needle
Needle Time
12% 20 kV 1 ml/h 50 mm 18G 20 min  
 
Once the parameters were optimised, obtaining a stable Taylor cone and 
scaffolds with fibres free of defects, a second study (PVA study 2) was performed to 
find their mechanical properties. In this study, the tensile strength and Young’s 
modulus were evaluated for the samples with the best morphology (the most similar 
to the natural ACL) obtained in relation to: 
 Revolution of the mandrel. 1000 rpm, 2000 rpm and 3000 rpm were 
studied under the conditions shown in Table 5.5. 
 
Table 5.5 Fixed process parameters varying the revolutions of the mandrel. 
 
Concentration Voltage Flow rate
Distance between 
collector and needle
Needle Time
12% 20 kV 1 ml/h 80 mm 18G 2 h  
 
  Size of the needle.  18G and 21G were studied performing the 
experiments with the following set up (Table 5.6). 
 
Table 5.6 Fixed process parameters varying the size of the needle. 
 
Concentration Voltage Flow rate
Distance between 
collector and needle
Revolutions of 
the mandrel
Time
12% 20 kV 1 ml/h 80 mm 2000 rpm 2 h  
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The third study (PVA study 3) was focussed on the degradation of the 
selected scaffold shown to have the morphology and mechanical properties closest to 
the natural ligament. This scaffold was manufactured with 10 ml of 12% polymer 
solution pumped with a flow rate of 1 ml/h through an 18 G needle. The voltage 
between the tip of the needle and the collector was set up at 20 kV. The fibres were 
projected from the tip of the needle over a sheet of aluminium foil attached to a 9.65 
cm diameter rotating collector working at 2000 rpm, in order to obtain aligned fibres 
and a maximum tensile strength similar to the natural ACL. The distance between the 
needle and the collector was set up 8 cm. The scaffolds were manufactured at room 
temperature and for 2 hours spin time. Prior to performing the degradation study, the 
samples were crosslinked following the procedure explained in the next section 
(5.3.3).  
  
 
5.3.3. CHEMICAL CROSSLINKING 
 
PVA is soluble in water and in any other biological solution [339]. This fact 
would directly affect the viability of the scaffold in a culture medium, to grow cells 
on it in order to obtain a tissue-engineered scaffold, and inside the body once the 
scaffold is implanted. Therefore, to slow down the degradation of the PVA scaffolds 
a crosslinking process of the samples has to be performed.  
 
Two crosslinking techniques were evaluated: immersion and vapour 
deposition. For crosslinking the samples by immersion, glutaraldehyde (GTA) and 
methanol were studied. For this technique, six samples were placed in 6 well plates 
Chapter 5. Suitability of PVA Electrospun Scaffolds for ACL Replacement 
 
  193         
  
with 2 ml of ≥ 99.6% methanol in three of the wells and 2 ml of 25% GTA in the 
other three wells for 2 hours.  
 
The crosslinking by vapour deposition was performed by pouring 25 ml of 
25% GTA in a Petri dish at the bottom of a sealed desiccator. 16 samples (created for 
PVA Study 3) were placed over a metallic mesh on top of the Petri dish and exposed 
to glutaraldehyde vapour for a 24 hour period inside the desiccator. After the vapour 
deposition crosslinking process, the samples were dried under a fume hood for 24 
hours in order to remove the moisture and reduce the toxicity of the samples due to 
the GTA. Two samples were reserved for topographical characterization after being 
crosslinked, an additional two samples were rinsed in PBS for 30 seconds and dried 
under a fume hood for 24 hours, and the remainder (12 samples) were used for the 
degradation assay explained in the next section (5.3.4).  
 
Moreover, 16 samples were crosslinked to be mechanically characterized in 
PVA Study 2 and dried under a fume hood for 24 hours. 
 
 
5.3.4. DEGRADATION ASSAY 
 
Twelve samples of the scaffold created with the optimum solution and 
process parameters were air-dried for 24 hours and placed in 6 well plates (2 samples 
per well) with 4 ml of PBS in each well. These samples were then left in an incubator 
at 37ºC and 4% CO2 in order to test their degradability over time in temperature 
conditions similar to human body conditions. These samples were left in PBS for 1, 
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5, 7, 14, 21 and 28 days. Before topographical characterization of the samples, they 
were air-dried for 24 hours in a fume hood to remove the moisture. 
 
 
5.3.5. SCAFFOLD/FIBRE CHARACTERIZATION 
 
5.3.5.1. Fibre morphology 
 
Fibre morphology was analysed for all scaffolds manufactured in PVA 
studies 1 and 2; this parameter was not fully evaluated for PVA study 3 due to the 
difficulty of measuring swollen electrospun fibres, this was explained in more depth 
in section 5.4.3. 
 
 As in the previous study with gelatin (Chapter 4), a SC7640 sputter coater 
(Quorum Technologies Ltd. Kent, UK) was used to coat the samples with gold prior 
to their visualization with a field emission scanning electron microscope (Zeiss Supra 
40, FE-SEM, Carl Zeiss SMT Ltd., Cambridge, UK). The intensity used for coating 
the samples was 20 mA, the voltage 0.8 kV and the duration of the coating was 120 
seconds. SEM images of each sample created with the different set ups were taken at 
around 6 mm working distance, with a voltage of 2 kV and with magnifications of 
1000x, 2000x and 3000x. Fibre diameters and inter-fibre separations were 
determined with AxioVision SE64 Rel. 4.9.1 (Carl Zeiss SMT Ltd., Cambridge, UK) 
by measuring 20 fibres per sample. Two samples (replicates) were measured for each 
different scaffold and two scaffolds (repeats) were produced for each configuration 
(16 different set ups) to guarantee the repeatability of the results, therefore a total of 
64 samples was analysed.   
Chapter 5. Suitability of PVA Electrospun Scaffolds for ACL Replacement 
 
  195         
  
 
5.3.5.2. Scaffold topography 
 
Scaffold topography was evaluated for PVA study 3. 6 white light 
interferometry images were taken per sample using an interferometer from ZeGage 
(Zygo Corporation). A total of 108 images were analysed for this study. The average 
roughness was compared between crosslinked samples (16 crosslinked samples) with 
different times in PBS and the initial non-crosslinked samples (2 non-crosslinked 
samples)  
 
5.3.5.3. Mechanical behaviour of the scaffolds 
 
A total of 76 samples were mechanically characterized. The mechanical 
behaviour of 5 different non-crosslinked scaffolds and 1 crosslinked scaffold (created 
with the optimum solution and process parameters) were analysed. From each non-
crosslinked scaffold, 6 longitudinal and 6 transverse samples were tested and for the 
crosslinked scaffold, 8 longitudinal and 8 transverse samples were mechanically 
characterized. Longitudinal samples were called to the samples with the fibres 
orientated longitudinally to the applied load during the tensile test. Transverse 
samples were the ones with their fibres orientated transversally to the applied load.  
 
The samples were removed from the mats with a dog-bone cutting die (25 x 4 
mm, test length x width). Their thickness was measured three times with a digital and 
an analogical calliper in order to check the consistency of the measurements. They 
were attached on a cardboard frame to help the alignment of the sample in the 
tensometer (Instron H10KS) and they were tensile tested until failure with a 100 N 
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load cell and 1 mm/min test speed. Tensile strength was determined for each sample 
and statistically analysed in order to evaluate the relationship between this 
mechanical property and the morphological properties. 
 
 
5.3.6. STATISTICAL ANALYSIS 
 
Mean and standard error of the mean (Std Error) were calculated for all 
quantitative structural and mechanical properties. 
 
Pearson coefficient of correlation and simple linear regressions were used to 
estimate the relationship between process and solvent parameters and the 
morphology, topography and mechanical properties of the scaffolds.  
 
All statistical analyses were conducted using SPSS (IBM Inc, Chicago, 
Illinois). 
 
 
5.4. RESULTS AND DISCUSSION 
 
 
5.4.1. PVA STUDY 1: OPTIMISATION OF THE SOLUTION AND PROCESS PARAMETERS 
 
5.4.1.1. Optimisation of polymer concentration 
 
 
Four concentrations of PVA with distilled water were considered in this 
experiment: 10%, 12%, 14% and 16%. Due to the high viscosity of the 16% solution, 
no scaffold could be manufactured with that concentration. 
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Scaffolds with beads were produced with concentrations below 12% (Figure 
5.1 A) and the viscosity of the solution caused difficulties in electrospinning with 
concentrations above 12%. SEM images of scaffolds produced with 10%, 12% and 
14% solutions are shown in Figure 5.1.  
 
 
Figure 5.1 PVA scaffolds with A) 10% B) 12% and C) 14% polymer concentration. 
  
 Studying the morphology of the scaffolds, it was observed that the diameter 
of the fibres increased with increased percentage of polymer solution as shown in 
Figure 5.2. The correlation between both parameters follows a perfect positive linear 
association with 0.999. In addition, the regression model follows the expression 
below: 
 
Diameter of the fibres (µm) = -0.191 + 2.7625 * concentration of the polymer (%) 
 
Figure 5.2 Diameter of the fibres versus concentration of polymer 
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There are two different groups of collagen fibrils in the native ligament, a 
group of fibrils with diameters between 40 and 75 nm and other group with 
diameters between 100 nm and 150 nm [33], [45]–[47], [209]. Due to 12% PVA 
being determined as the concentration that created the average diameter of the fibres 
most comparable to the fibrils (10%: 84±3.9 nm, 12%: 143±5.6 nm, 14%: 
194±6.9nm) and the ease of electrospinning PVA with that concentration, 12% was 
considered as the optimum concentration of polymer. Therefore, the rest of the 
experiments were set up with 12% PVA. 
 
5.4.1.2. Optimisation of flow rate 
 
The flow rate was modified from 0.5 ml/h, 1 ml/h, 2 ml/h to 5 ml/h until a 
stable Taylor cone and jet were obtained. Continuous drops were observed (not 
allowing the creation of a stable Taylor cone) with rates of 2 ml/h and 5 ml/h. At 0.5 
ml/h the flow was not high enough in speed to maintain a stable jet. A flow rate of 1 
ml/h created a stable jet without the presence of continuous drops, so this was 
determined to be optimum. 
 
5.4.1.3. Optimisation of voltage 
 
Once the polymer concentration and the flow rate were set up to 12% PVA 
and 1ml/h, the voltage was varied from 18 kV, 20kV, 22 kV to 25 kV until the  
electrostatic force overcame the cohesive force of the solution and a charged jet was 
visible. This was observed to occur from 20 kV. This phenomenon was also observed 
with 22 kV and 25 kV; however, due to the risk of static shock for the user and the 
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risk of damaging the electrospinner (higher risks as the voltage is increased) it was 
decided to set the electrospinner at the lowest voltage possible. 
 
5.4.1.4. Optimisation of the distance between needle and collector 
 
Three different distances were considered: 50 mm, 80 mm and 110 mm. 
Figure 5.3 shows the diameter of the fibres and the inter-fibre separations in relation 
to the distance between the needle and collector. 
 
 
Figure 5.3 A) Diameter of the fibres and B) Inter-fibre separation versus distance between needle and 
collector 
 
The diameters of the fibres and the inter-fibre separations were analysed 
statistically with respect to the distance between the needle and the collector. No 
significant linear regression between diameter of the fibre and this distance or inter-
fibre separation and the distance were observed. The Pearson coefficients between 
diameter and distance was -0.39 and between inter-fibre separation and distance was 
-0.76. The morphology of the three scaffolds can be observed in Figure 5.4. 
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Figure 5.4 Scaffolds fabricated with A) 50 mm distance between needle and collector, B) 80 mm and 
C) 110 mm. 
 
  
As no significant differences were determined for the morphology of the 
fibres against the distance between the needle and the collector, it was decided to set 
an optimum value of 80 mm distance. This decision was made based on two aspects: 
the total evaporation of the solvent and the productivity of the manufacturing 
process. Scaffold made with 50 mm distance between needle and collector exhibited 
problems of solvent evaporation. The production of scaffolds made with 110 mm 
distance were slower than with 80 mm distance between the needle and the collector, 
reducing the productivity.  
 
5.4.1.5. Optimisation of size of the needle 
 
The morphology of the scaffolds was studied using five needles with different 
sizes: 15G, 18G, 20G, 21G and 22G. Figure 5.5 shows the diameter of the fibres and 
the inter-fibre separation versus the size of the needle. 
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Figure 5.5 A) Diameter of the fibres and B) Inter-fibre separation versus size of the needle 
 
Statistically analysing both of these parameters against the size of the needle, 
it was observed that neither significant correlations nor significant regression models 
were obtained, therefore the selection of the size of the needle was taken through a 
manufacturing perspective. It was observed that a very small diameter of the needle 
(22G and 23G) produced thin scaffolds, due to the density of the fibres projected 
over the collector being low (Figure 5.6 E and F); therefore the time to create thicker 
scaffolds increased significantly and the productivity of the process was decreased. 
Electrospun scaffolds produced with the needle with the biggest diameter also 
produced a thin electrospun scaffold (observed inter-fibre separation for 15G in 
Figure 5.5 B), decreasing the productivity. Another aspect to take into consideration 
was the ease of obtaining a stable Taylor cone. It was easier to spin with a needle of 
18G diameter rather than smaller diameter needles, since it is less likely to block the 
needle and obtain a stable Taylor cone if the needle has a bigger diameter. For these 
reasons, and for the next experiment (section 5.4.1.6. Optimisation of the revolutions 
of the mandrel), it was considered that the optimum needle size was 18G. However, 
mechanical tests were performed to compare the maximum tensile strength for 
scaffolds created with 18G and 21G to corroborate that the assumption made in this 
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experiment was valid. Figure 5.6 shows the different scaffolds produced with the 
different needle sizes. 
 
Figure 5.6 Scaffolds fabricated with size of the needle of A) 15G, B) 18G, C) 20G, D) 21G, E) 22G 
and F) 23G 
 
 
5.4.1.6. Optimisation of revolutions of the mandrel 
 
 
The morphology of the fibres was studied as a result of changing the 
revolutions of the mandrel. 500 rpm, 1000 rpm, 2000 rpm and 3000 rpm were 
evaluated. Figure 5.7 shows the diameter of the fibres and the inter-fibre separations 
in relation to the revolutions of the collector. As was observed from the graphs 
(Figure 5.7 A and B), all of the scaffolds presented fibre diameters between 100 nm 
and 150 nm, comparable to the diameter of the collagen fibrils in the natural ACL 
[33], [45]–[47], [209]. The higher inter-fibre separation was observed for scaffolds 
made with mandrel revolutions of 2000 rpm, this is a key point since scaffolds with 
higher inter-fibre separation would promote more cellular migration inside the 
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scaffold than scaffolds with low inter-fibre separation. This was observed in Ionescu 
et al. [340], where higher porosity scaffolds were better infiltrated and exhibited a 
more uniform matrix deposition of proteoglycan and collagen. 
 
 
 
Figure 5.7 A) Diameter of the fibres and B) Inter-fibre separations versus revolutions of the mandrel 
  
 
 
 
As in the last section (5.4.1.5), neither significant correlations nor significant 
regression models were obtained after statistical analysis. Therefore, the optimum 
mandrel revolution was determined by observing which scaffold had the highest 
inter-fibre separation and which presented more aligned fibres. It is known that the 
collagen fibres are parallel and longitudinally orientated in the natural ACL, 
therefore, in terms of morphological structure of the scaffolds, the best revolution 
would be the one that produced aligned fibres free of defects comparable to the 
natural ACL. In the next section (5.4.2. PVA Study 2) different scaffolds created 
with different speeds were mechanically tested to corroborate whether scaffolds with 
aligned fibres produced higher maximum tensile strength than randomly orientated 
fibres.  The different scaffolds produced by varying the revolutions can be observed 
in Figure 5.8. 
 
Chapter 5. Suitability of PVA Electrospun Scaffolds for ACL Replacement 
 
  204         
  
 
Figure 5.8 Scaffolds fabricated with A) 500 rpm, B) 1000 rpm, C) 2000 rpm, and D) 3000 rpm 
 
Examining the scaffolds created, it was observed that values below 2000 rpm 
did not produce aligned electrospun mats and above 2000 rpm beads were produced, 
due to the vibration caused by the high revolutions of the mandrel. Therefore, 2000 
rpm was considered at this stage as optimum, because the fibres created with this 
setting exhibited higher inter-fibre separation, did not present any defect and were 
aligned mimicking the natural ACL. 
   
 
 
5.4.2. PVA STUDY 2: MECHANICAL CHARACTERIZATION 
 
After the initial study (PVA Study 1) to obtain the optimum solution and 
process parameters that provided a stable Taylor cone and optimum fibre 
morphology, a second study (PVA Study 2) was performed to evaluate the 
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mechanical properties of 6 different scaffolds. This second study was performed to 
corroborate whether the scaffolds created with the optimum solution and process 
parameters obtained in PVA Study 1 exhibited a maximum tensile strength  
comparable to the value observed in the natural ligament (38 MPa [59]). From the 
initial morphological study, it was determined that the optimum process and solution 
parameters were (Table 5.7): 
 
Table 5.7 Optimum process and solution parameters. 
 
Concentration Voltage Flow rate
Distance between 
collector and needle
Revolutions of 
the mandrel
Needle Time
12% 20 kV 1 ml/h 80 mm 2000 rpm 18G 2 h  
 
In this study, the influence of the mandrel revolution and the size of the 
needle against the maximum longitudinal and transverse tensile strength were 
analysed. For this study, 5 thicker scaffolds were produced to enable securing them 
in the grips without rupture due to stress concentrations; therefore 2 hours of 
electrospinning was necessary to create thick enough scaffolds.  
 
5.4.2.1. Revolution of the mandrel 
 
5.4.2.1.1. Maximum tensile strength parallel to the direction of the fibres   
  
As was predicted the scaffold that provided higher tensile strength parallel to 
the direction of the fibres was generated with a mandrel speed of 2000 rpm, because 
the fibres in that scaffold were more aligned than with other revolutions and were 
free of beads that weaken the scaffold. The fact that more aligned fibres generated 
higher maximum tensile strength was also observed by Bosworth et al. [263], where 
scaffolds with randomly distributed and aligned fibres were created with a mandrel 
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speed of 50 rpm and 600 rpm respectively. The results obtained for maximum tensile 
strength for 1000, 2000 and 3000 rpm are shown in Figure 5.9. 
 
 
Figure 5.9 Maximum tensile strength in the parallel direction of the fibres versus revolution of the 
mandrel 
 
 
  
For 2000 rpm a maximum tensile strength of 22.823 ± 1.978 MPa was 
obtained. Studies developed in Chapter 3 showed that the maximum tensile strength 
observed for jumping at maximum effort was 24.8 MPa and in walking was 17.57 
MPa [237]. The maximum tensile strength exhibited after tensile testing human ACL 
was 38 MPa [59]. Therefore, these results were comparable to the mechanical 
properties needed for an implant for ACL replacement. In order to increase the 
tensile strength and reduce the degradation rate, experiments with crosslinked 
samples were performed and they are shown in section 5.3.3. 
 
Moreover, the morphology of the fibres after being tensile tested and the 
morphology of a damaged ACL appeared similar as observed in Figure 5.10. 
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Figure 5.10 A) Morphology of the scaffold after being tested B) Damaged ACL [48] 
 
  
The previous figure (Figure 5.10 A) shows that the fibres maintained their 
alignment and crimp pattern after being tensile tested, this alignment and pattern also 
existed in damaged ligaments as can be observed in Figure 5.10 B. 
 
 After this analysis it was verified that 2000 rpm was the optimum revolution 
to provide a tensile strength and morphology comparable to the natural ACL.  
 
 
5.4.2.1.2. Maximum tensile strength perpendicular to the direction of the fibres   
 
  
 The maximum tensile strength in the perpendicular direction of the fibres was 
also analysed to detect which structure better resisted under a transverse load. This is 
important to bear shear forces, as it was proved in Chapter 3 that failure mechanisms 
are due to multidirectional loading, how the scaffolds mechanically behave under 
tensile, shear and torsion loading therefore has to be analysed [236], [237]. Figure 
5.11 shows the values of the maximum tensile strength against the mandrel 
revolutions. 
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Figure 5.11 Maximum tensile strength in the perpendicular direction of the fibres versus revolution of 
the mandrel 
 
 
As was expected the maximum tensile strength in the perpendicular 
direction of the fibres was considerable lower than in the parallel direction. 
However, this study showed that the highest maximum tensile strength in the 
perpendicular direction of the fibres was obtained with 2000 rpm of the mandrel. 
How the scaffolds created with this configuration behaved under shear loading was 
evaluated in Chapter 6. Future work should be focussed on the study of testing the 
natural ACL under shear loading and compared to the results observed in this 
thesis.  
 
The following figure (Figure 5.12) shows the morphology of the fibres after 
being tensile tested perpendicular to the direction of the fibres. 
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Figure 5.12 Morphology of the scaffold after being tested perpendicular to the direction of the fibres. 
 
  
In this case, the porosity of the scaffold increased as the fibres were 
separated. 
  
 
5.4.2.2. Size of the needle 
 
 
The same study as in section 5.4.1.5 was performed with two different needle 
sizes: 18G and 21G due to both providing aligned fibres free of defects and no 
significant relationship between fibre morphology and needle size being observed in 
section 5.4.1.5. 
 
5.4.2.2.1.  Maximum tensile strength parallel to the direction of the fibres   
 
After tensile testing the scaffolds in the parallel fibre direction, it was 
determined that 18G was the size of the needle that provided the highest maximum 
tensile strength, as shown in Figure 5.13. 
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Figure 5.13 Maximum tensile strength parallel to the direction of the fibres versus size of the needle 
 
Figure 5.14 shows the morphology of the scaffolds produced with 18G and 
21G needles. It was observed that the scaffolds manufactured with 18G needle size 
had more uniform fibres and were free of beads; however, the scaffolds created with 
21G needle showed some beads and heterogeneous fibres reducing the tensile 
strength compared to the scaffolds fabricated with the 18G needle.  
 
 
Figure 5.14 Scaffolds manufactured with needle size A) 18G and B) 21G 
 
5.4.2.2.2. Maximum tensile strength perpendicular to the direction of the fibres   
 
 The maximum tensile strength in the perpendicular direction to the fibres was 
higher for the scaffold manufactured with 18G needles compared to 21G needles, as 
observed in Figure 5.15. 
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Figure 5.15 Maximum tensile strength perpendicular to the direction of the fibres versus size of the 
needle 
 
 Therefore, it was confirmed that the optimum parameters to provide improved 
morphology and mechanical properties were as shown in Table 5.7: 12% PVA 
concentration, 20 kV, 1ml/h flow rate, 80 mm distance between needle and collector, 
2000 rpm and diameter of the needle of 18G. 
  
 
5.4.2.3. Crosslinked samples of the scaffold manufactured with the optimum 
solution and process parameters 
 
 
As previously explained (section 5.3.3), PVA is a soluble polymer, therefore 
to slow down its degradation process it was necessary to crosslink the scaffolds and 
characterize the new crosslinked samples. In this section, the scaffold that showed 
the highest maximum tensile strength and that was produced with the optimum 
solution and process parameters was crosslinked. The maximum tensile strength 
(longitudinal and transverse to the direction of the fibres) was calculated for this 
crosslinked scaffold, which remained stable and undegraded along the timeframe of 
the mechanical, morphological and topographical characterization. The comparison 
between non-crosslinked samples and crosslinked samples is shown in Figure 5.16. 
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Figure 5.16 Maximum tensile strength parallel and perpendicular to the direction of the fibres for non-
crosslinked and crosslinked samples produced with the optimum set up. 
 
 
From the results obtained, it was observed that the crosslinked samples 
increased their maximum tensile strength from 22 ± 1 MPa to 30 ± 1 MPa when the 
load was applied parallel to the direction of the fibres and reached 7 MPa for the 
crosslinked samples in the perpendicular direction of the fibres. Therefore, the 
maximum tensile strength for crosslinked samples was approximatly the maximum 
tensile strength of the native ACL (38 MPa [59]) and superior to the maximum 
tensile strength observed during jumping at maximum effort where it was recorded 
as 24.8 MPa [237]. Further studies modifying the geometry of the scaffolds to create 
3D scaffolds were mechanically characterised in Chapter 6 to verify if 3D PVA 
scaffolds could reach the appropriate tensile strength and could be considered for use 
as ACL implants. 
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5.4.3. PVA STUDY 3: DEGRADATION STUDY 
 
Two different techniques were considered to crosslink the samples: 
immersion in methanol and in GTA and vapour deposition in GTA. After performing 
the crosslinking, only the samples crosslinked by vapour deposition could be used for 
further studies; the samples treated by immersion dissolved after a few minutes of 
use of this technique.  
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Figure 5.17 Degradation of PVA samples examined under SEM A) non-crosslinked B) crosslinked C) 
crosslinked and rinsed D) 1 day E) 5 days F) 7 days G) 14 days H) 21 days I) 28 days of incubation in 
PBS. 
 
Figure 5.17 shows PVA samples under the following conditions: non-
crosslinked; dried after crosslinking; rinsed and dried after crosslinking; and dried 
after 1, 5, 7, 14, 21 and 28 days in incubation in PBS at 37°C and 4% CO2. Once the 
samples were soaked in PBS, the fibres of the scaffolds were difficult to visualize 
and to measure using an SEM. This is due to PVA behaving as a hydrogel when it 
was immersed in an aqueous liquid, and its fibres swelln. However, it was visually 
shown that the fibres remained, imitating the extracellular matrix, and that the 
crosslinked PVA electrospun scaffolds did not degrade after 28 days of incubation 
immersed in PBS (Figures 5.17 and 5.18); therefore they can be used in future cell 
culture experiments to investigate their attachment, proliferation or cell orientation, 
as was performed by other research groups [327], [341], [342].  
Chapter 5. Suitability of PVA Electrospun Scaffolds for ACL Replacement 
 
  215         
  
 
 
Figure 5.18 Degradation of PVA samples A) crosslinked B) crosslinked and rinsed C) 1 day D) 5 days 
E) 7 days F) 14 days G) 21 days H) 28 days of incubation in PBS. 
 
 
Despite the difficulties in measuring the fibres, 20 measurements (per 
sample) of fibre diameter were performed after 1 and 28 days of being immersed in 
PBS, resulting fibre diameters of 461 ± 4 nm and 453 ± 3 nm respectively. Although 
these values showed a swelling of the nanofibres, the cell behaviour would not be 
compromised, since previous studies with PVA electrospun scaffolds reported 
excellent cell adhesion and proliferation with values of fibre diameter between 379 ± 
37 nm and 524 ± 31 nm [324]. 
 
Moreover, it was demonstrated that crosslinked PVA hydrogels exhibited 
excellent biocompatibility [65], [217]–[219], [309], [318], [320], [323], [326], [327], 
[329], [330] and a water-swollen network similar to the extracellular matrix of the 
native ligament [65]. 
 
The average roughness of the scaffolds was analysed, in order to check if the 
crosslinking process and the incubation in PBS changed the topography of the 
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samples. Andrews et al. [189] reported that cellular behaviour is influenced by the 
scaffold topography. Moreover, values of roughness between 0.3 µm and 1.2 µm 
exhibited high percentage of cell coverage and cell spreading after 28 days of being 
seeded. These results induces to think that the scaffolds produced with roughness 
about 0.6 µm in this Chapter 5, would achieve comparable results of cell behaviour 
as the results reported. Figure 5.19 shows the roughness results of the present study. 
 
 
 
 
Figure 5.19 Roughness of the sample after being crosslinked and immersed in PBS 
 
 
After statistical analysis, the correlation between average roughness of the 
scaffold and days in PBS was a null negative correlation (-0.054). The ANOVA and 
regression model were not significant. Therefore, the roughness did not change either 
with the crosslinking or with the incubation in PBS, proving that those treatments did 
not affect the topography of the scaffolds.  
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5.5. CONCLUSIONS 
 
This study analysed the suitability of PVA electrospun scaffolds to be used as 
ACL implants. The first step of this study was focussed on finding the optimum 
process and solution parameters with which to manufacture scaffolds with 
morphology and mechanical strength similar to the native ligament. Once the 
optimum parameters were determined, scaffolds with those parameters were 
manufactured and their mechanical properties and degradation studied. 
 
The maximum tensile strength was calculated for non-crosslinked and 
crosslinked samples, recording values of 22 ± 1 MPa for the non-crosslinked samples 
and 30 ± 1 MPa for crosslinked samples, when the load was applied parallel to the 
direction of the fibres. The crosslinked samples exhibited values of maximum tensile 
strength similar to the native ACL (38 MPa [59]) and higher than the maximum 
tensile strength observed during jumping at maximum effort (24.8 MPa [237]) 
reported in Chapter 3; therefore these samples showed potential for use as ACL 
replacements, when considering just the maximum tensile strength.  
 
The scaffolds exposed to 25% glutaraldehyde remained undegraded and with 
an intact topography after 28 days of incubation in phosphate-buffered saline (PBS). 
Further studies should be performed in order to understand its degradation rate and 
“lifespan” in PBS. However, it can be concluded from the results that PVA 
electrospun scaffolds can be used to grow cells on them and therefore manufacture 
tissue-engineered implants in future work. 
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This study demonstrated that PVA scaffolds have a great potential to be used 
to manufacture ACL implants, since they exhibited excellent mechanical, 
morphological and topographical properties. Chapter 6 investigates the possibility of 
manufacturing 3D electrospun PVA scaffolds to enable full functionality for ACL 
implantable medical devices.  
 
 
Key points: 
1. This study evaluated for the first time the suitability of PVA electrospun scaffolds 
to produce biomimetic ACL implants.   
2. Before the development of Chapters 4 and 5, no studies for any polymer had 
focussed on an iterative optimisation of solution and process parameters, with the 
goal of achieving mechanical and morphological properties that mimic the desired 
biological tissue.   
3. The optimised PVA crosslinked scaffolds reached a maximum tensile strength of 
30 MPa, comparable to the native ACL.  
4. The topography of the scaffolds produced remained unaltered after being exposed 
to 25% GTA and 28 days of incubation in PBS. 
5. The scaffolds showed values of fibre diameter between 120 and 140 nm, 
comparable to the values of the collagen fibrils in the extracellular matrix.  
6. It was demonstrated that 2D PVA electrospun scaffolds exhibited excellent 
mechanical, morphological and topographical properties for use in the manufacture 
of ACL implants, and they formed the baseline to produce 3D structures.  
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6. Evaluation of 2D and 3D PVA electrospun 
structures 
 
 
The significant potential of PVA electropun scaffolds for use as ACL 
implants was demonstrated in Chapter 5. In Chapter 6, the mechanical and 
morphological properties of different 2D and 3D PVA electrospun structures is tested 
to evaluate their suitability for use as ACL grafts.  
 
 
6.1. ABSTRACT 
 
The ACL has the highest rate of injury in the knee. Currently, autografts are 
used in 90% of the surgeries to replace the damaged ACL and recover the stability of 
the joint. However, these grafts present donor-site morbidity and long postoperative 
rehabilitation. In order to reduce these disadvantages, tissue engineered electrospun 
grafts were proposed in this study.     
 
A range of 2D and 3D PVA electrospun scaffolds was studied to evaluate 
their suitability for use as ACL grafts. To this end, 2D electrospun scaffolds, one 
twisted filament scaffolds, 3 twisted filaments scaffolds and 3 twisted/braided 
filaments scaffolds were characterized morphologically and mechanically. It was 
assumed that similar fibre networks to the extra-cellular matrix would promote tissue 
ingrowth; and morphological structure and mechanical behaviour comparable to the 
natural ACL would provide the mechanical properties required.  The final aim of this 
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chapter was to determine which electrospun structure would provide the closest 
morphology and mechanical properties to the natural ligament, in dry and wet 
environments and under tensile and shear loading. 
 
 
 
6.2. INTRODUCTION 
 
The ACL rupture is the most common injury in the knee joint. Due to its 
low vascularization, this ligament has very poor healing mechanisms, making the use 
of ACL grafts necessary for its reconstruction or replacement [343]. 
 
Nowadays, the gold standards for ACL replacement are the patella-tendon, 
hamstring-tendon and quadriceps-tendon autografts [343]. However, the autografts 
exhibit various disadvantages, such as donor site morbidity, long rehabilitation time 
or lack of availability, potentially solved through the implantation of tissue 
engineered grafts [344]. 
 
An ideal tissue engineered ligament should be biocompatible (able to 
perform with an appropriate host response in a specific application), promote tissue 
ingrowth with an appropriate porosity, degrade at the same rate as the host tissue is 
growing and exhibit mechanical behaviour similar to the natural ligament [343], 
[345], with toe, linear and failure regions. The maximum tensile stress should be 
approximately 38 MPa [59], the Young’s modulus approximately 111 MPa [59] and 
the shear modulus approximately 68 MPa [346]. The structure of the implant ideally 
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should be similar to the hierarchical structure of the ligament, hence mimicking the 
extracellular matrix and so promoting cell proliferation, and imitating the mechanical 
response. Therefore, the fibres should be between 40 and 150 nm in diameter 
mimicking the collagen fibrils in the ACL, the bundle of fibres approx. 1 to 20 µm, 
and the filaments between 360 and 1500 µm in diameter simulating the fascicles of 
the natural ACL.  
 
Polymers such as collagen [347], silk fibroin [344], poly L-lactic acid [345], 
[347], poly-caprolactone [263], polyvinyl alcohol or polyethylene [65] have been 
used to manufacture tissue engineered scaffolds for tendon and ligament 
replacement.  
 
 As shown in Chapter 5, PVA is an inexpensive polymer with excellent 
physical, chemical and mechanical properties. Currently PVA nanofibrous 
electrospun scaffolds are used in tissue engineering applications due to PVA being a 
highly hydrophilic, biodegradable, nontoxic and biocompatible polymer [65], [218], 
[219] and as the scaffolds present a network of nanofibres that mimics the 
extracellular matrix, characteristic of electrospun scaffolds. Due to its water 
solubility and nontoxicity, PVA is easily manageable since it is not necessary to use 
any mechanism of extraction of toxic vapours. Moreover, optimising the solution and 
process parameters, tuneable and free from beads nanofibres can be produced with 
this polymer. All of these advantages enable PVA to be used as a baseline polymer 
for other experiments.  
 
However, independent of the material used and focussing on the 
manufacturing process, there is a lack of studies to assess 3D tissue engineered 
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ligaments, especially those produced by the electrospinning technique. Currently 
there are different techniques to create tissue engineered ligaments: twisting, 
braiding, weaving, knitting and combinations of the above-mentioned [345]. It is 
known that by modifying the geometrical pattern of the structure its mechanical 
properties can be changed [345], [348]. Braided structures are designed to transfer 
large loads, bearing axial and shear loads and provide torsion stability [345], [349]. 
Twisted fibres are used to improve the abrasion resistance and flexibility [345], 
[348].  Microfibres of the polymers previously mentioned were purchased and then 
twisted [344], [345], [350], [351], braided [345], [352], [353] and a combination of 
both [345] forming bundles of fibres simulating the ligamentous or tendinous 
structures.  
 
The electrospinning technique allows the creation of a network of 
nanofibres similar to the extracellular matrix of soft tissue. To the author’s 
knowledge, just two studies with one filament twisted electrospun scaffolds have 
been performed to date to produce tendon implants [263], [347] and no studies of this 
specific structure were performed for the ACL. Bosworth et al., investigated the 
mechanical behaviour between 2D PCL electrospun scaffolds with randomly and 
aligned distributed fibres and 3D PCL twisted electrospun scaffolds [263]. The 
conclusions of that study were that 3D electrospun bundles exhibited ten times more 
ultimate tensile stress than 2D electrospun scaffolds with randomly distributed fibres, 
and 2D electrospun scaffolds with aligned fibres showed three times more ultimate 
tensile stress than the same scaffold but with randomly distributed fibres. However, 
the in-vitro results obtained were far from the mechanical properties of the native 
ACL (maximum tensile stress 38 MPa and Young’s modulus 111 MPa [59]), 
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reporting a Young’s modulus of 14.11 MPa and an ultimate tensile stress of 4.74 
MPa [263]. Sensini A et al., mechanically evaluated one filament twisted electrospun 
scaffolds manufactured with PLLA/Coll-75/25, PLLA/Coll-50/50 and pure PLLA in 
dry and wet conditions, concluding that dry PLLA/Coll-75/25 samples exhibited the 
highest ultimate tensile stress of 15 MPa [347], inferior to the natural ACL that 
exhibits an ultimate tensile stress of 38 MPa. Mounthy et al., developed a 3D 
electrospun structure by manually twisting four filaments of polydioxanone (PDO) 
together, obtaining ultimate tensile stress between 45 and 48 MPa [354], superior to 
the natural ACL (38 MPa); however Young’s modulus between 60 and 80 MPa, 
inferior to the 111 MPa exhibited by the natural ACL, corresponding to laxity 
problems of the structure.  Rothrauff et al., studied the mechanical properties of PCL 
and PLLA braided and stacked electrospun scaffolds [355]. In that study, the highest 
ultimate tensile stress was 20 MPa, found in PCL braided electrospun scaffolds, but 
this was inferior to the natural ACL.  
 
Therefore, only four comparative studies have been performed to date. 
Moreover, none of them studied the morphology of the scaffold compared with the 
morphology of the extracellular matrix of the ACL. They also did not investigate any 
comparison between 2D electrospun structures and multiple 3D electrospun 
structures under cyclic tensile and shear loading and in wet and dry environments. 
Therefore, a study of potential 2D and 3D electrospun structures must be performed 
in order to determine the most appropriate structure in terms of morphology and 
mechanical properties that could mimic the natural ACL.  
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Many studies have been performed to determine the function of the ACL. 
An important number of those studies analysed the shear force experienced by the 
ligament during anterior tibial translation, since the ACL restrains the anterior 
translation of the tibia and the posterior translation of the femur [85], [101], [124], 
[356]–[362]. These studies have established predictive models to estimate the 
anterior tibial shear force in relation to knee angles or muscle forces. These models 
were based on in vivo motion capture technique in combination with computational 
models and statistical analysis. Due to the relevance of these studies and the results 
of the biomechanical study (Chapter 3) [236], [237], where it was demonstrated that 
the ACL is subjected to multidirectional loading, it was considered important to 
study the behaviour of different structures under shear loading to determine which 
structure could bear a comparable shear loading to the native ACL. This study brings 
a novel point of view in the mechanical testing of ligament implants, since the 
majority of the tests are developed under tensile load and the shear load is not 
considered in the design of the ligament implants. 
 
  The aim of this final study was to determine the suitability of different 
PVA electrospun structures for use as ACL replacements. In order to achieve that 
goal, crosslinked and non-crosslinked 2D and 3D structures were mechanically 
analysed, in dry and wet conditions under cyclic tensile and shear forces, and their 
morphology was studied and compared to the natural ACL [363], [364]. 
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6.3. MATERIALS AND METHODS 
 
 
6.3.1. MATERIALS  
 
As in Chapter 5, PVA purchased from Sigma Aldrich (UK) was diluted in 
distilled water (dH2O) by heating and stirring until a homogenous solution was 
achieved. From Chapter 5 it was determined that the optimum concentration of PVA 
was 12% w/v, concentrations above this increased the viscosity of the solution 
making it difficult to electrospun, and below this bead formation and beaded fibres 
were observed, reducing the mechanical properties of the scaffold.  
 
Crosslinked samples were manufactured using 25% gluteraldehyde acquired 
from Sigma Aldrich (UK). 
 
 
6.3.2. MANUFACTURING PROCESS 
 
Crosslinked and non-crosslinked 2D and 3D electrospun structures were 
created to study their morphology and mechanical behaviour in order to determine 
which structure would be more suitable for an ACL replacement. 
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6.3.2.1. Fabrication of the 2D electrospun scaffolds 
 
All the scaffolds were manufactured following the optimum set up found for 
PVA, described in the last chapter (Chapter 5). The scaffolds created with this set-up 
showed diameter of the fibres of 143 ± 5 nm (close to the diameter of the collagen 
fibrils of 100-150 nm [33], [45]–[47], [124]) and a maximum tensile strength of 30 ± 
1 MPa (close to the natural ligament 38 MPa [59]). An electrospinning device 
(Spraybase®, Ireland) was used to fabricate the electrospun meshes. A 20 ml syringe 
was loaded with 10 ml of polymer solution and it pumped with a flow rate of 1 ml/h 
through a 18 G needle. An electrostatic field was created applying high voltage of 20 
kV between the tip of the needle and the collector. The fibres were projected from 
the tip of the needle over a sheet of aluminium foil attached to a 9.65 cm diameter 
rotating collector working at 2000 rpm, in order to obtain aligned fibres and a 
maximum tensile strength similar to the natural ACL. The distance between the 
needle and the collector was set up to 8 cm. The scaffolds were manufactured at 
room temperature and for 3 hours spin time. Non-crosslinked 2D structures were 
fabricated by cutting the electrospun mesh in a dog-bone shape in order to test them 
mechanically and compare the mechanical behaviour to the 3D electrospun 
structures. Crosslinked 2D samples were manufactured and studied in the same way 
but they were exposed to a crosslinker agent for 24 hours, this procedure will be 
explain in section 6.3.3.   
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6.3.2.2. Fabrication of the 3D electrospun structures 
 
The 2D electrospun meshes were cut into rectangles of 2 x 15 cm, pealed 
carefully from the aluminium foil and manually twisted clockwise to form a packed 
filament. The four first images in Figure 6.1 show the process to manufacture the 
filaments. Each filament was then cut in half to optimise the sample size to be tested 
and three different types of scaffolds were created with those filaments: one filament 
scaffolds, 3 twisted filaments scaffolds and 3 twisted/braided filaments scaffolds.   
 
a) One twisted filament scaffolds were created by manually twisting the 2D 
electrospun scaffolds as explained above. A sample of this structure is 
shown in Figure 6.1 A). 
 
b) 3 twisted filaments scaffolds were fabricated by twisting together three of 
the one filament scaffolds. The three filaments were twisted together, in a 
clockwise manner, until a packed and stable structure was created. A 
structure was considered packed and stable when it could not be manually 
twisted anyfurther and kept the created shape. In order to create a 
homogeneous structure the three filaments were selected with similar 
diameter. An example of this kind of 3D structure is shown in image B) 
of Figure 6.1. 
 
c) 3 twisted/braided filaments scaffolds were manufactured by manually 
braiding three twisted filaments with similar diameters. As with the other 
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two structures, the braid was manufactured in as tight form as possible 
(until the braid kept its shape) in order to create a packed and stable 
structure. This structure is shown in image C) of Figure 6.1. 
 
Crosslinked 3D samples were manufactured and exposed to glutaraldehyde in 
order to avoid degradation of the polymer (this method is explained in section 6.3.3.). 
However, the fabrication procedure and the subsequent analyses are identical to the 
non-crosslinked scaffolds. 
 
 
Figure 6.1 1) PVA electrospun scaffold. 2) 2 x 15 cm rectangular PVA meshes. 3) Peeled scaffold. 4) 
Twisted filament scaffold. A) 1 twisted filament scaffold. B) 3 twisted filaments scaffold. C) 3 
twisted/braided filaments scaffold. 
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6.3.3. CROSSLINKING PROCESS 
 
PVA is easily dissolved in water, and therefore in serum or culture medium. 
In order to avoid degradation of the PVA scaffolds a crosslinking process had to be 
performedcon the samples.  
 
Two crosslinking techniques were evaluated in the last chapter (Chapter 5, 
section 5.3.3.). Following that evaluation, vapour deposition was found to be the 
most suitable technique for avoiding degradation and damage to the network of the 
electrospun scaffolds, demonstrating that the scaffolds remained stable and with 
similar topography for at least 28 days (Chapter 5, section 5.4.3.). In the same study, 
the concentration of crosslinker agent was analysed and 25% glutaraldehyde (GTA) 
was determined as the optimum percentage for completely crosslinking the polymer.  
 
As described in Chapter 5 (section 5.3.3.), 25 ml of 25% GTA was poured 
into a Petri dish at the bottom of the desiccator, then the air-dried samples to be 
crosslinked were placed over a metallic mesh on top of the Petri dish and the 
desiccator sealed. The samples were exposed to glutaraldehyde vapour for 24 hours 
inside the desiccator. After the crosslinking process, the samples were dried under a 
fume hood for 24 hours in order to remove the moisture and reduce the toxicity of 
the samples. 
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6.3.4. MECHANICAL CHARACTERIZATION 
 
Three different mechanical assays were performed to evaluate the mechanical 
behaviour of the 2D and 3D structures created: Cyclic tensile tests with dry samples, 
cyclic tensile test with wet samples and cyclic shear tests with dry samples. No cyclic 
shear tests were performed with wet samples due to the difficulty of obtaining 
comparable data for native ACL. Future work should compare the mechanical 
behaviour of these structures to the natural ACL under torsion and shear loading in 
dry and wet conditions.     
 
The 2D samples were prepared by cutting the scaffold mesh with a dog-bone 
cutting die (25 x 4 mm, test length x width). The 3D samples were manufactured as 
described in a previous section (Chapter 6 section 6.2.2.2.). 92 samples were 
separately attached on cardboard frames to maintain the sample alignment in the 
tensometer (Instron H10KS, US). One image of each 3D structure over a cardboard 
frame is shown in Figure 6.1. The samples to be crosslinked were introduced with 
the cardboard frame into a sealed desiccator to be treated with GTA vapour as was 
explained in the last section (Chapter 6 section 6.3.3.). These samples were 
crosslinked with the cardboard frame to avoid any deformation of the scaffolds, as 
crosslinker agents tend to shrink the samples and makes handling difficult. 
 
The thickness of each sample was measured three times with a digital 
calliper, an analogue calliper and through SEM images in order to compare the 
measurements and check if the results of the three methods are consistent. These 
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measurements were used to calculate the cross sectional area of each scaffold and 
with it be able to calculate the stress and normalize the mechanical results. 
 
All samples were tested under cyclic loading. As the number of loading and 
unloading cycles increases, the stress / strain curves of each cycle are getting closer. 
Therefore, these tests enable checking the laxity of the sample and determining the 
number of loops needed to preload the sample until no significant differences 
between stress / strain curves are obtained. Although three different mechanical tests 
were performed to evaluate different conditions, the set up for the tensometer was 
identical for all experiments. Each sample was subjected to ten loading cycles and 
then tested to failure. The determination of the number of cycles was shown and 
explained in section 6.3.4.1. Each cycle stretched the sample up to 13% strain, since 
the maximum % strain in a gait cycle was found to be 13%, following previous 
studies performed by this and other research groups [75], [237]. All the tests were 
performed with a 100 N load cell and 5 mm/min test speed.  
 
Mechanical properties including Young’s modulus in the 1st and in the 21st 
curve (each load had a loading curve and an unloading curve. The 21st curve 
corresponded to the test to failure), tensile strength and strain at break were 
calculated for each sample and compared with crosslinked and non-crosslinked 
samples of the four different structures studied. 
 
6.3.4.1.  Cyclic tensile tests in dry conditions 
 
In order to determine the optimum hysteresis test, a study of the number of 
cycles was performed. For this study 2D non-crosslinked samples were used. These 
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samples were subjected to load cycles of 3, 5, 10 and 20 cycles. One sample was 
used for each condition. The proximity of the curves and their gradient (Young’s 
modulus) were evaluated. 
 
Once the number of loops were defined (in this case 10 cycles up to 13% 
strain and then failure), a total of 64 samples (8 crosslinked samples and 8 non-
crosslinked samples for each 2D and 3D structure, i.e. 4 structures in total), were 
tested to determine the Young’s modulus in the 1st and in the 21st curve 
(corresponding to the 1st and 10th cycle), tensile strength and strain at break. The 
Young’s modulus for these two curves was evaluated to understand the changes in 
the mechanical behaviour of the scaffolds when the number of cycles increased. The 
mechanical properties of the samples were compared to the properties of the natural 
ACL, since the purpose of these experiments was to evaluate the different structures 
to determine which exhibited mechanical properties similar to the natural ACL under 
dry conditions.  
 
6.3.4.2. Cyclic tensile tests in wet conditions 
 
 It is well known that the material properties change if the scaffolds are tested 
in dry or in wet conditions, reducing the maximum tensile stress of the scaffold when 
it is tested in a wet environment [347]. The ACL is surrounded by the synovial 
membrane of the knee joint, which makes the ligament extrasynovial although in an 
intraarticular position [34]. Even though the ACL is not immersed in synovial liquid 
since the synovial membrane envelopes it, it is placed in a wet environment. 
Therefore, the designed implants should be able to withstand adequate load in wet 
conditions in order to function as the natural ligament. 
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For this second experiment (cyclic tensile tests in wet conditions) a study of 
the mechanical behaviour of the scaffold immersed in PBS (phosphate-buffered 
saline) for different periods of time was previously performed. This initial study 
helped to determine which period of time was optimum to perform the rest of the 
experiments. For this previous experiment, 1 twisted filament scaffolds were 
immersed in PBS for periods of 1 minute, 5 minutes, 15 minutes and 1 hour and the 
Young’s modulus in the 1st and in the 21st curve, tensile strength and strain at break 
were calculated to determine the optimum time period. 
 
After the initial experiment a total of 12 samples, 3 samples of each of the 
crosslinked 2D and 3D structures, were analysed after being immersed for 1 minute 
in PBS. The purpose of these experiments was to evaluate which structure was the 
most appropriate under wet conditions, in order to produce the most similar 
characteristics to the natural ACL. Two examples of the different wet structures can 
be observed in Figure 6.2. 
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Figure 6.2 A) PVA 2D crosslinked wet electrospun scaffold. B) 3 twisted filaments crosslinked wet 
scaffold. 
 
 
It should be noted that all experiments in wet conditions were performed 
under the same set up used in the experiments in dry conditions. However, due to the 
elastic character of the PVA in wet conditions a preload of 0.1N was added to fully 
align the sample in the tensometer. 
 
  As for the experiments in dry conditions the Young’s modulus in the 1st and 
in the 21st curve, tensile strength and strain at break were calculated for each sample. 
 
6.3.4.3. Cyclic shear tests 
 
Different papers have been reviewed in order to obtain the angle of 
inclination of the ACL in the sagittal plane [365]–[367].  Following this review, it 
was determined that the angle of the ACL in the sagittal plane was approximately 
50° (the angles varies between 51.6° ± 3.3° and 46.9° ± 4.9°). Images A and B of 
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Figure 6.3 show two MRIs of the knee with the sagittal angle and the direction of the 
shear force. The shear force was mimicked with a tensometer (Instron H10KS), 
placing the samples in a cardboard frame to facilitate the alignment of the sample, 
and with the sagittal angle of the native ACL, as shown in images D and E of Figure 
6.3.  
 
As in the last section (6.3.4.2), all experiments to calculate the maximum 
shear stress were performed under the same set-up as previously, with a tensometer 
(Instron H10KS, US), 10 cycles of load to 13% strain and then to failure, 100 N load 
cell and 5 mm/min test speed. The difference in this case lies in the orientation of the 
sample, as the goal is to measure the shear force instead of the tensile force. To 
develop this experiment a total of 12 samples, 3 samples of each crosslinked 2D and 
3D structures were tested. The purpose of these experiments was to evaluate which 
structure was most appropriate under shear loading, i.e. demostranting the most 
similar characteristics to the natural ACL. 
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Figure 6.3  A) MRI of the right knee showing the shear force. Modified from [368]. B) ACL angle in 
the sagittal plane. Modified from [368]. C) Applied force in a tensometer. D) Shear force experienced 
by 1 twisted crosslinked filament scaffold in a tensometer. E) Orientation 
 
 
6.3.5. MORPHOLOGICAL CHARACTERIZATION 
 
A SC7640 sputter coater (Quorum Technologies Ltd. Kent, UK) was used to 
coat the samples with gold prior to their visualization with a field emission scanning 
electron microscope, Zeiss Supra 40 (FE-SEM, Carl Zeiss SMT Ltd., Cambridge, 
UK). The intensity used for coating the samples was 20 mA, the voltage 0.8 kV and 
the duration of the coating was 120 seconds, which provided a coating thickness of 
32.6 nm following equipment specifications. SEM images were taken between 5 and 
6 mm working distance, at 2 kV and with magnifications of 100x, 1000x, 5000x and 
20000x in order to measure the nanofibres, the bundle of fibres and fascicles. Two 
images for each magnification and scaffold were taken and two scaffolds for each 3D 
structure and each set of testing conditions were analysed. Fibre diameter and 
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thickness of the bundles of fibres and fascicles were determined with AxioVision 
SE64 Rel. 4.9.1 software (Carl Zeiss SMT Ltd., Cambridge, UK) by measuring 20 
fibres/image in two 20000x magnification SEM images, 3 bundles of fibres/image in 
two 5000x magnification SEM images and the fascicles of each sample in two 100x 
magnification SEM images, for each 3D structure and each set of testing conditions. 
The created filaments were considered as fascicles, since their diameters were 
comparable. Figure 6.1 shows how the fibres, bundle of fibres and fascicles were 
measured. 
 
 
Figure 6.4 A) Diameter of the fibres. B) Dimension of groups of fibres. C) Diameter of the fascicle. 
 
The dimensions of the fibres, bundles and fascicles of the scaffolds were 
compared with the dimensions of the fibrils, fibres and fascicles of collagen in the 
native ACL found in the literature. 
 
 
6.3.6. DATA ANALYSIS 
 
Mean and standard error of the mean (Std Error) were calculated for each of 
the structural and mechanical properties for all 2D and 3D crosslinked and non-
crosslinked structures. 
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 In order to compare these properties between the 2D and 3D scaffolds and 
testing conditions, one-way analysis of variance (ANOVA) with a 95% confidence 
was performed. Moreover, two one-way ANOVAs were performed to determine the 
optimum number of cycles for the cyclic mechanical tests, and to determine the time 
of the samples immersed in PBS for the wet condition tests.  
 
All statistical analyses were conducted using SPSS (IBM Inc, US). 
 
 
6.4. RESULTS AND DISCUSSION 
 
This section 6.4 analyses the mechanical behaviour and the morphology of 
the 2D and 3D structures. Once the scaffolds were characterized, they were 
compared against data from the literature on the natural ligament and its collagen 
fibres, in order to determine the best solution for consideration as an ACL implant.  
 
 
6.4.1. MECHANICAL CHARACTERIZATION 
6.4.1.1. Cyclic tensile tests in dry conditions 
 
In this experiment the mechanical properties of dry samples were evaluated. 
These hysteresis tensile tests were developed in order to determine the preload 
necessary in the implant prior to being placed into the knee. As the samples were 
loaded the loading curves were getting closer together and the stiffness of the 
polymer was more and more comparable. Therefore, an initial study evaluating the 
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number of cycles perfomed in the hysteresis test was required prior to the mechanical 
characterization of the different structures.  
 
After this test, the Young’s modulus in the 1st and 21st curve, the maximum 
tensile stress and the strain at break were calculated for each 2D and 3D structure. 
 
 
6.4.1.1.1. Study of the number of cycles 
 
For this test, the mechanical behaviour of 2D non-crosslinked scaffolds was 
studied under different numbers of load cycles: 3, 5, 10 and 20 cycles and then tested 
to failure. The choice of performing this initial test with 2D non-crosslinked 
scaffolds was to simplify the test in terms of time and resources used.  Therefore, it 
was assumed that the results obtained with 2D non-crosslinked samples could be 
extrapolated to the 3D structures. 
 
 For the correct understanding of the rest of this section, it is noteworthy to 
clarify that each cycle consists of two curves, the loading curve and the unloading 
curve. Therefore, the hysteresis test of 3 loading cycles had 6 loading/unloading 
curves plus the last curve to break; hence, the 3 cycles test had 7 curves, the 5 cycles 
test had 15, the 10 cycles test had 21 curves and the 20 cycles hysteresis test 41 
curves. 
 
Figure 6.5 shows the “Force (N) / Extension (mm)” curves for 3, 5, 10 and 
20 hysteresis cycles in four 2D non-crosslinked samples. From this figure it was 
easily observed that the loading curves were getting closer and closer together as the 
number of cycles was increased, and also that the Young’s modulus values calculated 
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from the different loading curves were increasingly comparable; therefore it could be 
concluded that the samples behaved in a similar way after a certain number of cycle 
were reached.  
 
 
Figure 6.5 A) 3 hysteresis cycles. B) 5 hysteresis cycles. C) 10 hysteresis cycles. D) 20 hysteresis 
cycles 
 
 
Table 6.1 shows Young’s Modulus of the different curves calculated from a 
2D non-crosslinked sample under 20 loading cycles. 
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Table 6.1 Young’s modulus from different loading curves for a 2D non-crosslinked sample 
 
 
 
From Figure 6.5 it was determined that the optimum number of cycles was 
10, since the last loading curves of numbers 19 and 21 were not significantly 
different (p > 0.05). This fact can be also observed in Table 6.1 where the Young’s 
modulus calculated from 11% to 12% strain was constant from curve 19 until 41. 
Therefore, the rest of the cyclic tests were performed with 10 loading cycles. 
 
6.4.1.1.2. Mechanical properties of dry 2D and 3D scaffolds 
 
In this section the maximum tensile stress in MPa, and the Young’s 
Modulus in the 1st and 21st curves are calculated and compared, for each crosslinked 
and non-crosslinked structure. 
 
a) Maximum tensile stress: 
 
Table 6.2 shows the maximum tensile stress after 10 loading cycles of the 8 
samples analysed for each crosslinked and non-crosslinked structure. The mean, 
standard deviation and standard error of the mean were also calculated and used to 
plot a graph where all structures were compared (Figure 6.6). 
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Table 6.2 Maximum tensile stress for 2D and 3D samples 
 
 
 
 
 
 Figure 6.6 Maximum tensile stress after 10 loading cycles 
 
 
It was known that the maximum tensile stress for the natural ACL is approx. 
38 MPa [59] and it was calculated in Chapter 3, that the maximum tensile stress for 
jumping at maximum effort was 24.8 MPa and for walking was 17.57 MPa [237]. 
These values were considered, along with other parameters such as Young’s modulus 
or the morphology of the scaffolds, to determine which structures would be the most 
appropriate for use as an ACL substitute.   
 
It can be observed in Table 6.1 and Figure 6.6 that the structure with the 
highest maximum tensile stress was the one twisted filament scaffold, with 37 ± 4 
Non-crosslinked Crosslinked Non-crosslinked Crosslinked Non-crosslinked Crosslinked Non-crosslinked Crosslinked 
41 20 57 39 18 19 32 38 
38 23 28 44 15 27 27 42 
27 21 38 50 17 11 25 51 
18 21 37 46 19 24 32 47 
20 25 39 40 23 15 33 32 
14 33 21 49 17 17 16 31 
33 30 32 150 19 32 25 38 
25 28 47 15 15 21 26 25 
Mean (MPa) 27 25 37 54 18 21 27 38 
SD 10 5 11 40 3 7 5 9 
±Std Error  3 2 4 14 1 2 2 3 
2D samples 1 twisted filament samples 3 twisted filaments samples 3 twisted/braided filaments samples 
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MPa for the non-crosslinked samples and 54 ± 14 MPa for the crosslinked samples. 
However, the 3 twisted/braided filaments crosslinked samples with 38 ± 3 MPa also 
reached the necessary tensile stress required for the ligament; therefore, both 
structures were studied to determine which one was the most suitable for an ACL 
replacement.  
 
The fact that the 1 twisted filament structure exhibited a higher tensile stress 
compared to the 3 twisted/braided filaments is due to the 3 filaments each being 
different. If all of the filaments of the structure were loaded identically, the resultant 
strength would be the sum of the strength of each filament. In order to maximize the 
tensile properties each filament should be equally loaded. However, in 
twisted/braided structures, the tension exerted in each filament, while the tensile test 
was performed, was different and resulted in a weaker and less stiff implant as it was 
also observed in Kim D. H. et al. [369], where the effect of twisting and braiding 
human hamstring tendon grafts resulted in a reduction of tensile strength and 
stiffness. Hearle J.W.S et al. [370] affirmed that the act of twisting or braiding fibres 
contributes to increasing the flexibility and handiness of a fabric. The manufacturing 
of 3D structures based on twisting and braiding filaments was used in this study to 
reduce the stiffness and improve the handling and the flexibility of the scaffolds, as 
was demonstrated in the studies cited above [369], [370]. 
 
b) Young’s modulus: 
 
This section has the purpose of drawing conclusions about the stiffness of 
the 2D and 3D scaffolds when they are pre-loaded. To this end, a comparison 
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between the Young’s modulus calculated from the 1st and the 21st curve of the 2D 
structures and the different three 3D structures was performed. This comparison 
aided understanding of how the PVA scaffolds mechanically behave under cyclic 
tensile tests and their stiffness.   
 
Young’s modulus was calculated in order to gain information about how the 
polymer behaves after a certain loading cycles until 13% strain, which is the 
maximum % strain that the ligament exhibits during a daily task as during walking. It 
was calculated from the 1st and the 21st loading curves and between 11% and 12% 
strain of the 8 samples analysed for each crosslinked and non-crosslinked structure. 
This property was crucial to choose the most suitable 3D structure for use as an ACL 
replacement, since the implant would be subjected to continuous loading cycles once 
implanted into the knee. 
 
Tables 6.3 and 6.4 show Young’s modulus from the 1st and 21st loading 
curves. 
 
 
Table 6.3 Young’s modulus from the 1st curve for 2D and 3D samples 
 
 
 
 
Non-crosslinked Crosslinked Non-crosslinked Crosslinked Non-crosslinked Crosslinked Non-crosslinked Crosslinked 
862 507 471 235 46 18 115 97 
1174 663 241 297 67 31 53 101 
713 289 336 362 33 26 94 214 
419 434 393 294 46 38 156 148 
404 384 372 249 61 100 81 55 
397 658 158 426 60 111 72 177 
966 564 174 641 78 198 40 136 
838 486 370 108 58 135 66 135 
Mean (MPa) 722 498 315 326 56 82 85 133 
SD 292 130 112 158 14 64 37 49 
±Std Error  103 46 39 56 5 23 13 17 
2D samples 1 twisted filament samples 3 twisted filaments samples 3 twisted/braided filaments samples 
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Table 6.4 Young’s modulus from the 21st curve for 2D and 3D samples 
 
 
 
The mean, standard deviation and standard error of the mean were also 
calculated and used to plot a graph where all structures were compared. Figure 6.7 
shows the Young’s modulus (Mean ± Std Error) calculated from the 1st and 21st 
curves for all of the scaffolds. 
 
 
Figure 6.7 Young’s modulus of 1st and 21st curves for 2D and 3D samples 
 
 
The Young’s modulus of the ACL is approximately 111MPa [59]. The 
structures that were closer to that value were the 3 twisted/braided filaments samples 
with a Young’s modulus of 133 MPa calculated from the 1st curve for crosslinked 
samples and 129 MPa calculated from the 21st curve for non-crosslinked samples. 
Non-crosslinked Crosslinked Non-crosslinked Crosslinked Non-crosslinked Crosslinked Non-crosslinked Crosslinked 
413 225 272 234 85 28 167 120 
459 138 232 303 71 50 110 130 
310 213 322 373 72 32 135 212 
195 247 364 286 90 60 189 172 
228 365 361 250 98 91 147 94 
802 301 146 424 68 102 95 173 
176 289 178 710 109 187 77 154 
423 971 340 106 91 123 112 135 
Mean (MPa) 376 344 277 336 85 84 129 149 
SD 204 262 84 178 15 54 37 37 
±Std Error 72 93 30 63 5 19 13 13 
2D samples 1 twisted filament samples 3 twisted filaments samples 3 twisted/braided filaments samples 
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This structure exhibited the closest values of Young’s modulus to the natural ACL in 
all its variations (in the 1st and 21st curve and non-crosslinked and crosslinked).  
 
Moreover, from this graph it was observed that all 3D structures behave 
more consistently than the 2D structures. This fact is surprising since the author 
expected to add more variation with the manual process used to manufacture the 3D 
scaffolds. However, the 3D samples behaved better mechanically and with less 
variability, as was observed from the similar values of mean and standard error of the 
mean for these structures.   
 
Moreover, the 3D structures behaved as expected. Crosslinked samples were 
stiffer than the non-crosslinked samples from the same structure, demonstrated 
through higher values of Young’s modulus. This was predictable, since the 
crosslinking process creates bonds to link one polymer chain to another, increasing 
the stiffness of the structure.  
 
Additionaly, the values of Young’s modulus for the 21st curves were higher 
than for the 1st curves in the 3 twisted and 3 twisted/braided filaments samples. This 
was due to the dry PVA scaffolds starting to deform plastically before the 13% 
strain, increasing their stiffness. This means that the implant would not recover its 
original shape after cycles of load comparable to walking and therefore these PVA 
structures would show laxity issues in a dry environment. 
 
 However, it was assumed that wet samples would behave more elastically 
than dry samples. For this reason, and because the ACL implant would be in a wet 
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environment inside the body, experiments with wet samples are presented in section 
6.4.1.2. Therefore, although the values of Young’s modulus and maximum tensile 
stress for 3 twisted/braided filaments samples were very similar to the natural 
ligament, its mechanical behaviour was not identical to the ACL and should be 
improved, evaluating its elasticity under wet conditions. 
 
The time for the total degradation of 2D PVA electrospun scaffolds was one 
hour. Therefore, it is necessary to crosslink the PVA scaffolds in order to slow down 
the degradation once the scaffold is implanted in the body.  For this reason, although 
the closest value of Young’s modulus was obtained with non-crosslinked scaffolds, 
only stable crosslinked samples were considered as suitable scaffolds for its 
implantation in the body, and only those samples were tested in the rest of the 
experiments performed.   
 
6.4.1.1.3. Hysteresis curves for the different 3D structures in dry conditions 
 
This purpose of this section is to study the laxity of the 2D and 3D scaffolds 
when they are pre-loaded. The “Force (N) / Extension (mm)” of the different 3D 
structures with non-crosslinked and crosslinked structures was analysed through the 
chapter. Again, from Figures 6.8 - 6.10 it was determined that the crosslinked 
samples were stiffer than the non-crosslinked samples, since the gradient of the 
curves were steeper. In addition, the non-crosslinked samples elongated more than 
the crosslinked samples for the same group of structures; graphs B in Figures 6.8 - 
6.10 exhibited lower values of extension (and therefore strain at beak) than graphs A 
in the respective figures. 
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As previously explained, dry PVA scaffolds started to deform plastically 
before 13% strain. As these scaffolds were plastically deformed, they did not 
recovered their original length; therefore, their length and laxity increased after being 
tested. 
 
 
Figure 6.8 Force (N) / Extension (mm) in 1 twisted filament samples A) Non-crosslinked B) 
Crosslinked 
 
 
 
Figure 6.9 Force (N) / Extension (mm) in 3 twisted filaments samples A) Non-crosslinked B) 
Crosslinked 
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Figure 6.10 Force (N) / Extension (mm) in 3 twisted/braided filaments samples A) Non-crosslinked B) 
Crosslinked 
 
 
 
 
 
Key Points from Cyclic Tensile Tests in Dry Conditions: 
1. 10 pre-loading cycles was determined as the optimum. 
2. The maximum tensile stress closest to the natural ACL (38 MPa [59]) was 
observed for the 3 twisted/braided filaments crosslinked samples, which exhibited a 
maximum tensile stress of 38 ± 3 MPa. This value was the most similar to the value 
of the natural ACL reported in the field.    
3. 3 twisted/braided filaments samples exhibited values of Young’s modulus, 
calculated from the 1st and 21st curves, comparable to the natural ACL (111MPa 
[59]). Values of 133 MPa for 3 twisted/braided filaments crosslinked samples 
calculated from the 1st curve and 129 MPa for 3 twisted/braided filaments non-
crosslinked samples calculated from the 21 st curve were observed. 
4. 3D structures exhibited more consistent mechanical behaviour than 2D samples. 
5. Crosslinked samples were stiffer than non-crosslinked samples. 
6. Dry samples exhibited laxity issues due to their plastic mechanical behaviour. 
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6.4.1.2. Cyclic tensile tests in wet conditions 
 
The same experiments under the same parameters as performed in a dry 
environment were performed in wet conditions. However, in this case an initial study 
had to be performed in order to determine the time during which the scaffolds should 
be immersed in PBS.  For this experiment and as mentioned in the methods (section 
6.3.4.2.), four 1 twisted filament crosslinked samples were immersed in PBS for 1, 5, 
15 and 60 minutes and the mechanical properties of each sample were determined. 
The results of this experiment will be explained in section 6.4.1.2.1. 
 
Once the immersion time in PBS was decided, the same tensile parameters 
specified for the dry samples were used with the wet samples to calculate the 
mechanical properties of the different scaffolds. The results of these experiments will 
be presented in the second section below (6.4.1.2.2.). 
 
6.4.1.2.1. Determination of sample immersion time in PBS. 
 
a) Maximum tensile stress: 
 
Table 6.5 and Figure 6.11 show the maximum tensile stress in MPa of 1 
twisted filament crosslinked samples after being immersed for specific periods of 
time in PBS. 
 
As was appreciable from the results and a one-way ANOVA no significant 
differences were observed (p > 0.05). Therefore, in terms of the maximum tensile 
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stress there was not any significant difference in testing the samples after 1 minute of 
being immersed in PBS or after 1 hour.  
 
Table 6.5 Maximum tensile stress of 1 twisted crosslinked filament samples after being immersed in 
PBS. 
 
 
 
 
Figure 6.11 Maximum tensile stress after 10 loading cycles in 1 twisted filament crosslinked samples 
immersed in PBS 
 
 
The time of the scaffolds immersed in PBS was also determined through the 
calculation of the Young’s modulus from the first loading curve. The results are 
presented below. 
 
b) Young’s modulus:  
Table 6.6 and Figure 6.12 show the Young’s modulus (MPa) calculated 
from the first loading curve of 1 twisted filament crosslinked samples after being 
immersed for specific periods of time in PBS. 
Maximum tensile stress (MPa) Time in PBS 
12 1 min 
14 5 min 
13 15 min 
12 60 min 
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In this case no significant differences were observed for periods of time 
between 1 minute and 60 minutes. However, the Young’s modulus dropped slightly 
after 1 hour of immersion. Hence, in order to speed up the process of the experiments 
and due to a lack of significant differences in the mechanical properties with respect 
to immersion time, the decision was taken to immerse the samples in PBS for 1 
minute to perform the rest of the experiments. 
 
 
Table 6.6 Young’s modulus from the 1st curve of 1 twisted filament crosslinked samples after being 
immersed in PBS. 
 
 
 
 
Figure 6.12 Young’s modulus (MPa) of the first curve of loading in 1 twisted filament crosslinked 
samples immersed in PBS 
 
 
 
 
Young's modulus (MPa) Time in PBS 
20 1 min 
20 5 min 
21 15 min 
16 60 min 
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6.4.1.2.2. Mechanical properties of wet 2D and 3D scaffolds 
 
Once the time in PBS of each sample was determined, the next step was to 
test each type of 2D and 3D crosslinked structures after 1 minute in PBS to evaluate 
their material properties (maximum tensile stress and Young’s modulus in the 1st and 
21st curves). To develop this experiment three samples of each structure were 
studied. 
 
a) Maximum tensile stress: 
 
Table 6.7 and Figure 6.13 show the maximum tensile stress in MPa for all 
the 2D and 3D crosslinked samples tested after being immersed for 1 minute in PBS. 
 
  
Table 6.7 Maximum tensile stress of 2D and 3D crosslinked samples after being immersed for 1 min. 
in PBS. 
 
 
 
2D samples 1 twisted filament samples 3 twisted filaments samples 3 twisted/braided filaments samples 
39 10 10 
12 8 9 
1 25 9 8 
Mean (MPa) 1 25 9 9 
SD 13 1 1 
±Std Error 9 1 1 
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Figure 6.13 Maximum tensile stress (MPa) after 10 loading cycles in 2D and 3D samples immersed in 
PBS 
 
 
Examining the results, it can be concluded that the structure with the highest 
maximum tensile stress was the 1 twisted filament; however, this structure exhibited 
a high variability in the results, larger than the other 3D crosslinked structures. 
Therefore, more robust structures, such as 3 twisted filaments scaffolds or 3 
twisted/braided filaments scaffolds, showed more consistent mechanical properties 
than thinner structures. This phenomenon was also observed in the tensile tests in dry 
conditions (Tables 6.2 - 6.4) and it was a factor in the selection of the most suitable 
structure.  
 
Moreover, the 1 twisted filament structure could bear the maximum loading 
required during a high impact activity, such as jumping at maximum effort (24 MPa) 
[237]; however it did not reach the maximum tensile stress observed in the natural 
ACL (38 MPa [59]). Therefore, other materials or the combination of several 
materials should be studied mechanically under wet conditions in order to reach an 
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approximate value of maximum tensile stress comparable to the natural ACL. 
Further investigations will be focussed in this direction. 
 
The crosslinking process tended to deform the scaffolds reducing their size. 
In order to avoid a huge deformation of the sample and to be able to test it properly, 
the samples were placed on a cardboard frame before being crosslinked. However, 
when the 2D samples were immersed in PBS, the pressure of the PBS column above 
the sample broke the sample. To be able to test the 2D samples in a wet environment, 
instead of immersing the samples in the PBS for 1 minute, a few drops of PBS were 
placed over the sample to reduce the pressure of PBS column. However, due to the 
extreme fragility of the 2D samples, only one out of three 2D samples could be tested 
in wet conditions. 
 
It was noteworthy that although the maximum tensile stress dropped 
significantly compared to the dry samples for all type of structures, all samples tested 
failed next to the lower grip (Figure 6.14), due to the high stress concentration in that 
part of the sample caused by the clamp. Many trials were performed with different 
pneumatic clamps, tapes to hold the sample and level of pressure in the clamps; 
however, the samples still broke due to the stress concentration created by the clamp. 
Therefore, the author expects that with improved gripping techniques for elastic 
polymers these results will be increased.  
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Figure 6.14 Example of wet samples after being mechanically tested 
 
In the next section the Young’s modulus calculated from the 1st and 21st 
curves and a comparison between both are presented. 
 
 
b) Young’s modulus: 
 
Table 6.8 shows the values of Young’s modulus calculated from the 1st and 
21st loading curves and between 11% and 12% strain. These values were calculated 
in three crosslinked samples of each type of structure and after being immersed in 
PBS for 1 min. The mean, standard deviation and standard error of the mean were 
also calculated and used to plot a graph where all structures were compared (Figure 
6.15). 
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Table 6.8 Young’s modulus from the 1st and 21st curves of 2D and 3D crosslinked samples after being 
immersed for 1 min. in PBS. 
 
 
 
As explained in section a) above, due to the extreme fragility of the 2D 
samples only one 2D sample could be tested in wet conditions. For this reason 
neither the standard deviation nor the standard error of the mean were calculated for 
that structure. 
 
 
Figure 6.15 Young’s modulus (MPa) of the 1st and 21st curves of loading for 2D and 3D samples 
immersed in PBS 
 
Observing the values obtained for Young’s modulus calculated from the 1st 
curve, there was not any structure with values of Young’s modulus close to the 
natural ligament (close to 111 MPa). The highest value was observed with 1 twisted 
filament samples with a mean of Young’s modulus of 54.24 MPa; however, as with 
the maximum tensile stress, the standard deviation and consequently the standard 
2D samples 1 twisted filament samples 3 twisted filaments samples 3 twisted/braided filaments samples 
66 9 11 
52 8 15 
42 45 7 12 
Mean (MPa) 42 54 8 12 
SD 11 1 2 
±Std Error 8 1 1 
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error of the mean were higher than in the other 3D structures. This implied that the 1 
twisted filament structure did not provide consistent results, and therefore other 3D 
structure such as the 3 twisted/braided filaments structure would be a better solution 
in terms of the manufacturing process for fabricating an ACL replacement.  
 
The results obtained from Young’s modulus from the 21st curve did not 
change qualitatively from the results obtained from the first curve. The highest 
Young’s modulus from the 21st curve was observed in 1 twisted filament scaffolds 
and the lowest value was observed for 3 twisted filaments samples. However, it was 
observed that the results were more consistent in the 21st curve for 1 twisted filament 
scaffolds than the results calculated from the first curve; and all samples exhibited 
higher Young’s modulus when calculating it from the 21st curve. 
 
Although this experiment showed lower mechanical properties than the 
natural ACL, it is still worth looking at how the different structures behave, to adopt 
the most suitable design in future experiments with materials that could reach the 
appropriate Young’s modulus. 
 
As was expected from the results obtained in dry conditions, the highest 
Young’s modulus was observed in 1 twisted crosslinked samples followed by the 3 
twisted/braided filaments crosslinked scaffolds. As in dry conditions the Young’s 
moduli calculated from the 21st curves were higher than the Young’s moduli 
calculated from the 1st curves, however there were no significant differences found 
between them. The mechanical behaviour of all wet samples was elastic and all of 
them recovered their original shape after a load was applied and then removed.  
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Following the results and the discussion for dry and wet conditions, it can 
concluded that the 3 twisted/braided filaments crosslinked structure would be the 
best solution for use as an ACL replacement in order to obtain the most comparable 
mechanical properties to the natural ACL. Therefore, the next section 6.4.1.2.3 
focusses on the mechanical behaviour of these scaffolds. 
 
6.4.1.2.3. Hysteresis curves of 3 twisted/braided filaments crosslinked structures in 
wet conditions 
 
Figure 6.16 shows the “Force (N) / Extension (mm)” of the most suitable 
structure for an ACL replacement, the 3 twisted/braided filaments crosslinked 
scaffolds.  
 
 
Figure 6.16 Force (N) / Extension (mm) in 3 twisted/braided filaments crosslinked samples 
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What is more surprising and beneficial in order to be considered as a 
potential ACL implant is its elastic character and the toe region observed in every 
wet sample. In this study, it was demonstrated that the dry PVA electrospun scaffolds 
behaved plastically and no toe region was observed when a tensile test was 
performed; this fact was also observed in Merkle V.M et al. [327], where mechanical 
properties of PVA, gelatin and PVA/Gelatin core/shell scaffolds were investigated. 
However, the wet PVA scaffolds behaved elastically and all of them exhibited a 
well-defined toe region, as observed in Figure 6.16. This is due to the capacity of 
PVA to absorb water; PVA is a highly hydrophilic polymer that behaves as a 
hydrogel in aqueous solution. PVA hydrogels have the characteristic of showing a 
large elongation with low levels of tensile force giving rise to a toe region followed 
by an elastic region as observed in Zhang Y. et al. [371], where different 
concentrations of PVA hydrogels (1 wt%, 2 wt%, 4 wt%, 6 wt%) were tensile tested.  
 
Therefore, these wet structures did not exhibit any problems with laxity, due 
to their ability to recover their original shape and length after being deformed.  
 
However as demonstrated in Chapter 3, the failure mechanisms of the ACL 
are not due to just tensile force, therefore the study of the implants under a shear 
force has to be performed. This study is presented in section 6.4.1.3. 
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Key Points from Cyclic Tensile Tests in Wet Conditions: 
1. There were no significant differences between Young’s modulus of samples after 
1 minute in PBS or after 60 minutes. 
2. The maximum tensile stress closest to the natural ACL (38 MPa [59]) was 
observed for the 1 twisted crosslinked samples, which exhibited a maximum tensile 
stress of 38 ± 25 MPa. However, these structures showed a high variability in the 
results compared to other structures.     
3. The closest value of Young’s modulus to the natural ACL (111MPa [59]) was 
observed for 1 twisted filament samples. Values of 54 MPa calculated from the 1st 
curve and 58 MPa calculated from the 21st curve were observed. However, as 
previously mentioned these structures showed a high variability compared to other 
structures. 
4. More robust structures such as 3 twisted/braided filaments and 3 twisted filaments 
samples exhibited more consistent mechanical behaviour than 2D samples or 1 
twisted filament structures. Therefore, they are preferable to the thinner structures. 
5. Wet samples exhibited an elastic character with a well-defined toe region. 
Therefore, they showed a mechanical behaviour comparable to the native ACL. 
6. Wet samples did not present laxity issues due to their elastic behaviour. 
 
 
 
6.4.1.3. Cyclic shear tests 
2D and 3D scaffolds were tested under shear load, mimicking the 
anterior/posterior shear force experienced by the ACL during sudden stops or 
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changes of direction, that normaly occur during high impact activities such as 
cutting. 
 
A tensometer (Instron H10KS) was used to experimentally test these shear 
forces. This equipment is designed to exert a tensile force on the sample; therefore, 
in order to mimic the shear force the sample must be positioned at a specific angle as 
explained in section 6.3.4.3.  
 
As in previous experiments (cyclic tensile tests in dry and wet conditions, 
sections 6.4.1.1 and 6.4.1.2), the 2D and 3D crosslinked samples were subjected to 
10 loading cycles under dry conditions. The maximum shear stress and the Young’s 
modulus in curves 1 and 21 were calculated. Three samples were manufactured and 
tested for each 2D and 3D structure; however, just two 2D samples were considered 
in the study due to the great variability of the results obtained with the third sample. 
Therefore the results of that sample were considered as outlier and they were 
excluded from the study. 
 
6.4.1.3.1. Mechanical properties of dry 2D and 3D scaffolds under shear loading 
 
a) Maximum shear stress: 
Table 6.9. and Figure 6.17 show the maximum shear stress in MPa for all 
2D and 3D crosslinked samples tested in dry conditions. 
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Table 6.9 Maximum shear stress (MPa) of all 2D and 3D crosslinked samples 
 
 
 
 
 
Figure 6.17 Maximum shear stress (Mean ± Std Error) of the 2D and 3D crosslinked scaffolds 
 
 
The 3 twisted/braided filaments crosslinked structure exhibited the highest 
maximum shear stress compared with the other structures, allowing the samples to 
bear higher shear loads than the rest of the structures. This fact is in agrement with 
the studies performed by Kawabata and Walters [372], [373] where it was 
demonstrated that braiding techniques can bear and transfer axial loads, improving 
shear resistance and providing mechanical reinforcement.  
 
 
 
2D samples 3 twisted/braided filaments samples 
60 21 98 
12 43 16 124 
7 31 14 101 
Mean (MPa) 10 44 17 108 
SD 3 14 3 14 
±Std Error 2 8 2 8 
1 twisted filament samples 3 twisted filaments samples 
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b) Shear modulus: 
Table 6.10 and Figure 6.18 show the shear modulus calculated from the 1st and 21st 
curves, between 11% and 12% strain, for all the 2D and 3D crosslinked samples 
tested in dry conditions. 
 
 
Table 6.10 Shear modulus calculated from the 1st and 21st curves (MPa) of all 2D and 3D crosslinked 
samples 
 
 
 
 
Figure 6.18 Shear modulus calculated from the 1st and 21st curves (Mean ± Std Error) of the 2D and 
3D crosslinked scaffolds 
 
1st Curve 21st Curve 1st Curve 21st Curve 1st Curve 21st Curve 1st Curve 21st Curve 
70 101 12 27 99 155 
298 139 64 87 9 17 117 180 
183 99 27 47 8 12 70 99 
Mean (MPa) 241 119 54 78 10 19 95 145 
SD 81 29 24 28 2 8 24 42 
±Std Error 58 20 14 16 1 5 14 24 
2D samples 1 twisted filament samples 3 twisted filaments samples 3 twisted/braided samples 
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The highest shear modulus calculated from the first curve was observed in 
2D samples with a value of 240 MPa and the minimum value for the 3 twisted 
filaments crosslinked samples with a mean value of 10 MPa. 
 
The highest shear modulus calculated from the 21st curve was observed in 3 
twisted/braided filaments crosslinked samples with a value of 144 MPa and the 
minimum value for the 3 twisted filaments crosslinked samples with a mean value of 
18 MPa. 
 
As the tensile test also showed, the shear moduli calculated from the 21st 
curves of the samples were higher than the moduli calculated from the first curves in 
all 3D structures analysed. This was because the dry samples deformed permanently 
before 13% strain was reached. 
 
Due to the fact that the ACL is normally mechanically characterized through 
measuring its reaction under axial loads, very few studies have been done to 
calculate the shear modulus of the natural ACL. However, one computational study 
found that the short-term shear modulus of the ACL was 68 MPa and the long-term 
shear modulus was 45 MPa [346]. Following these data, the closest structure to those 
values was the 1 twisted crosslinked filament; however, the mechanical behaviour of 
this structure was quite far from the behaviour expected for the natural ACL in the 
tensile experiments under dry and wet conditions. Therefore, the 1 twisted 
crosslinked filament was rejected as a possible ACL implant. 
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The next structure most comparable to the shear modulus value obtained in 
the literature was the 3 twisted/braided filaments crosslinked scaffolds. Therefore, 
considering the results obtained from all tensile and shear tests performed on the 
different scaffolds, it was concluded that the best structure to use as an ACL implant 
would be the 3 twisted/braided filaments crosslinked scaffolds. The next section 
6.4.1.3.2 will show the force/extension curves obtained after the shear tests for this 
type of scaffolds. 
 
6.4.1.3.2. Hysteresis curves of 3 twisted/braided filaments crosslinked structures in 
dry conditions and under a shear load 
 
Figure 6.19 shows the “Shear force (N) / Extension (mm)” of the most 
suitable structure for an ACL replacement, the 3 twisted/braided filaments 
crosslinked scaffolds.  
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Figure 6.19 Shear force (N) / Extension (mm) in 3 twisted/braided filaments crosslinked samples 
 
As observed in the tensile tests with dry PVA samples, when the samples 
were tested under shear loads, all structures behaved plastically and no toe region 
was observed. To the author’s knowledge, to date there is no shear data from natural 
ACL to compare to experimental data from the scaffolds. Future work should be 
focussed on mechanically characterizing the natural ACL under shear forces and 
torsion.  
 
 
Key Points from Cyclic Shear Tests in Dry Conditions: 
1. 3 twisted/braided filaments crosslinked samples exhibited the highest maximum 
shear stress of 107 MPa. 
2. The highest shear modulus calculated from the 21st curve was found in 3 
twisted/braided filaments crosslinked samples, at 145 MPa. 
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3. To date, there is a shortage of natural ACL shear data. Future work should be 
focussed on charaterizing the native ACL under shear and torsion. 
 
 
6.4.2. MORPHOLOGICAL CHARACTERIZATION  
 
The natural ACL consists of collagen fibrils of 40-150 nm in diameter, these 
fibrils are organized in groups forming fibres with diameters between 1 and 20 µm; 
simultaneously the collagen fibres are arranged in groups creating fascicles of 360-
1500 µm in diameter [33], [45]–[47], [124]. An SEM image of the fibres of collagen 
in the ACL is shown in Figure 6.20. 
 
 
Figure 6.20 Collagen fibres of a natural ACL [48]. 
 
A morphological characterization of the scaffolds was performed in order to 
finalize the decision on which 3D structure would be the most suitable to be used as 
an ACL replacement. To this end, PVA fibrils, fibres and fascicles of similar 
dimensions as the natural ligament were created, since it was assumed that these 
structures would mimic the mechanical and biological properties of the natural 
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ligament. Moreover, a study of the influence of chemical, environmental and 
mechanical conditions on the morphology of the 3D scaffolds was performed. 
 
The morphological characterization of the 3D scaffolds was focussed on 
four different points: 
 The morphology of the original 3D structures (prior to any other 
treatment). 
 How the crosslinking technique modified the morphology of the 
scaffolds. 
 Influence of wet conditions on the morphology of crosslinked 
scaffolds. 
 Influence of tensile and shear forces on the morphology of the 
scaffolds. 
 
6.4.2.1. Morphological characterization of 3D non-crosslinked structures  
 
As shown in Chapter 5 wherein PVA electrospun scaffolds were studied, the 
production of 2D electrospun scaffolds generated a homogeneous network of fibres. 
The manufacturing of 3D structures allowed the creation of bundles of fibres and 
fascicles that were not present in the 2D structures, mimicking the morphology of the 
natural ACL.  
 
As explained in the methodology (section 6.3.5), four SEM images with 
different magnifications were taken from each 3D structure in order to determine the 
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diameter of the PVA fibres, the diameter of the groups of fibres and the diameter of 
the fascicles. 
 
Figures 6.21-6.23 show the morphology of 1 twisted filament non-
crosslinked samples, 3 twisted filaments non-crosslinked samples and 3 
twisted/braided filaments non-crosslinked samples respectively. For each 3D 
structure three different magnifications are presented below (100x, 5000x and 
20000x magnifications) in order to demostrate the macro, micro and nano structures 
of the three types of 3D scaffolds.  At the same time, these images were used to 
measure the diameter of the fibres, the bundles of fibres and the fascicles. 
 
 
Figure 6.21 1 twisted filament non-crosslinked samples A) 100x B) 5000x C) 20000x 
 
The diameter of the PVA fibres in the 1 twisted filament structure was 97 ± 
5 nm, the thickness of the bundle of fibres was 8 ± 1µm and the size of the fascicles 
was 711 ± 19 µm.  
 
Contrasting these values with the diameter of the fibrils, fibres and fascicles 
of the natural ACL, it was observed that all were statistically comparable and no 
significant difference was observed between them. 
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Figure 6.22 3 twisted filaments non-crosslinked samples A) 100x B) 5000x C) 20000x 
 
The diameter of the fibres, the dimension of the bundles of fibres and the 
diameter of the fascicles were also measured for the 3 twisted filaments structure. 
The diameter of PVA fibres was 146 ± 8 nm, the thickness of the group of fibres was 
25 ± 5 µm and the diameter of the fascicles was 614 ± 64 µm. As in the previous 
structure, none of these values showed any significant difference with the dimensions 
of fibres, bundles of fibres and fascicles of the natural ACL, i.e. they were 
statistically comparable. 
 
 
Figure 6.23 3 twisted/braided filaments non-crosslinked samples A) 100x B) 5000x C) 20000x 
 
 
In the case of the 3 twisted/braided filaments structure, the mean diameter of 
the PVA fibres was 121 ± 6 nm, the thickness of the group of fibres was 18 ± 5 µm 
and the diameter of the fascicles was 593 ± 27 µm. 
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If these measurements were compared with the diameters of the collagen 
fibrils, fibres and fascicules of the natural ACL, it was observed that all 
measurements were in the same range of dimension as the structure of the collagen in 
the natural ligament and no significant differences were observed. The diameters of 
the PVA fibres were in the range of values for collagen fibrils diameters, the 
thickness of the group of fibres were in the range of the values for collagen fibres 
diameters and the size of the fascicules of the PVA fibres were in the range of values 
of the fascicules of collagen in the ACL. 
 
In this study, it was also demonstrated that the nanofibres were not damaged 
in the manufacturing process and their diameter of the fibres and alignment were 
unmodified compared to the 2D electrospun scaffolds. 
 
6.4.2.2. Influence of the crosslinking agent on the morphology of 3D 
structures  
 
From the mechanical study, it was determined that the most suitable 3D 
structure was the 3 twisted/braided filaments structure, therefore the rest of this 
section will solely focus on this type of structure (Figure 6.24). 
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Figure 6.24 3 twisted/braided filaments crosslinked sample A) 55x B) 1000x C) 5000x D) 20000x 
 
The mean diameter of the crosslinked PVA fibres in the 3 twisted/braided 
filaments structure was 177 ± 19 nm, the thickness of the group of fibres was 18 ± 4 
µm and the size of the fascicles was 675 ± 48 µm. 
 
 Comparing the crosslinked structure with the non-crosslinked, it was 
observed that the diameter of the fibres increased with the crosslinking. This was 
predictable since the crosslinking process creates bonds between the fibres increasing 
their diameters. This was also observed in Kishan A.P. et al. [374], where an increase 
of 24% in the diameter of the fibres was reported after crosslinking the scaffolds with 
gluteraldehyde.  
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6.4.2.3. Influence of a wet environment on the morphology of 3D structures  
 
Figure 6.25 shows a 3 twisted/braided filaments sample after immersion in 
PBS for 1 minute.  
 
 
Figure 6.25 3 twisted/braided filaments crosslinked sample in wet conditions A) 100x B) 1000x 
 
For wet conditions, only the diameter of the fascicles could be determined, 
being 569 ± 9 µm for the 3 twisted/braided filaments structure. Once the samples 
were soaked in PBS the dimensions of the groups of fibres and fibres were difficult 
to measure, since it is not possible to observed the surface of wet samples under the 
SEM. However, it was proved in the last study (section 5.4.3.) that the crosslinked 
PVA electrospun scaffolds were not degraded after 28 days of incubation in PBS, 
therefore PVA structures would be suitable for in vivo use as was demonstrated by 
other researchers [336], [375]–[378]. Moreover, crosslinked PVA hydrogels 
exhibited excellent biocompatibility [336], [375] and a water-swollen network 
similar to the extracellular matrix of the native ligament [65]. Future studies will 
focus on investigation of the adhesion, proliferation and orientation of human 
primary fibroblasts on the 3D electrospun scaffolds. 
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6.4.2.4. Influence of mechanical forces on the morphology of 3D structures  
 
Visually comparing the collagen fibres from a damaged ACL (Figure 6.26) 
and one of the 3 twisted/braided filaments structures post tensile testing (Figure 
6.27), it was observed that they had similarities in the disorganization of the fibres; 
previously the fibres were aligned and after tensile testing they had no preferential 
orientation. 
 
 
Figure 6.26 Collagen fibres of a damaged natural ACL [48]. 
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Figure 6.27 3 twisted/braided filaments non-crosslinked sample after tensile testing A) 55x B) 1000x 
C) 5000x D) 20000x 
 
In the case of the 3 twisted/braided filaments structures already tensile 
tested, the mean diameter of the PVA fibres was 110 ± 9 nm, the thickness of the 
group of fibres was 28 ± 8 µm and the diameter of the fascicles was 496 ± 22 µm. 
 
A 3 twisted/braided filaments structure after being tested under shear load 
was also morphologically characterized (Figure 6.28).  
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Figure 6.28 3 twisted/braided filaments non-crosslinked sample after being tested under shear load A) 
100x B) 1000x C) 5000x D) 20000x 
 
After shear loading, the mean diameter of the PVA fibres was 103 ± 6 nm, 
the thickness of the group of fibres was 20 ± 3 µm and the diameter of the fascicles 
was 506 ± 46 µm. 
 
In this last study it was observed that the diameter of the fibres and the 
diameter of the fascicules were reduced in the tested samples. This was due to the 
fascicles and fibres being stretched during the tensile and shear tests, reducing their 
diameters. However, the thickness of the group of fibres increased after being tested, 
this was because the groups of fibres after the test were closer to one each other, 
increasing the thickness of the group of fibres. 
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6.5. CONCLUSIONS 
 
The principal goal for Chapter 6 was to determine which 3D electrospun 
scaffold would be the most suitable for an ACL replacement, as a result of exhibiting 
the most similarities to the natural ACL. To reach this aim multiples variables 
(mechanical: maximum tensile strength, Young’s modulus, shear stress, laxity, 
repeatability of force/elongation behaviour; and morphological: diameter of the 
fibres, bundle of fibres and fascicles) were studied and compared to the natural ACL 
in dry and wet conditions under load cycles.  
 
In dry conditions, the 3 twisted/braided filaments crosslinked structure 
demonstrated the most similar mechanical properties to the natural ACL. This 
structure produced a maximum tensile stress of 38 ± 3 MPa and a Young’s modulus 
after 10 loading cycles of 149 ± 13 MPa. The principal disadvantage was that dry 
electrospun PVA scaffolds had a plastic behaviour, therefore these scaffolds did not 
recover their shape after deformation and they exhibited laxity issues. Moreover, the 
stress/strain curve for dry samples did not exhibit any toe-region characteristic of the 
mechanical behaviour of soft tissue and more specifically the ACL. In order to solve 
these issues and mimic the environment inside the knee joint, wet samples were 
characterized. 
 
It was observed that when wet PVA were tested scaffolds they behaved 
elastically and all of them exhibited a well-defined toe region, as was found in the 
natural ACL. They did not show any laxity issue, since all samples recovered their 
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original length after being unloaded. However, the mechanical properties reduced 
significantly for all structures studied. As an example, the 3 twisted/braided filaments 
crosslinked structure, the most suitable structure under dry conditions, produced a 
maximum tensile stress of 9 ± 1 MPa and a Young’s modulus after 10 loading cycles 
of 24 ± 4 MPa in wet conditions. Nevertheless, these values were lower than they 
should be; since all samples tested in wet conditions failed due to the clamp causing 
high stress concentrations near to the lower grip. In spite of this inconvenience, 
which only occurred in the tensile tests in wet conditions, it could be affirmed that 
the results were qualitatively valid and allowed the comparison between the different 
structures. Future work should be directed to the study of new gripping techniques 
for elastic polymers in wet conditions to be able to increase the accuracy of the 
results. 
 
As demonstrated in the gait analysis study (Chapter 3) not only the tensile 
properties have to be considered. The failure mechanics of the ACL were due to 
multidirectional loading; therefore, it was also important to determine how the 
scaffolds behaved under shear loading. After shear testing, it was shown that the 3 
twisted/braided filaments crosslinked scaffolds exhibited the highest maximum shear 
stress compared with the other structures, allowing the samples to bear higher shear 
loads than the rest of the structures. 
 
After these three mechanical studies, performed with 2D and 3D structures, 
it was concluded that the most suitable structure to be considered as ACL 
replacement was the 3 twisted/braided filaments crosslinked structure, with the 
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closest values to the mechanical properties of the ACL in dry conditions and bearing 
higher shear loading.  
 
In terms of morphology, it was demonstrated that the manufacturing process 
did not damage the nanofibres and their nano-morphology and alignment were not 
modified. However, this process affected the distribution of the PVA fibres, creating 
bundles of fibres easily measurable with a SEM. Moreover, the dimension of the 
PVA fibres, bundle of fibres and fascicles agreed with the diameters of the collagen 
fibrils, fibres and fascicles in the natural ligament. After a tensile test to failure, the 
morphology of the 3D structure was visually comparable to the morphology of the 
collagen fibres of a damaged ACL. 
 
In conclusion, within the current confines of this study, it was demostrated 
that the 3 twisted/braided filaments scaffolds is the most suitable structure to be used 
as a replacement for the ACL. Future work should be focussed on the biological 
characterization of this specific structure analysing aspects such as cellular adhesion, 
proliferation and orientation.  
 
A discussion of all of the studies performed in this thesis with their 
limitations and the potential for future work is covered in the next chapter (Chapter 
7). 
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Key points: 
1. This study, for the fist time, evaluated and compared 2D and multiple 3D 
electrospun structures with the aim of determining which structure reproduced more 
closely reproduced the mechanical behaviour and morphology of the natural ACL.  
2. Cyclic tensile and shear loading under dry and wet conditions had not been 
previously analysed for 3D electrospun scaffolds. 
3. Neither 2D nor 3D PVA electrospun structures had been previously studied for 
ligament replacement.   
4. 3 twisted/braided filaments scaffolds in dry conditions exhibited a maximum 
tensile stress of 38 MPa identical to the native ACL and a Young’s modulus of 129 
MPa comparable to the 111 MPa [59] reported for the natural ACL. 
5. More robust structures exhibited more consistent mechanical properties than 
thinner structures, a finding not reported before in the field.  
6. Wet samples exhibited an elastic character with a well-defined toe region 
comparable to the natural ACL. Moreover, they did not show any laxity issue. 
7. 3 twisted/braided filaments scaffolds exhibited the highest mechanical properties 
under shear loading. 
8. No significant differences were observed between the diameter of fibre, bundles of 
fibres and fascicles created and the diameter of collagen fibrils, bundles of fibres and 
fascicles of the natural ACL. 
9. This study demonstrated that the nanofibres were not damaged in the 
manufacturing process and their diameter and alignment were not modified 
compared to the 2D electrospun scaffolds. 
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7. Discussion 
 
The ACL is one of the ligaments with higher injuries rate in professionals and 
amateurs athletes [1] and the most commonly injured (49%) ligament in the knee [2]. 
More than 200,000 patients are diagnosed with ACL rupture each year in the United 
States, of which 175,000 cases require surgery [22]. The high number of surgeries is 
because this ligament can not regenerate it, due to its ver poor content of fibroblasts. 
Currently biological and synthetic scaffolds are used for ACL replacements. 
However, the grafts and ligament implants currently available exhibit a number of 
different disadvantages that have to be solved to develop the appropriate mobility 
and stability of the knee. One alternative to the current grafts is to develop tissue-
engineered ligaments, avoiding rejection of the implant and providing biological and 
mechanical properties comparable to the natural ligament. 
   
The overall goal of this project was to create 3D electrospun scaffolds 
morphologically and mechanically comparable to the native ACL to use as ligament 
replacements. To achieve that goal, the first step was to analyse ACL in vivo 
mechanical behaviour in order to mimic it and propose improvements for the design 
of new ligament implants to replace the native ACL. A second step was to evaluate 
the suitability of two materials to fabricate ligament prototypes through use of the 
electrospinning technique. Finally, 3D electrospun structures were created and their 
mechanical behaviour analysed in order to determine the optimum scaffold, 
achieving the most comparable morphology and mechanical properties (maximum 
tensile strength, Young’s modulus and shear modulus) to the natural ACL. 
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This Chapter 7 has the objective of providing a general discussion of each 
study performed with their contribution to knowledge and limitations. 
 
 
 
7.1. BIOMECHANICAL SPECIFICATIONS FOR DESIGNING ACL 
IMPLANTS 
 
The mechanical behaviour of the ACL has been studied through many 
techniques to date. Some studies used cadaveric knees [40] subjected to different 
loads but these studies exhibited limitations mimicking the in vivo mechanical 
behaviour of the ACL. Other techniques used video and motion capture [70], [71] to 
understand ACL injury mechanisms; these techniques studied the joint kinematics, 
however ACL length, strain or force were not addressed. Some studies calculated the 
in vitro ACL strain [72] and in vivo ACL strain during cycling and squatting [73], 
[74] using strain gauges, but this technique requires surgery to implant the gauge and 
only records the strain in small locations not across the whole ligament. Other 
techniques used motion capture and biplanar fluoroscopy [75], [76] and motion 
capture and musculoskeletal simulations [77]–[79] to determine ACL length and 
strain during walking and jumping with both legs but activities with a high injury 
rates such as jumping with one leg or cutting have not been evaluated.  
 
There are discrepancies in the results calculating in vivo ACL strain and 
force because of the different techniques and their limitations. For instance, some 
studies reported ACL forces of 0.2 N/BW [102] during walking and other researchers 
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with the same task reported 1 N/BW [103], [104]. Therefore, in order to compare 
between activities and to have mechanical specifications to design ACL ligaments, it 
was necessary to build a novel, reliable, reproducible and easy methodology to 
investigate the in vivo mechanical behaviour of the ACL during different activities in 
just one study.  
 
Moreover, the mechanical characterization of tissue engineered ligament 
implants are based on tensile loading and the calculation of Young’s modulus, 
ultimate tensile strain or tensile stress at yield. Up to now, no ligament implants have 
been designed considering shear loading; however, it was demonstrated in Chapter 3 
that ACL failure mechanisms are due to multidirectional loading and not solely 
tensile loading; therefore, the current ACL implants are not designed to bear multi-
planar loading and consequently do not guarantee to bear the real loading in all space 
planes that the native ligament does. Moreover, the in vivo mechanical behaviour of 
the ACL had not been considered for the design and development of new ligament 
implants. Therefore the design of the current ligament implants is not focussed on 
replicating the in vivo mechanical behaviour, and consequently the current ACL 
implants cannot accurately reproduce the in vivo mechanical behaviour of the ACL .  
 
 
7.1.1. CONTRIBUTIONS TO KNOWLEDGE IN THE FIELD 
 
The gait analysis studies showed a novel method to evaluate the in vivo ACL 
length, tensile forces, strain and knee angles during 7 activities (climbing stairs, 
jumping with maximum effort, run, crossover cutting, sidestep cutting, walking and 
jumping with one leg), and allowed the comparison of those values between the 
Chapter 7. Discussion 
 
  285         
  
different activities. This was a significant advancement because, as was explained 
previously, the wide range of techniques available to determine those parameters and 
the limitations associated with the techniques, produced large variations in the results 
for the same activity; therefore, the comparison between activities with different 
calculation methods was invalid.  
 
Nowadays all ligament implants are solely mechanically characterized under 
tensile loading; however, this study indicated that ACL failure mechanisms are due 
to a combination of loads. Therefore, in order to mimic the mechanical behaviour of 
the ACL it is necessary to understand the performance under tensile, shear and 
torsional loading. This study is the first that emphasized the importance of 
multidirectional loading of the ACL to develop implants that can bear the accurate 
loading of the natural ACL. Therefore, to create more accurate biomimetic implants 
it is necessary to change the standard procedure for the design of this ligament. 
 
In this PhD, the manufactured ACL prototypes were not solely assessed 
under cyclic tensile loading but under cyclic shear loading and in dry and wet 
conditions, to ensure that the prototypes can bear the same loading and under the 
same conditions as the natural ACL.  
 
Two further improvements have been made compared to other gait studies in 
the field. The first improvement was related to the degrees of freedom of the knee 
model. Most of the studies considered the knee as a 1DOF joint [75], [76]; however, 
a 3DOF knee model was developed in this thesis. This model was able to determine 
the angles not only in the sagittal plane but also in the axial and coronal planes, 
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contributing to calculating the length of ligament more accurately. In certain studies 
[260] the location of the insertion points of the ACL, the scale of the model and 
therefore the measurement of the ACL length are incorrect. However, the 
configuration of the scale tool, the placement of the insertion points and the 
measurement of the ACL length have been meticulously studied in this project and 
the results verified from literature, as shown in Chapter 3.  
 
The 3DOF knee model developed in this study could help not only to design 
biomimetic ligament implants (since this model allows us to know the in vivo 
mechanical behaviour of the ACL and therefore the strain and forces during different 
tasks), but to prevent injury risks (since it calculates the in vivo ACL loading and can 
identify the activities with high risks of injury), improve rehabilitation protocols 
(recognising the activities or exercises that can strengthen certain muscles to enhance 
the stability of the knee without overloading the ACL), study graft insertion points in 
order to reduce failure rates (since the behaviour of the ACL graft against different 
locations of its insertion points can be studied with the model and the placement 
optimised), or design ligaments according to patient’s needs (since it was proved that 
age and gender affects the ACL loading, therefore requiring the ACL graft to bear 
different loads).  
 
The novelty of this study was the development of a methodology to calculate 
in vivo ACL length, strain and tensile forces during different dynamic activities, in 
order to be able to design and manufacture biomimetic ACL grafts. These grafts can 
replicate the in vivo mechanical behaviour and so bear the same loading as the 
natural ACL. This methodology is a great step forward in the field, since to date no 
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studies have been performed to create scaffolds that can mimic the in vivo loading 
and can bear the multi-planar loading of the natural ACL.  
 
 
7.1.2. LIMITATIONS 
 
Some limitations are linked to this methodology. The first limitation is the 
assumption of having 3 DOF per knee instead of 6 DOF. However, the translations 
of the knee joint in the model are negligible compared to the angles in the knee, 
therefore these displacements do not significantly affect the accuracy of the results. 
Moreover, the use of these 3DOF is easier and less time consuming than working 
with a 6DOF knee model and therefore more useful to study the in vivo mechanical 
behaviour of the ACL in other activities.   
 
The second limitation is associated with the fact that the ACL tensile forces 
were calculated from the ACL strain and this in turn was calculated by tracking the 
coordinates of the ACL insertion points and considering the ACL as a single straight 
bundle; however, it is known that the fibre bundles of the ACL are twisted and 
wrapped around the bones. This study evaluated the ACL length, strain and force for 
healthy ACLs with no issues of laxity in order to be able to mimic this behaviour in 
new grafts; therefore, the length for the twisted bundles of the ligament is negligible 
compared to the length between the insertion points of the ligament, moreover the 
final 3D structures created showed twisted bundles mimicking the nano and micro 
morphology of the natural ligament, consequently this assumption did not contribute 
significantly to the accuracy of the results.  
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The third limitation is related to the calculation of the unloaded length of the 
ACL. This value is unknown, since the only way to measure it is to remove the ACL 
from the participants of the study, and therefore it was calculated from well-
established reference lengths and strains [308]. In modelling, there are always some 
assumptions that are needed in order to achieve an outcome.  
 
 
 
7.2. SUITABILITY OF GELATIN ELECTROSPUN SCAFFOLDS IN THE 
DEVELOPMENT OF LIGAMENT IMPLANTS UNDER A 
MORPHOLOGICAL, TOPOGRAPHICAL AND MECHANICAL 
PERSPECTIVE 
 
 
Gelatin has been used for many applications such as pharmaceutical, 
biomedical or food packaging [304], [307]–[310], [312] due to its low cost, 
biodegradability, non-toxicity and biocompatibility. Moreover, gelatin is a natural 
polymer derivated from collagen; therefore, this polymer seems to be ideal to mimic 
the mechanical and biological properties of the collagen, the most abundant protein 
of the extracellular matrix of the soft tissue and specifically ligaments. 
 
Although this polymer is commonly used, it has shown three main 
disadvantages for the manufacturing of ligament implants through the 
electrospinning technique and its subsequent implantation in the body. The first 
disadvantage is the difficulty of working with electrospun aqueous gelatin solutions 
at room temperature [215], [266], due to the tendency of gelatin solutions to jell at 
temperature below 30ºC preventing the solution from flowing properly through the 
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needle. The second disadvantage is related to its high degradation rate; this polymer 
dissolves in biological medium in a few hours, complicating its biological 
characterization and use as an implant. The third disadvantage is its poor mechanical 
properties with low tensile stress and strain at break.   
 
However, all of these disadvantages can be addressed to enhance its use for 
tissue engineering applications. To date, no studies have focussed on the optimisation 
of process and solution parameters to face these problems and so produce gelatin 
electrospun scaffolds more comparable to the natural ACL. Currently, electrospun 
gelatin scaffolds have been developed for wound healing applications [282], [283], 
nerve [284]–[286], dental [287], bone [288]–[291] and skin tissue [292], [293], 
tendon [294] and vascular grafts [295]. However, no studies of electrospun gelatin 
scaffolds have been performed with the purpose of manufacturing ligament implants. 
Moreover, the electrospun gelatin scaffolds performed for tendon replacements did 
not reach the mechanical strength needed for their application and they were far from 
obtaining values comparable to those exhibited for the ACL.   
 
 
7.2.1. CONTRIBUTIONS TO KNOWLEDGE IN THE FIELD 
 
The aim of this work was to evaluate the suitability of gelatin electrospun 
scaffolds for use as ACL tissue engineered implants.   
 
This study has a  number of different novelties. The first novelty was the aim 
of the study itself, to evaluate the suitability of gelatin electrospun scaffolds for use 
as ACL replacements. This polymer has been studied for other applications but never 
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for ACL implants. The second novelty was to optimise the process and solution 
parameters to obtain a scaffold with the morphology, topography and mechanical 
properties more comparable to the native ACL, in order to create biomimetic ACL 
grafts. To that end, the study of how the solvent concentration affected the 
mechanical, morphological and topographical properties of the gelatin scaffolds was 
performed. The final novelty lay in the understanding of how the use of a 
crosslinking agent changes the morphology of the nanofibres and their network, and 
how this affects the suitability of this polymer to constitute ACL grafts.  
 
Moreover, the optimised scaffolds developed in this thesis demostrated 
mechanical properties significantly higher than the electrospun studies reported for 
tendon applications, demonstrating the importance of optimise in both solution and 
process parameters. As an example, the scaffolds created in this study (Chapter 4) 
reached maximum tensile strength of 4.6 MPa, however the maximum tensile 
strength, with the same polymer (gelatin), reported for tendon replacement was 1 
MPa [294].  
 
Another positive outcome from this study was that it showed that gelatin is 
not suitable to be used as the sole polymer for the manufacture of ACL implants even 
after being optimised. This finding increased knowledge of the mechanical 
limitations of gelatin and moves the field forward to investigate other alternative 
polymers for new ACL prototypes.   
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7.2.2. LIMITATIONS 
 
Gelatin electrospun scaffolds exhibited low mechanical properties. After the 
process and the solution parameters were optimised, a maximum average tensile 
strength of 4±1 MPa and 2 % of strain at break were recorded. Those values were 
significantly lower than native ACL that showed 38 MPa of maximum tensile 
strength and 44 % of strain at break.  
 
Moreover, the morphology and topography of gelatin scaffolds were modified 
after performing a degradation study, demonstrating that gelatin electrospun 
scaffolds are not stable enough to performe cell tests 
 
However, they allow better understanding of the mechanical behaviour and 
degradation process for use of gelatin in other possible applications and move the 
field forward to research another alternative polymer that can achieve the properties 
needed for consideration in the development of ACL replacements. 
  
 
 
7.3. SUITABILITY OF POLYVINYL ALCOHOL (PVA) IN THE 
MANUFACTURING OF ELECTROSPUN TISSUE ENGINEERED 
LIGAMENT IMPLANTS: MORPHOLOGICAL, TOPOGRAPHICAL AND 
MECHANICAL STUDY 
 
PVA is an expensive, biocompatible, hydrophilic, biodegradable and 
nontoxic polymer [65], [217]–[219]. Besides, this polymer is easily electrospinnable, 
able to be diluted in water and to produce nanofibres free of defects. All these 
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characteristics enable PVA to be used as a baseline for experiments with other 
materials. 
 
Previous studies have been performed to understand how the process and 
solution parameters affected the morphology of the scaffold [217], [218]; however, 
none of them studied how these factors influence the mechanical properties of the 
scaffolds, nor optimised these parameters to achieve the properties needed for an 
specific application. Chapter 5 studied the optimisation of solution and process 
parameters to create biomimetic ACL prototypes with morphology and mechanical 
behaviour comparable to the natural ACL; moreover, the degradation of the optimum 
scaffold was also evaluated.  
 
A number of studies demonstrated that crosslinked PVA hydrogels exhibited 
excellent biocompatibility [336], a water-swollen network similar to the extracellular 
matrix of the native ligament [65] and in combination with ultrahigh  molecular 
weight polyethylene (UHMWPE) can produce an appropriate mechanical 
performance comparable to the natural ACL [65]. However, its use as electrospun 
scaffolds and as a potential sole material for ligament implants still has to be proved 
mechanically and morphologically.  
 
 
7.3.1. CONTRIBUTIONS TO KNOWLEDGE IN THE FIELD 
 
Electrospinning is commonly known as a technique that produces scaffolds 
with low mechanical properties. However, this study proved that through optimising 
the process and solution parameters the production of implants with morphology and 
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mechanical properties comparable to the native soft tissue is possible. This is the first 
time that a progressive optimisation process has been performed for any electrospun 
polymer with the aim of achieving mechanical and morphological properties that 
mimics the desired biological tissue (i.e. ligaments). 
 
Chapter 5 studied and proved for the first time the suitability of PVA 
electrospun scaffolds to be used for the manufacture of ACL grafts, reporting 
excellent values of maximum tensile strength (30 ± 1 MPa) comparable to 38 MPa 
exhibited in the native ACL [48], and an unaltered topography after being exposed to 
25% GTA and left for 28 days of incubation in PBS. Moreover, the scaffolds showed 
values of fibre diameter between 120 and 140 nm comparable to the values of the 
collagen fibrils in the extracellular matrix. 
 
Therefore, this study demonstrated that PVA scaffolds exhibited excellent 
mechanical and morphological properties to be used for the manufacturing of ACL 
implants and they were the baseline to produce 3D structures, moving the field 
forward towards the goal of creating biomimetic ACL prototypes.  
 
 
7.3.2. LIMITATIONS 
 
The main limitation was not to have evaluated the scaffolds biologically. 
However, the history of good biocompatibility of PVA in biomedical applications 
such as wound healing, tissue engineered bone, skin or vascular tissue [65], [217]–
[219], [309], [318], [320], [323], [326], [327], [329], [330] and the fact that the 
scaffolds mimic the morphology of the extracellular matrix of the ACL, provide 
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good expectations about cell growth on the created scaffolds. As described in the 
future work section (section 7.5.), the cells proliferation and the capacity of cell to 
create extracellular matrix will be evaluated in further experiments. 
 
The other limitation of this study was the difficulty of measuring PVA 
electrospun fibres after the degradation study. Although the topography of the 
scaffolds was proved to be unmodified and the nanofibres maintained imitation of 
the extracellular matrix during the incubation time, the morphology of the scaffolds 
was difficult to characterize after being immersed in PBS. This phenomenon may be 
due to the fact that PVA is a high hydrophilic polymer that could keep the water 
inside the fibre network even after 24 hours of being dried in a fume hood and so 
complicating scaffold visualization with SEM. However, as was reported in Chapter 
5, 20 measurements (per sample) of fibre diameter were performed after 1 and 28 
days of being immersed in PBS, producing fibres diameter of 461 ± 4 nm and 453 ± 
3 nm respectively. These values showed a swelling of the nanofibres, however the 
cell behaviour would not be compromised, since previous studies reported excellent 
cell adhesion and proliferation with values of fibre diameter between 379.14±37 nm 
and 524±31 nm [324].  Moreover, to have water-swollen nanofibres network is not a 
limitation itself, given that similar behaviour was observed with the collagen of the 
extracellular matrix of the native ligament [65]. Moreover, it was widely reported 
that aspects such as cellular adhesion, movement or orientation, critical to develop 
ligament implants that require aligned fibroblasts along the scaffold, is significantly 
dependent on the type and size of the surface topography [379], and this remain 
similar after the degradation study. Further research must be done into increasing the 
incubation periods in order to evaluate the lifespan of the scaffold.   
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7.4. EVALUATION OF 2D AND 3D PVA STRUCTURES 
 
Currently 90% of ACL replacements are made from autografts [184]; 
however, this technique shows disadvantages such as muscle weakness at the donor 
site, graft site morbidity, knee pain, infection, loss of sensitivity due to nerve damage 
and long operation and rehabilitation time.  
 
Allografts and xenografts also exhibit drawbacks associated with the 
possibility of transmitting diseases and risk of immunogenic response, limitations in 
the availability of donor tissue and difficulties with the sterilization of the graft.  
 
Commercial synthetic ligament implants have the advantage of eliminating 
issues such as donor site morbidity, transfer of diseases and long operation times. 
However, implants such as Gore-Tex, Dacron or LARS have shown poor 
biocompatibility causing infection and synovitis and although they exhibit good 
mechanical behaviour in the short-term, they failed in the long-term due to an 
increase of the laxity, stiffness, mechanical failure and rerupture of the graft [25], 
[28]. 
 
Tissue engineered implants aim to eliminate all the disadvantageous 
characteristics of synthetic commercial grafts allowing cell growth on them, 
biodegrading the polymer at the same time as new ligamentous tissue is created and 
mimicking the mechanical properties of the natural ACL. 
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The idea of developing electrospun tissue engineered ligament implants lies 
in the possibility of reproducing the extracellular matrix through the electrospinning 
technique eliminating all issues caused by autografts, allografts, xenografts and 
current commercial ACL implants shown above.  
 
 
7.4.1. CONTRIBUTIONS TO KNOWLEDGE IN THE FIELD 
 
This study evaluated and compared for the first time 2D and multiple 3D 
electrospun structures with the goal of determining which structure reproduces more 
faithfully the functionality of the natural ACL in dry and wet environments and 
under tensile and shear loading.  
 
Some studies with individual twisted electrospun scaffolds have previously 
been performed [263], [347], [355], [380], however this study is the first that 
compares between different structures (2D structures, 3D structures such as 1 twisted 
filament, 3 twisted filaments and 3 twisted/braided filaments) under cyclic tensile 
and shear loading and in wet and dry environments.   
 
This study stablished the fundaments to evaluate the new implants under 
shear load, implementing a novel and easy methodology to test the scaffolds under 
these loading mechanisms. This novel methodology is a step forward for testing new 
implants and ligaments contributing to the design and evaluation of new ACL 
implants.   
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Moreover, neither 2D nor 3D PVA electrospun structures had been studied 
for ligament replacement previously, therefore the study of those structures was a 
novelty itself.   
 
Regarding the mechanical results obtained: 3 twisted/braided ligaments 
scaffolds in dry conditions exhibited a maximum tensile stress of 38 MPa identical to 
the native ACL [59] and a Young’s modulus of 129 MPa comparable to 111 MPa 
reported for the natural ACL [59]. Moreover, wet samples exhibited an elastic 
behaviour with a well-defined toe region comparable to the natural ACL and they did 
not show any laxity issues. 3 twisted/braided filaments scaffolds exhibited the 
highest mechanical properties under shear loading. Moreover, it was observed that 
more robust structures exhibited, more consistent mechanical properties than thinner 
structures, a finding not previously reported in the field.  
 
Analysing the morphology of the scaffolds: no significant differences were 
observed between the diameter of fibres, bundle of fibres and fascicles created and 
the diameter of collagen fibrils, bundle of fibres and fascicles of the natural ACL. 
Moreover, this study demonstrated that the nanofibres were not damaged in the 
manufacturing process and their diameter and alignment were not modified 
compared to the 2D electrospun scaffolds. 
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7.4.2. LIMITATIONS 
 
Electrospun PVA scaffolds showed excellent morphology and mechanical 
properties (Young’s modulus and maximum tensile stress) comparable to the native 
ACL and better than the other four comparable studies performed in the field [263], 
[347], [355], [380]. However, a plastic behaviour was observed in the scaffolds 
created, potentially causing laxity issues once the scaffold was implanted in the knee.   
 
Wet PVA scaffolds behaved elastically, they do not exhibit any laxity issues 
and all of them showed a well-defined toe region comparable to the natural ACL. 
However, the mechanical properties of wet samples are lower than in dry conditions. 
Part of these low results is due to the grip technique, since the clamp caused high 
stress concentrations near to the lower grip and all samples tested in a wet 
environment failed near to the clamp. Further investigation is needed to produce an 
improved gripping technique for elastic polymers to obtain more accurate and 
reproducible results. 
 
A great step forward in the field has been achieved in testing the electrospun 
scaffolds under tensile and shear loading; however to test the samples under torsion 
is extremely challenging and is beyond the scope of many facilities, for these reasons 
the scaffolds produced during this thesis were not tested under torsion. Future studies 
must address the in vivo shear and torsion of the ligament and develop techniques to 
test ligament implants under torsion, as was explained in the first study (Chapter 3), 
in that ACL failure mechanisms are likely due to a combination of multidirectional 
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loads. Therefore new ACL implants should be designed to bear different loading 
mechanisms, not solely tensile loading as currently happens. 
 
The last limitation is related to the manual fabrication technique. All samples 
were braided or twisted manually; therefore, they were not as homogeneous as they 
could be if they had been manufactured with automated braiding or twisting 
machines. However, 3D scaffolds showed a  standard deviation and standard error of 
the mean for Young’s modulus and maximum tensile strength significantly lower 
than 2D scaffolds, demonstrating that more robust samples (3D structures) exhibited 
more consistent and reproducible mechanical properties than 2D structures, and 
therefore the manual manufacturing technique contributed positively to the 
mechanical reproducibility of the scaffolds. 
 
The next section (section 7.2) will show the further work needed to create a 
tissue-engineered ACL graft suitable to be implanted.  
 
 
 
7.5. FUTURE PERSPECTIVES 
 
Further work must be performed before the tissue-engineered scaffolds 
developed in this thesis could move forward towards eventual clinical use. The most 
important future studies are presented below: 
 
a) From the biomechanical study, it was demonstrated that failure 
mechanisms are due to multidirectional loading. Therefore, the first step 
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would be to calculate the in vivo shear force and torsion of the ACL to be able 
to design ACL implants that could bear those values; this has not been 
investigated in the literature to date. Some initial calculations of the shear 
force have been performed following the expression: F = G*θ/S. Where G is 
the shear modulus (G = 45 MPa [346]), θ the abduction/adduction angle in 
radians and S the cross sectional area of the ligament (S = 29.2 mm2 [41]). 
Appling this equation to each participant and each activity, the following 
maximum shear force for men, women and the average between them were 
obtained (Figure 7.1). 
 
 
Figure 7.1 Maximum shear force for men, women and the average between them. 
 
 
 
Some calculations of the torsion were also performed following the 
expression: T = G*θ*J/L. Where T is the torque, G is the shear modulus (45 
MPa [346]), θ the rotation angle in radians, J polar moment of inertia (J = 
π*d4/32, with d = 6.1 mm diameter of the ACL) and L the length of the 
ligament. Applying this last equation to each participant and each activity, the 
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maximum torque in Nmm for women, men and the average between both 
while they were performing the different activities were obtained (Figure 
7.2). 
 
 
Figure 7.2 Maximum torsion for men, women and the average between them. 
 
 
 
Although some initial calculations have been done, a more accurate model 
should be developed based on finite elements analysis, since these initial 
estimations cannot faithfully simulate the mechanical behaviour for large 
deformations that any biological soft tissue exhibits.   
 
b) Once the mechanical specifications for shear and torsion are 
determined, the scaffolds must be tested under torsion to compare the results 
with the estimated values. The methodology to test the samples under shear 
has been explained in Chapter 6; however, how to test the samples under 
torsion has to be studied. This study will allow the design, manufacture and 
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testing of ACL implants with comparable mechanical properties to the natural 
ACL. 
 
c) The mechanical properties of wet PVA samples were lower than the 
mechanical properties of the ACL. Therefore, another polymer or a 
composition of several polymers must be studied to reach the same 
mechanical behaviour as the natural ACL in wet conditions. Moreover, all 
wet samples failed due to the high stress concentration caused by the clamps, 
therefore different gripping techniques for elastic polymers must be studied.  
 
d) Once the mechanical properties are achieved, biological 
characterization of the scaffold has to be performed, evaluating aspects such 
as cellular viability and morphology, cellular adhesion, cellular proliferation, 
the capacity of the seeded fibroblast to produce collagen and generate the new 
extracellular matrix, and cell migration. This step would be essential in the 
development of a future tissue engineered ACL implant. 
 
e) Aspects such as degradation rate, lifespan of the implant and 
behaviour under fatigue must also be considerated before any animal trails are 
performed. These topics have been initially studied during this thesis with 
degradation assays of 28 days and 10 tensile and shear loading cycles; 
however, a degradation assay longer than 28 days calculating the degradation 
rate and the evaluation of loading cycles until failure would be necessary to 
determine the life cycle of the scaffold and its suitability to be implanted. 
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f) Further studies will be focussed on the fixation of the implant in 
animal and subsequently human knees and their recovery process. These first 
steps would be necessary for its development: to perform a literature review 
of all fixation methods currently available with their advantages and 
disadvantages; study the healing process and how to promote osteosyntesis at 
the ligament enthesis; investigate the operative procedure for implantation; 
evaluate the use of sutures and the prevention of high stree concentrations; 
finally implant the graft in an animal model and test its mechanical and 
biological behaviour.    
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8. Conclusion 
 
The ACL presents the highest ligament injury rates in both recreational and 
professional athletes. Currently the gold standard for ACL reconstruction is using 
autografts; however this technique exhibits deficiencies such as muscle weakness at 
the donor site and graft site morbidity, therefore other alternatives must be studied.   
 
This PhD aims to produce proof of concept for the design and manufacture of 
3D electrospun prototypes with comparable mechanical properties and morphology 
to native ACL.  In order to achieve this goal a literature review was first done with a 
description of the ligament and current implants. An in vivo mechanical study of the 
ACL was then performed to obtain the mechanical specifications, necessary for the 
scaffold design. The next step was to assess the suitability of a biological and a 
synthetic polymer to be used as ACL replacements. Finally, once one of the 
polymers was determined to have potential for use as ligament implants, different 3D 
structures were evaluated to obtain a prototype with comparable morphological and 
mechanical properties to the natural ACL.   
 
From the biomechanical study, a novel methodology to calculate the in vivo 
ACL length and tensile forces during different dynamic activities was established. It 
was proved that significant differences between genders and ages exists, with the 
force experienced by the women’s ACL significantly higher compared to men’s and 
the ACL tensile force in aged people significantly higher compared to young people. 
Moreover, novel regression models for ACL lengths with respect to knee angles for 
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the different activities were calculated enabling prediction of the mechanical 
behaviour of the ligament. One of the most unexpected and relevant findings in this 
study was that peak tensile ACL force during cutting or running was lower than 
walking; this determined that failure mechanisms are due to multidirectional 
(including shear and torsion) loading instead of simply tensile loading. Therefore, 
future implants have to be designed and tested to bear multidirectional forces, not 
solely tensile loads as for current ACL implants. 
 
 
 
The electrospinning technique was selected to create the scaffolds for this 
thesis, due to this manufacturing process best mimicking the morphology of the 
extracellular matrix of soft tissue. Gelatin and PVA were studied for their great 
potential for manufacturing ligament implants, because both are inexpensive, 
nontoxic, biocompatible, biodegradable and easy to electrospin. Moreover, these 
polymers have never been investigated or used as electrospun structures for the 
manufacture of ligament implants. 
 
From the study of gelatin electrospun scaffolds, it was concluded that the 
solvents and their concentrations significantly affected the morphology, topography 
and mechanical behaviour of the scaffolds. Therefore, it is necessary to optimise the 
solution and process parameters to be able to replicate the morphology, topography 
and mechanical properties of the natural ACL. This step is essential and it is not 
reported in the literature related to development of tendon/ligament electrospun 
implants. The diameter of the fibres and inter-fibre separations increased when the 
solvent concentration increased and the roughness decreased when the concentration 
of DMSO increased. Once the solvent concentration was optimised, a maximum 
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average tensile strength of 4 ±1 MPa and 2 % of strain at break was recorded, these 
values being much lower than native ACL. Moreover, after performing a degradation 
study a modification of the original morphology of the scaffold was observed. 
Therefore, this study demonstrated that gelatin is not suitable to be used as the sole 
polymer for the manufacturing of ACL implants, which increases the knowledge of 
the mechanical limitations of gelatin and moves the field forward to investigate other 
alternative polymers for new ACL prototypes.  
 
 
The suitability of PVA electrospun scaffolds to be used as ACL implants was 
also assessed. This study was focussed on the optimisation of the process to 
manufacture scaffolds with morphology and mechanical strength comparable to the 
native ligament. Crosslinked scaffolds exhibited a maximum tensile strength of 30 ± 
1 MPa, a value very close to the maximum tensile strength of the native ACL 
(approx. 38 MPa). Moreover, scaffolds exposed to 25% GTA remained undegraded 
and with an intact topography after 28 days of incubation in PBS. Therefore, after 
having fully characterised the PVA scaffolds, it can be concluded that these scaffolds 
produced better behaviour than that previously investigated by the field demostrating 
comparable mechanical properties values as the values for the ACL. Therefore, it 
was shown that PVA electrospun scaffolds are suitable for the development of 
ligament implants and so could form the baseline to produce 3D structures.  
 
Finally, 2D and 3D electrospun scaffolds were studied to determine which 
structure was the most suitable for an ACL replacement. Only 4 researchers had 
previously focussed on 3D electrospun scaffolds; however, non of them compared 
multiple structures mechanically and morphologically and they were far from 
achieving mechanical properties comparable to the natural ACL. The results from 
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Chapter 6 revealed that the 3 twisted/braided filaments crosslinked structure 
provided a maximum tensile stress of 38 ± 3 MPa and a Young’s modulus after 10 
loading cycles of 148 ± 13 MPa in dry conditions. This was shown to be the structure 
with the mechanical properties closest to the natural ACL (38 MPa of maximum 
tensile stress and 111 MPa Young’s modulus). Wet PVA scaffolds exhibited an 
elastic mechanical behaviour with a well-defined toe region, as appears in the natural 
ACL. However, the maximum tensile stress and Young’s modulus after 10 loading 
cycles dropped to 9 ± 1 MPa and 24 ± 4 MPa respectively. Although these values are 
lower than values of the natural ACL, they are higher than the values reported by 
other researchers in the field. After shear tests, the 3 twisted/braided filaments 
crosslinked structure was found to exhibit the highest maximum shear stress, 
allowing the samples to bear higher shear loads than the other structures studied. Due 
to the lack of previous experiments to quantify this mechanical property, the 
selection of the 3D structure was based on the similarity of the shear modulus 
observed in each structure with the value in the natural ACL. The fact that the 
maximum shear strength and modulus were considered as a design parameter was 
unique in the field and necessary as was proved in Chapter 3. Analysing the 
morphology of the 3D scaffolds, it was demonstrated that the manufacturing process 
did not damage the nanofibres nor their nano-morphology and alignment. Moreover, 
the dimension of the PVA fibres, bundle of fibres and fascicles agreed with the 
diameters of the collagen fibrils, fibres and fascicles in the natural ligament. In 
conclusion and following the findings of this last study, it is recommended that the 3 
twisted/braided filaments scaffolds are the most suitable structure to be used as a 
replacement for the ACL.  
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This thesis demonstrated that to be able to design and develop ACL implants 
with mechanical and morphological properties comparable to the natural ACL, it is 
necessary to consider tensile and shear loading and optimise the solution and process 
parameters; this was novel and not reported in the literature of the field. Moreover, 
the suitability of produced electrospun prototypes with excellent mechanical and 
morphological properties comparable to the natural ACL was demonstrated. 3 
twisted/braided filaments scaffolds should be taken for further investigation with cell 
testing, animal models and finally clinical trials.   
 
Figure 8.1 summarizes the aim, novelties and conclusions of each study 
performed in this thesis. 
 
Figure 8.1 Aims, novelties and conclusions of each study performed in this thesis. 
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10. Appendix 
 
 
 
Chemical characterization of gelatin samples was performed through use of a 
Fourier Transform Infrared Spectrometer. The aim of characterizing the gelatin 
scaffolds was to observe any significant changes to the chemical bonds of the gelatin 
after being dissolved in different concentrations of Acetic Acid (HAc) and Dimethyl 
sulfoxide (DMSO). 
 
The results presented in Figures 10.1 and 10.2 show that the peaks for each 
concentration of solvent are coincident with the same wavenumber; therefore, the 
chemical structure of the polymer was not affected by the concentration of the 
solvent. 
    
 
 
 
Figure 10.1 Fourier Transform Infrared Spectrosmetry for gelatin samples with 25% HAc and 0%, 
5% and 10% DMSO. 
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Figure 10.2 Fourier Transform Infrared Spectrosmetry for gelatin samples with 10% DMSO and 
75%, 50% and 25% HAc. 
